
<html lang="en"     class="pb-page"  data-request-id="e6b8bd80-3036-4753-ae4c-e283a2a1ccd2"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-4;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c01677"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Facile Synthesis of Cyclic Peptide–Phthalocyanine Conjugates for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy" /></meta><meta name="dc.Creator" content="Jacky C. H.  Chu" /></meta><meta name="dc.Creator" content="Wing-Ping  Fong" /></meta><meta name="dc.Creator" content="Clarence T. T.  Wong" /></meta><meta name="dc.Creator" content="Dennis K. P.  Ng" /></meta><meta name="dc.Description" content="A facile procedure for in situ peptide cyclization and phthalocyanine conjugation was developed by utilizing a bifunctional linker incorporated with a bis(bromomethyl)benzene unit and a cyclopentad..." /></meta><meta name="Description" content="A facile procedure for in situ peptide cyclization and phthalocyanine conjugation was developed by utilizing a bifunctional linker incorporated with a bis(bromomethyl)benzene unit and a cyclopentad..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 12, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01677" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01677" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01677" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01677" /></link>
        
    
    

<title>Facile Synthesis of Cyclic Peptide–Phthalocyanine Conjugates for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01677" /></meta><meta property="og:title" content="Facile Synthesis of Cyclic Peptide–Phthalocyanine Conjugates for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0013.jpeg" /></meta><meta property="og:description" content="A facile procedure for in situ peptide cyclization and phthalocyanine conjugation was developed by utilizing a bifunctional linker incorporated with a bis(bromomethyl)benzene unit and a cyclopentadiene moiety. These functional groups facilitated the nucleophilic substitution with the two cysteine residues of the linear peptides followed by the Diels–Alder reaction with the maleimide moiety attached to a zinc(II) phthalocyanine. With this approach, three cyclic peptide–phthalocyanine conjugates were prepared in 20–26% isolated yield via a one-pot procedure. One of the conjugates containing a cyclic form of the epidermal growth factor receptor (EGFR)-binding peptide sequence CMYIEALDKYAC displayed superior features as an advanced photosensitizer. It showed preferential uptake by two EGFR-positive cancer cell lines (HT29 and HCT116) compared with two EGFR-negative counterparts (HeLa and HEK293), resulting in significantly higher photocytotoxicity. Intravenous administration of this conjugate into HT29 tumor-bearing nude mice resulted in selective localization in tumor and effective inhibition of tumor growth upon photodynamic treatment." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01677"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01677">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01677&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01677&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01677&amp;href=/doi/10.1021/acs.jmedchem.0c01677" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 2064-2076</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01570" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01717" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Facile Synthesis of Cyclic Peptide–Phthalocyanine Conjugates for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jacky C. H. Chu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jacky C. H. Chu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jacky+C.+H.++Chu">Jacky C. H. Chu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wing-Ping Fong</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wing-Ping Fong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Life Sciences, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wing-Ping++Fong">Wing-Ping Fong</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0468-9883" title="Orcid link">http://orcid.org/0000-0002-0468-9883</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Clarence T. T. Wong</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Clarence T. T. Wong</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#a9cac5c8dbccc7cacc84dddd87dec6c7cee9d9c6c5d0dc87cccddc87c1c2"><span class="__cf_email__" data-cfemail="187b74796a7d767b7d356c6c366f77767f58687774616d367d7c6d367073">[email protected]</span></a>. Phone: (+852) 34008674.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Clarence+T.+T.++Wong">Clarence T. T. Wong</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Dennis K. P. Ng</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dennis K. P. Ng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#75111e051b3516001d1e5b1011005b1d1e"><span class="__cf_email__" data-cfemail="096d627967496a7c6162276c6d7c276162">[email protected]</span></a>. Phone: (+852) 39436375. Fax: (+852) 26035057.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+K.+P.++Ng">Dennis K. P. Ng</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9087-960X" title="Orcid link">http://orcid.org/0000-0001-9087-960X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01677&amp;href=/doi/10.1021%2Facs.jmedchem.0c01677" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 2064–2076</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 12, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>24 September 2020</li><li><span class="item_label"><b>Published</b> online</span>12 February 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 February 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01677" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01677</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2064%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJacky%2BC.%2BH.%2BChu%252C%2BWing-Ping%2BFong%252C%2BClarence%2BT.%2BT.%2BWong%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D4%26contentID%3Dacs.jmedchem.0c01677%26title%3DFacile%2BSynthesis%2Bof%2BCyclic%2BPeptide%25E2%2580%2593Phthalocyanine%2BConjugates%2Bfor%2BEpidermal%2BGrowth%2BFactor%2BReceptor-Targeted%2BPhotodynamic%2BTherapy%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2076%26publicationDate%3DFebruary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01677"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1094</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01677" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Facile Synthesis of Cyclic Peptide–Phthalocyanine Conjugates for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jacky&quot;,&quot;last_name&quot;:&quot;C. H. Chu&quot;},{&quot;first_name&quot;:&quot;Wing-Ping&quot;,&quot;last_name&quot;:&quot;Fong&quot;},{&quot;first_name&quot;:&quot;Clarence&quot;,&quot;last_name&quot;:&quot;T. T. Wong&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;K. P. Ng&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;2064-2076&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01677&quot;},&quot;abstract&quot;:&quot;A facile procedure for in situ peptide cyclization and phthalocyanine conjugation was developed by utilizing a bifunctional linker incorporated with a bis(bromomethyl)benzene unit and a cyclopentadiene moiety. These functional groups facilitated the nucleophilic substitution with the two cysteine residues of the linear peptides followed by the Diels–Alder reaction with the maleimide moiety attached to a zinc(II) phthalocyanine. With this approach, three cyclic peptide–phthalocyanine conjugates were prepared in 20–26% isolated yield via a one-pot procedure. One of the conjugates containing a cyclic form of the epidermal growth factor receptor (EGFR)-binding peptide sequence CMYIEALDKYAC displayed superior features as an advanced photosensitizer. It showed preferential uptake by two EGFR-positive cancer cell lines (HT29 and HCT116) compared with two EGFR-negative counterparts (HeLa and HEK293), resulting in significantly higher photocytotoxicity. Intravenous administration of this conjugate into HT29 tumor-bear&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01677&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01677" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01677&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01677" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01677&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01677" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01677&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01677&amp;href=/doi/10.1021/acs.jmedchem.0c01677" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01677" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01677" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01677%26sid%3Dliteratum%253Aachs%26pmid%3D33577327%26genre%3Darticle%26aulast%3DChu%26date%3D2021%26atitle%3DFacile%2BSynthesis%2Bof%2BCyclic%2BPeptide%25E2%2580%2593Phthalocyanine%2BConjugates%2Bfor%2BEpidermal%2BGrowth%2BFactor%2BReceptor-Targeted%2BPhotodynamic%2BTherapy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D4%26spage%3D2064%26epage%3D2076%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291912" title="Fluorescence">Fluorescence</a>,</li><li><a href="/action/doSearch?ConceptID=291240" title="Cyclization">Cyclization</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/jmcmar.2021.64.issue-4/20210225/jmcmar.2021.64.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A facile procedure for in situ peptide cyclization and phthalocyanine conjugation was developed by utilizing a bifunctional linker incorporated with a bis(bromomethyl)benzene unit and a cyclopentadiene moiety. These functional groups facilitated the nucleophilic substitution with the two cysteine residues of the linear peptides followed by the Diels–Alder reaction with the maleimide moiety attached to a zinc(II) phthalocyanine. With this approach, three cyclic peptide–phthalocyanine conjugates were prepared in 20–26% isolated yield via a one-pot procedure. One of the conjugates containing a cyclic form of the epidermal growth factor receptor (EGFR)-binding peptide sequence CMYIEALDKYAC displayed superior features as an advanced photosensitizer. It showed preferential uptake by two EGFR-positive cancer cell lines (HT29 and HCT116) compared with two EGFR-negative counterparts (HeLa and HEK293), resulting in significantly higher photocytotoxicity. Intravenous administration of this conjugate into HT29 tumor-bearing nude mice resulted in selective localization in tumor and effective inhibition of tumor growth upon photodynamic treatment.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07457" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07457" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Photodynamic therapy (PDT) has emerged as a promising anticancer modality.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> It utilizes light with an appropriate wavelength to excite a light-sensitive drug localized in tumor to generate cytotoxic reactive oxygen species (ROS) through the interactions with molecular oxygen. Owing to the presence of various potential advantages, such as a convenient and noninvasive treatment procedure, without the problem of drug resistance, and few side effects, PDT has received growing attention in the medical community, and there has been considerable interest in the development of advanced photosensitizing systems with a view to improving the therapeutic outcome.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7">(4−7)</a> To date, a handful of photosensitizers have been clinically used or under clinical trials for oncological indications, which are mainly based on porphyrins, chlorins, and phthalocyanines.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">One of the major challenges in PDT is the low tumor specificity of the photosensitizers, which inevitably would cause undesired photodamage on normal cells and tissues. In addition, the limited water solubility and strong aggregation tendency of common tetrapyrrole-based photosensitizers would also reduce their ROS generation efficiency. To address these issues, photosensitizers can be conjugated with biomolecules, such as antibodies, proteins, peptides, and monosaccharides that can bind specifically with the corresponding cancer-associated biomarkers.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> Among these tumor-targeting ligands, peptides are particularly attractive owing to their ease of chemical modification, high biocompatibility, low immunogenicity, and high tissue permeability.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10−13)</a> Using the phage display library, a number of peptide sequences which can bind specifically with various tumor-associated receptors have been identified.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> Being an important target of cancer therapy, epidermal growth factor receptor (EGFR) is a transmembrane receptor overexpressed in a range of cancer cells.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> A number of EGFR-targeting peptides, including LARLLT,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> QRH*,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and GE11,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> have been conjugated with phthalocyanine-based photosensitizers with a view to enhancing their tumor-localization property. However, the low stability of the linear peptides used toward enzymatic proteolysis in serum may affect the pharmacokinetics and bioavailability and eventually the therapeutic efficacy.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">To circumvent this problem, cyclization of these peptide sequences could enhance the metabolic stability. In general, cyclic peptides have higher proteolytic stability than the linear counterparts.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Their macrocyclic and rigid architecture could also enhance the bioactivity and binding specificity because of the smaller number of possible conformations to dock onto the corresponding protein targets.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> As a result, cyclic peptides have been widely used as potent and specific inhibitors against proteins and ligands toward tumor-associated receptors.<a onclick="showRef(event, 'ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27">(25−27)</a></div><div class="NLM_p last">A conventional peptide cyclization method involves the activation of the <i>C</i>-terminus to condense with the <i>N</i>-terminus of a fully protected peptide via direct amide coupling, followed by the global deprotection.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> However, this method needs to overcome the disfavored entropy during the cyclization process and the reaction conditions need to be optimized to avoid epimerization and polymerization. Macrocyclization of long peptides involving more than 15 amino acids cannot proceed readily because of their preferred extended conformation arising from the more stable all-<i>trans</i> configuration of amide bonds.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In addition to the direct coupling, other methods such as lactamization, azide–alkyne cycloaddition, and ring-closing metathesis have also been used in peptide cyclization.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30−32)</a> These methods, however, have inherent limitations, such as the use of unnatural amino acids or metal catalysts and the need of stringent reaction conditions. Recently, Heinis et al. reported an efficient peptide cyclization methodology which involves dibenzylation of the sulfhydryl groups of two cysteine residues in a linear peptide with a bis(bromomethyl)benzene moiety.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> This methodology does not require prior protection of the amino acids and can proceed smoothly under a mild basic condition (pH 7–9). Using this synthetic strategy, we have recently synthesized an antimicrobial cyclic peptide–phthalocyanine conjugate for antimicrobial PDT.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> We report herein an extension of this methodology to prepare a series of phthalocyanine-based photosensitizers conjugated with a cyclic peptide that can potentially bind to human colorectal carcinoma cells with a view to developing selective theranostic agents for bioimaging and photodynamic treatment of colon cancer, which is one of the most common malignancies worldwide.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> One of these conjugates was found to exhibit strong binding affinity toward EGFR overexpressed in colorectal carcinoma cells, resulting in high and selective in vitro and in vivo theranostic efficacy.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12738" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12738" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Molecular Design and Synthesis</h3><div class="NLM_p">This one-pot synthetic strategy involves the use of a linear peptide with two cysteine residues, which undergoes site-selective nucleophilic substitution with the bis(bromomethyl)benzene unit of a linker appended with a cyclopentadiene moiety at the other terminus that can further conjugate with a maleimide-functionalized zinc(II) phthalocyanine via the Diels–Alder reaction (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Compared with the conventional cyclization and conjugation methods, this one-pot strategy could prepare cyclic peptide–phthalocyanine conjugates readily using fully unprotected peptide precursors under mild reaction conditions. For the peptide component, three peptide sequences that are potential ligands for human colorectal carcinoma cells were selected, including H<sub>2</sub>N-CPIEDRPMC-CONH<sub>2</sub> (labeled RPM), which was reported to show high affinity toward poorly differentiated colon carcinoma cells,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> AcNH-CTPSPFSHC-CONH<sub>2</sub> (labeled TCP-1), which was found to localize in the metabolically active part of colon tumor and the neighboring blood vessels,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and H<sub>2</sub>N-CMYIEALDKYAC-CONH<sub>2</sub> (labeled EBP), which could target EGFR-overexpressed colon carcinoma cells.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> They were prepared manually according to our previously described procedure.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The bifunctional linker <b>1</b> was prepared by treating 1,3,5-tris(bromomethyl)benzene with one equiv of sodium cyclopentadienylide. For the photosensitizer part, a zinc(II) phthalocyanine core was used due to its superior photophysical properties and high photostability.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> To facilitate the coupling through the cyclopentadiene moiety of the linker, a maleimide unit was introduced to the phthalocyanine. With an electron-deficient and sterically unhindered π system, maleimide serves as an excellent dienophile.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Compared to furan and 2,4-hexadiene derivatives, maleimide has a much higher reactivity toward cyclopentadiene and the resulting endo cycloadduct also has a higher thermal stability which does not undergo the retro-Diels–Alder reaction below 275 °C.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Moreover, the Diels–Alder cycloadducts are generally more stable in serum than the maleimide–thiol conjugates formed via Michael addition.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The target maleimide-substituted phthalocyanine <b>2</b> was synthesized according to our previously described procedure.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. One-pot synthesis of cyclic peptide–phthalocyanine conjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The conditions of peptide cyclization were first optimized for the reaction of EBP and 1,3-bis(bromomethyl)benzene. Various peptide concentrations and solvent systems were used, and the yield of the product was determined by reversed-phase high-performance liquid chromatography (HPLC). As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figure S1</a> in the Supporting Information and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, the use of a mixture of <i>N</i>,<i>N</i>-dimethylformamide (DMF) and NH<sub>4</sub>HCO<sub>3</sub> buffer (pH 8.0) (1:1 v/v) as a solvent could lead to the formation of cyclic peptide <b>3</b> in 74 and 55% HPLC yield after 2 h when a peptide concentration of 0.5 and 1 mM was used, respectively. Some side products were also formed in this reaction. It seems that a lower concentration of peptide could favor the cyclization process. By changing the solvent to DMF/borate buffer (pH 10.0) (1:1 v/v), the reaction proceeded smoothly, and the yield of the product was essentially quantitative regardless of the peptide concentration, showing that the buffer could largely affect the cyclization process. It is likely that as the p<i>K</i><sub>a</sub> of cysteine is 8.3, the use of a buffer at higher pH (10.0 vs 8.0) can promote the deprotonation process, favoring the formation of more nucleophilic thiolate anions for the dialkylation. The cyclic peptide <b>3</b> was purified by HPLC and characterized with matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figure S2</a> in the Supporting Information).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Screening of the Reaction Conditions for the Cyclization of EBP</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0012.gif" alt="" id="GRAPHIC-d7e361-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center" char=".">[EBP] (mM)</th><th class="colsep0 rowsep0" align="center">solvent</th><th class="colsep0 rowsep0" align="center">yield<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left">DMF/NH<sub>4</sub>HCO<sub>3</sub> buffer (pH 8.0) (1:1 v/v)</td><td class="colsep0 rowsep0" align="left">74%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="left">DMF/NH<sub>4</sub>HCO<sub>3</sub> buffer (pH 8.0) (1:1 v/v)</td><td class="colsep0 rowsep0" align="left">55%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left">DMF/borate buffer (pH 10.0) (1:1 v/v)</td><td class="colsep0 rowsep0" align="left">quantitative</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="left">DMF/borate buffer (pH 10.0) (1:1 v/v)</td><td class="colsep0 rowsep0" align="left">quantitative</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Determined by HPLC.</p></div></div></div><div class="NLM_p">The optimized conditions were then used to perform the one-pot cyclization of all the three linear peptides mentioned above with the bifunctional linker <b>1</b>, followed by conjugation with the maleimide-functionalized phthalocyanine <b>2</b>. The course of the formation of the resulting conjugates was monitored by HPLC. <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> shows the results for the reaction of EBP given for illustration. First, the linear peptide EBP (1 mM) was treated with <b>1</b> (1 mM) in a mixture of DMF and borate buffer (pH 10.0) (1:1 v/v). After stirring at room temperature for 2 h, the reaction was essentially completed as shown by the disappearance of the signals due to the two starting materials and the occurrence of a strong signal assignable to the cyclopentadiene-functionalized cyclic peptide <b>4</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>c), which was characterized with MALDI-TOF mass spectrometry (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figure S3</a> in the Supporting Information). Without isolating the intermediate product, <b>2</b> (2 mM) was added and the resulting mixture was stirred continuously overnight. The target conjugate <b>5</b> formed via the Diels–Alder reaction was obtained in 95% HPLC yield (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>e). The conjugate could be purified readily by HPLC and was characterized with MALDI-TOF mass spectrometry (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figure S4</a> in the Supporting Information). Through this one-pot procedure, the conjugate was obtained in 26% isolated yield. The other two conjugates <b>6</b> and <b>7</b> were also prepared by the same protocol using the linear peptides RPM and TCP-1, respectively, as the starting materials (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The results were similar to those for the preparation of <b>5</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figures S5 and S6</a> in the Supporting Information and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). All the intermediate and final products were also characterized using MALDI-TOF mass spectrometry (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figures S7–S10</a> in the Supporting Information). It is worth noting that these in situ cyclization and conjugation processes do not require prior protection of the amino acids and the use of any metal catalysts and coupling reagents. This synthetic strategy also has the advantages of high efficiency, clean transformation, and ease of operation. It is envisaged that this methodology can be extended further for the preparation of other cyclic peptide–theranostic agent conjugates for various biomedical applications.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Monitoring the course of the formation of <b>5</b> using HPLC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Molecular structures of conjugates <b>6</b> and <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. One-Pot Preparation of Cyclic Peptide-Conjugated Zinc(II) Phthalocyanines</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">peptide</th><th class="colsep0 rowsep0" align="center">product</th><th class="colsep0 rowsep0" align="center" char=".">HPLC yield (%)</th><th class="colsep0 rowsep0" align="center" char=".">isolated yield (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">EBP</td><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">RPM</td><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">81</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">TCP-1</td><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr></tbody></table></div></div><div class="NLM_p last">It is worth mentioning that the peptide cyclization process was susceptible to the solvent and should better be carried out in a mixture of DMF and borate buffer (pH 10.0) (1:1 v/v). If the bifunctional linker <b>1</b> is coupled with phthalocyanine <b>2</b> first, the resulting conjugate would not be able to dissolve in this solvent system, and solvents with a higher organic solvent content would be required that would affect the reaction yield. Hence, this methodology was designed as a one-pot stepwise process with peptide cyclization occurring prior to coupling with photosensitizers. This stepwise strategy using the bifunctional linker <b>1</b> also provides a high flexibility for the preparation of other cyclic peptide-conjugated theranostic agents.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Electronic Absorption and Photophysical Properties</h3><div class="NLM_p">Electronic absorption spectra of <b>5</b> and <b>2</b> were first measured in DMF. The latter was used as a reference compound for comparison. Both compounds showed an intense and sharp Q band at 688 nm, which strictly followed the Lambert–Beer’s law (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">S11</a> in the Supporting Information), reflecting their nonaggregated nature. Upon excitation at 610 nm, both compounds exhibited a fluorescence band at 700 nm with a fluorescence quantum yield (Φ<sub>F</sub>) of 0.19 (for <b>5</b>) or 0.21 (for <b>2</b>) relative to the unsubstituted zinc(II) phthalocyanine (ZnPc) (Φ<sub>F</sub> = 0.28 in DMF) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The singlet oxygen quantum yields (Φ<sub>Δ</sub>) of these compounds were also determined in DMF using 1,3-diphenylisobenzofuran (DPBF) as a singlet oxygen probe. The absorbance of DPBF at 415 nm was monitored spectroscopically along with the irradiation time. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figure S12a</a> in the Supporting Information, both compounds could consume DPBF via the singlet oxygen generated, forming 1,2-dibenzoylbenzene via an unstable peroxide intermediate.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The values of Φ<sub>Δ</sub> were found to be 0.59 and 0.60 for <b>5</b> and <b>2</b>, respectively, relative to ZnPc (Φ<sub>Δ</sub> = 0.56 in DMF).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The results showed that the cyclic peptide moiety did not significantly affect these properties of the phthalocyanine core. The relatively red-shifted Q band, lower fluorescence quantum yield, and higher singlet oxygen generation efficiency are the general features of 1,4-disubstituted zinc(II) phthalocyanines compared with the other substituted analogues.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> These data of <b>5</b> and <b>2</b> are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Electronic absorption and (b) fluorescence (excited at 610 nm) spectra of <b>5</b> and <b>2</b> (both at 2 μM) in DMF and PBS with Tween 80 (0.1% v/v).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Electronic Absorption and Photophysical Properties of <b>5</b> and <b>2</b> in DMF</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">λ<sub>abs</sub> (nm) (log ε)</th><th class="colsep0 rowsep0" align="center" char=".">λ<sub>em</sub> (nm)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Φ<sub>F</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">Φ<sub>Δ</sub><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">340 (4.74), 621 (4.55), 688 (5.30)</td><td class="colsep0 rowsep0" align="char" char=".">700</td><td class="colsep0 rowsep0" align="char" char=".">0.19</td><td class="colsep0 rowsep0" align="char" char=".">0.59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">340 (4.73), 621 (4.54), 688 (5.30)</td><td class="colsep0 rowsep0" align="char" char=".">700</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char=".">0.60</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Excited at 610 nm.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Using ZnPc as the reference (Φ<sub>F</sub> = 0.28 in DMF).</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Using ZnPc as the reference (Φ<sub>Δ</sub> = 0.56 in DMF).</p></div></div></div><div class="NLM_p last">The same properties of these two compounds were also measured in phosphate-buffered saline (PBS) at pH 7.4 with Tween 80 (0.1% v/v) used to enhance the water solubility of the compounds and reduce their aggregation in aqueous media. As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a,b, the Q band was slightly broadened and the fluorescence emission was also significantly weaker than those recorded in DMF for both compounds, which could be attributed to their higher aggregation tendency in this aqueous medium. Nevertheless, both compounds could sensitize the formation of singlet oxygen upon light irradiation with comparable efficiency as that of ZnPc (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figure S12b</a> in the Supporting Information). In the presence of bovine serum albumin (BSA) (2 μM), both <b>5</b> and <b>2</b> became highly aggregated as shown by the very broad Q band, vanished fluorescence emission, and negligible singlet oxygen formation (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figure S13</a> in the Supporting Information). Even in the presence of the cyclic EBP peptide in <b>5</b>, the aggregation characteristic was not significantly changed.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Stability in Serum</h3><div class="NLM_p">The stability of <b>5</b> in serum was examined by treating it with fetal bovine serum (FBS) (20% v/v) in Dulbecco’s modified Eagle medium (DMEM) and compared with that of the linear peptide EBP. <a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figure S14a</a> in the Supporting Information shows the HPLC chromatograms of the mixtures at different time points over 2 h. It was found that the cyclic peptide conjugate <b>5</b> remained intact, while the linear counterpart EBP was degraded significantly during this period of time. Attempts were made to isolate and characterize the two major degradation products of linear EBP by electrospray ionization (ESI) mass spectrometry. Although intense signals due to the diprotonated molecular ions were observed (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figure S14b</a> in the Supporting Information), we were not able to identify the species. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, which summarizes the results for both peptides, the half-life was less than 20 min for EBP. This study clearly demonstrated that the cyclization of the peptide could enhance its proteolytic stability.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Relative percentages of <b>5</b> and EBP in DMEM with FBS (20% v/v) at different time points as determined by integrating the peak areas in the HPLC chromatograms. Data are expressed as the mean value ± standard deviation (SD) of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Cellular Uptake</h3><div class="NLM_p">To examine the tumor-targeting effect of the cyclic EBP peptide moiety, the cellular uptake of <b>5</b> was studied using confocal microscopy and flow cytometry against a range of cancer cell lines with different expression levels of EGFR, including the EGFR-overexpressed HT29 human colorectal adenocarcinoma cells<a onclick="showRef(event, 'ref18 ref19 ref44'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref44">(18,19,44)</a> and HCT116 human colorectal carcinoma cells,<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> as well as the low EGFR-expressed HeLa human cervical carcinoma cells<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> and HEK293 human embryonic kidney normal cells.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Again, the peptide-free phthalocyanine <b>2</b> was used as the negative control. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a, after incubation with <b>5</b> for 2 h, the two EGFR-positive HT29 and HCT116 cell lines showed significantly stronger intracellular fluorescence compared with the EGFR-negative HeLa and HEK293 cells. In contrast, the intracellular fluorescence intensities remained moderate for all the four cell lines with no significant difference after incubation with <b>2</b>. <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>b shows the quantified fluorescence intensities determined by flow cytometry under these conditions. It can be seen that the fluorescence intensities of <b>5</b> in the two colorectal cell lines were substantially higher than those in the other two cell lines. The intensity in HT29 cells was about 25-fold and 8-fold higher than that in HeLa and HEK293 cells, respectively. No significant difference was observed for <b>2</b>. The results clearly demonstrated the EGFR-targeting effect of the cyclic EBP peptide. It is worth noting that the EGFR-binding affinity of <b>5</b> was higher than that of the previously reported linear EBP–doxorubicin conjugate for which an approximately 5-fold difference in cellular uptake between the EGFR-positive and EGFR-negative cells was observed.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The stronger EGFR-binding affinity arising from the cyclic EBP peptide compared to the linear counterpart is in accordance with the relative specificity of other tumor-targeting peptides, such as the RGD sequence.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Bright-field, fluorescence, and the merged images of HT29, HCT116, HeLa, and HEK293 cells after incubation with <b>5</b> or <b>2</b> (both at 2 μM) for 2 h. (b) Fluorescence intensity profiles of the four cell lines after incubation with <b>5</b> or <b>2</b> (both at 2 μM) for 2 h and the corresponding mean intracellular fluorescence intensities as determined by flow cytometry. (c) Fluorescence intensity profiles of HT29 cells after preincubation with <b>3</b> (100 or 400 μM) for 30 min at 37 °C, followed by coincubation with <b>5</b> (2 μM) for further 2 h and the corresponding mean intracellular fluorescence intensities as determined by flow cytometry. Data are expressed as the mean value ± standard error of the mean (SEM) of three independent experiments. **<i>p</i> < 0.01 and ***<i>p</i> < 0.001 as calculated by the Student’s <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further reveal the role of the cyclic EBP peptide, a competition assay using the nonphthalocyanine-conjugated <b>3</b> as a competitor was performed. HT29 cells were incubated with different concentrations of this cyclic peptide (100 and 400 μM) for 30 min at 37 °C, and then, <b>5</b> (2 μM) was added for coincubation for further 2 h. The intracellular fluorescence intensity was then determined by flow cytometry. As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>c, the intensity decreased significantly when the concentration of <b>3</b> increased, suggesting that the internalization of the conjugate was mediated by the cyclic peptide moiety.</div><div class="NLM_p last">The cellular uptake of the other two cyclic peptide–phthalocyanine conjugates was also examined using flow cytometry. For <b>6</b>, as it was reported that the disulfide-constrained RPM sequence can distinguish HT29 cells from HCT116 cells by immunohistochemical assays,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> these two cell lines were used for this study. However, it was found that after incubation with <b>6</b> for 2 h, the intracellular fluorescence intensity for HT29 cells was only slightly higher than that for HCT116 cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figure S15</a> in the Supporting Information). The cell selectivity for this conjugate seems to be lower than that for the disulfide-constrained counterpart. The uptake behavior of <b>7</b> was similar to that of <b>5</b>. As shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figure S16</a> in the Supporting Information, the intracellular fluorescence intensity was also higher for HT29 and HCT116 cells compared with HeLa and HEK293 cells, but the difference (ca. 2–6-fold) was smaller than that observed for <b>5</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>b). All these results suggested that <b>5</b> exhibited the highest selectivity toward the two colorectal cell lines through binding with the overexpressed EGFR. Therefore, this conjugate was selected for further in vitro and in vivo studies.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Subcellular Localization</h3><div class="NLM_p">The subcellular localization of <b>5</b> was further examined with confocal microscopy. After incubation with <b>5</b> (2 μM) for 2 h, the HT29 cells were stained with LysoTracker Green DND-26 (2 μM), MitoTracker Green FM (0.2 μM), or ER-Tracker Green (1 μM) for 30, 15, or 15 min, respectively. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, the fluorescence image and intensity profile for <b>5</b> could overlap well with those for LysoTracker but not for the other two trackers. These results suggested that <b>5</b> tended to reside in the lysosomes, which are the last compartments of the endocytic pathway of receptor-mediated endocytosis.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Visualization of the intracellular fluorescence of <b>5</b> and various subcellular trackers in HT29 cells. The corresponding bright-field and merged images are given in column 1 and 4, respectively. The figures on the right show the fluorescence intensity profiles of <b>5</b> and the different trackers traced along the lines in the corresponding images on the left.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vitro Photodynamic Activities</h3><div class="NLM_p">The dark and phototoxicities of <b>5</b> against all the four cell lines were also investigated using an MTT assay [MTT = 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, <b>5</b> did not show significant dark cytotoxicity toward all these cell lines up to 60 nM. However, upon irradiation (λ > 610 nm, 23 mW cm<sup>–2</sup>, 28 J cm<sup>–2</sup>), a substantial cytotoxicity was observed for the EGFR-positive HT29 and HCT116 cells with an IC<sub>50</sub> value of 6 and 8 nM, respectively. The photocytotoxicity was much higher than that of the analogues with a linear EGFR-targeting QRH* or GE11 sequence of which the IC<sub>50</sub> values for EGFR-positive cell lines were found to be 0.23 μM (for HT29 cells) and 14 μM (for A431 cells), respectively.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> It is believed that the cyclic form of EBP plays an important role in selective binding with the EGFR, and the high potency of <b>5</b> can be attributed to its high cellular uptake toward the HT29 and HCT116 cells. In contrast, for the EGFR-negative HeLa and HEK293 cells, the cell viability remained nearly unchanged even upon light irradiation, showing that <b>5</b> was essentially nontoxic to these cells within this concentration range. The remarkable difference in photocytotoxicity against the EGFR-positive and EGFR-negative cells clearly demonstrated the targeting role of the cyclic EBP moiety in the conjugate, making it a very potent and cell-selective photosensitizer.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Cell viability of <b>5</b> on HT29, HCT116, HeLa, and HEK293 cells after drug incubation for 2 h in the (a) absence or (b) presence of light irradiation (λ > 610 nm, 23 mW cm<sup>–2</sup>, 28 J cm<sup>–2</sup>). Data are expressed as the mean value ± SEM of three independent experiments, each performed in quadruplicate. ***<i>p</i> < 0.001 as calculated by the Student’s <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vivo Biodistribution</h3><div class="NLM_p">To further explore the in vivo targeting property of <b>5</b>, the biodistribution of this conjugate in HT29 tumor-bearing nude mice was monitored over a period of 24 h. The nonpeptide-conjugated <b>2</b> was used as the negative control. As shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>a, shortly after the intravenous injection, both compounds were distributed throughout the whole body. After the metabolic clearance, the fluorescence of <b>5</b> was still observed at the tumor region at 24 h postinjection, but the fluorescence intensity of <b>2</b> at the tumor remained very weak over this period of time. The mice were then euthanized after 24 h, and the tumor and major organs, including the heart, liver, spleen, lung, and kidney, were harvested. The fluorescence intensities in the tumor and these organs (per unit area) were then measured and compared. <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>b,c shows that the accumulation of <b>5</b> in tumor, as reflected by the fluorescence intensity therein, was generally higher than that in other organs, except the liver, which is the primary site for drug metabolism, and was about 3-fold higher than that of <b>2</b> in the tumor. These results indicated that <b>5</b> also exhibited high affinity toward the HT29 tumor in vivo.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (a) Fluorescence images of HT29 tumor-bearing nude mice before and after intravenous injection of <b>5</b> or <b>2</b> over a period of 24 h (excitation wavelength = 680 nm, emission wavelength ≥700 nm). (b) Ex vivo distribution of <b>5</b> and <b>2</b> in the tumor and different organs of the mice at 24 h postinjection. (c) Fluorescence intensities of the tumor and different organs in HT29 tumor-bearing nude mice at 24 h after intravenous injection of <b>5</b> or <b>2</b>. Data are expressed as the mean value ± SD for <i>n</i> = 4. ***<i>p</i> < 0.001 as calculated by the Student’s <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vivo Photodynamic Therapy</h3><div class="NLM_p">Finally, the in vivo PDT efficacy of <b>5</b> was also examined. Nude mice bearing an HT29 tumor were intravenously injected with <b>5</b> (40 nmol) in 200 μL of distilled water containing 2.5% DMSO and 0.1% Tween 80. The tumor was irradiated with a diode laser at 680 nm (0.3 W cm<sup>–2</sup>) for 10 min after the injection for 24 h. As a negative control without applying the drug and light irradiation, the mice were simply injected with PBS. After the treatment, the tumor size was monitored continuously for 14 days. As shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>a,b, <b>5</b> could effectively suppress the tumor growth in mice while the tumor grew continuously for the PBS control group. The body weight of the mice was also monitored during the treatment period (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>c). The negligible change indicated that the PDT treatment did not cause apparent side effect on the mice. Hematoxylin and eosin (H&E) staining was also performed on the tumor and the major organs after the treatment with <b>5</b> with light irradiation or PBS without light irradiation as the control. As shown in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>d, cellular damage and necrosis were observed in the H&E-stained image of the tumor after the PDT treatment. For the images of the major organs, there was no apparent abnormality or noticeable damage. Even the liver where the photosensitizer was localized (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>b,c), no apparent damage was observed, which is due to the fact that light irradiation was not applied at this site. These results suggested that <b>5</b> could also function as an efficient and apparently safe PDT agent in this animal model.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) Photographs of the HT29 tumor-bearing nude mice before and after the treatment with <b>5</b> with light irradiation (680 nm, 0.3 W cm<sup>–2</sup>, 180 J cm<sup>–2</sup>) or PBS without light irradiation. (b) Tumor-growth curves for HT29 tumor-bearing nude mice after intravenous injection with <b>5</b> and illuminated with a diode laser at 680 nm for 10 min (0.3 W cm<sup>–2</sup>, 180 J cm<sup>–2</sup>) at 24 h postinjection (<i>n</i> = 5) or PBS in the absence of light (<i>n</i> = 3). (c) Body weights of the mice being injected with <b>5</b> or PBS on different days. Data are expressed as the mean value ± SD for <i>n</i> = 5 (for <b>5</b>) or 3 (for the PBS control). (d) H&E-stained slices of the tumor and major organs of the mice after 14 days of the treatment with <b>5</b> with light irradiation or PBS without light irradiation. ***<i>p</i> < 0.001 as calculated by the Student’s <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87067" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87067" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have developed a facile one-pot methodology for in situ cyclization of peptides and conjugation with photosensitizers through a bifunctional linker. The bis(bromomethyl)benzene and cyclopentadiene moieties of the linker undergo selective nucleophilic substitution with the two cysteine residues of the linear peptides and Diels–Alder reaction with the maleimide unit attached to a zinc(II) phthalocyanine, respectively. Three cyclic peptide-conjugated phthalocyanines have been prepared in 20–26% isolated yield. The conjugate with a cyclic EBP peptide (compound <b>5</b>) exhibits remarkably high and selective binding affinity to EGFR. The cellular uptake as reflected by the intracellular fluorescence intensity toward the EGFR-positive HT29 and HCT116 cells is up to 25-fold higher than that against the EGFR-negative HeLa and HEK293 cells. This conjugate also shows high photocytotoxicity toward HT29 and HCT116 cells with an IC<sub>50</sub> value of 6 and 8 nM, respectively. In vivo studies have demonstrated that the conjugate exhibits high tumor-retention property and is able to retard the tumor growth in HT29 tumor-bearing nude mice upon light irradiation. All the results suggest that <b>5</b>, which can be prepared readily via a one-pot reaction, is a promising photosensitizer for EGFR-targeted PDT.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45445" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45445" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General</h3><div class="NLM_p">All the reactions were performed under an atmosphere of nitrogen. DMF was purified using an INERT solvent purification system. All other solvents and reagents were of reagent grade and used as received. All the reactions were monitored by thin layer chromatography performed on Merck precoated silica gel 60 F254 plates. Chromatographic purification was performed with column chromatography on silica gel (Macherey-Nagel, 230–400 mesh) and/or size-exclusion chromatography on Bio-Beads S-X1 beads (200–400 mesh). Compounds <b>1</b> and <b>2</b> were prepared as described.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">MALDI-TOF mass spectra were recorded on a Bruker Autoflex Speed MALDI-TOF mass spectrometer. ESI mass spectra were recorded on a Thermo Finnigan MAT 95 XL mass spectrometer. Electronic absorption and steady-state fluorescence spectra were taken on a Cary 5G UV–vis–NIR spectrophotometer and a HORIBA FluoroMax-4 spectrofluorometer, respectively. The purity of <b>5</b>, <b>6</b>, and <b>7</b> was examined by HPLC and found to be >95% (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figures S4a, S8a, and S10a</a>, respectively, in the Supporting Information).</div><div class="NLM_p last">Reversed-phase HPLC separation was performed on an XBridge BEH300 C18 column (5 μm, 4.6 mm × 150 mm) at a flow rate of 1 mL min<sup>–1</sup> for analytical purpose or on an XBridge BEH300 Prep C18 column (5 μm, 10 mm × 250 mm) at a flow rate of 3 mL min<sup>–1</sup> for preparative purpose using a Waters system equipped with a Waters 1525 binary pump and a Waters 2998 photodiode array detector. The solvents used for HPLC analysis were of HPLC grade. The condition used for the analysis was set as follows: solvent A = 0.1% trifluoroacetic acid (TFA) in acetonitrile and solvent B = 0.1% TFA in deionized water; gradient: 5% A + 95% B in the first 5 min, then changed to 15% A + 85% B in 10 min, further changed to 100% A + 0% B in 30 min, maintained under this condition for 5 min, changed to 0% A + 100% B in 5 min, and maintained under this condition for a further 5 min.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Preparation of EBP, RPM, and TCP-1</h3><div class="NLM_p last">These three peptides were synthesized manually using a modified Fmoc solid-phase peptide synthesis protocol with the commercially available <i>N</i>-α-Fmoc-protected amino acids. The rink amide resin was used as the solid support. A solution of 20% piperidine in DMF was used to remove the Fmoc-protecting group, and 1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate (HATU) was used as the carboxyl group-activating agent. An excess of the Fmoc-protected amino acids (4 equiv), HATU (4 equiv), and <i>N</i>,<i>N</i>-diisopropylethylamine (8 equiv) in DMF were used for each coupling at room temperature. For an <i>N</i>-terminal acetylated TCP-1 peptide, CH<sub>2</sub>Cl<sub>2</sub>, pyridine, and acetic anhydride (2:1:1 v/v/v) were added and the mixture was stirred at room temperature for 30 min. After the final coupling and Fmoc deprotection, the resin was treated with a solution containing 95% TFA, 2.5% triisopropylsilane, and 2.5% CH<sub>2</sub>Cl<sub>2</sub> for 1 h to cleave the peptide from the resin and remove the protecting groups. The resin was removed by filtration, and the filtrate was precipitated by the addition of diethyl ether. After centrifugation, the supernatant was removed. The solid was redissolved in dimethylsulfoxide (DMSO) and then precipitated again by the addition of diethyl ether. The crude peptide was further purified with HPLC. HRMS (MALDI-TOF) of EBP (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figure S17</a> in the Supporting Information): <i>m</i>/<i>z</i> calcd for C<sub>62</sub>H<sub>97</sub>N<sub>14</sub>O<sub>18</sub>S<sub>3</sub> [M + H]<sup>+</sup>, 1421.6262; found, 1421.6391. HRMS (MALDI-TOF) of RPM (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figure S18</a> in the Supporting Information): <i>m</i>/<i>z</i> calcd for C<sub>42</sub>H<sub>72</sub>N<sub>13</sub>O<sub>13</sub>S<sub>3</sub> [M + H]<sup>+</sup>, 1062.4529; found, 1062.4607. HRMS (MALDI-TOF) of TCP-1 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">Figure S19</a> in the Supporting Information): <i>m</i>/<i>z</i> calcd for C<sub>43</sub>H<sub>63</sub>N<sub>12</sub>O<sub>13</sub>S<sub>2</sub> [M + H]<sup>+</sup>, 1019.4073; found, 1019.4110.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Peptide Cyclization</h3><div class="NLM_p last">The linear peptide EBP and the linker 1,3-bis(bromomethyl)benzene were dissolved in a mixture of DMF and NH<sub>4</sub>HCO<sub>3</sub> buffer (pH 8.0) (1:1 v/v) or borate buffer (pH 10.0) (1:1 v/v) at different peptide concentrations (0.5 or 1 mM). After 2 h, the reaction was analyzed by HPLC. The product <b>3</b> was purified by HPLC and dried by lyophilization. HRMS (MALDI-TOF): <i>m</i>/<i>z</i> calcd for C<sub>70</sub>H<sub>103</sub>N<sub>14</sub>O<sub>18</sub>S<sub>3</sub> [M + H]<sup>+</sup>, 1523.6731; found, 1523.6792.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> One-Pot Peptide Cyclization and Phthalocyanine Conjugation</h3><div class="NLM_p last">The linear peptide EBP, RPM, or TCP-1 (1 mM) and the bifunctional linker <b>1</b> (1 mM) were dissolved in a mixture of DMF and borate buffer (pH 10.0) (1:1 v/v). After complete consumption of the linear peptide as revealed by HPLC, a solution of <b>2</b> in DMF (2 mM) was added. The mixture was stirred overnight, and then the product was isolated by HPLC followed by drying by lyophilization. HRMS (MALDI-TOF) of <b>5</b>: <i>m</i>/<i>z</i> calcd for C<sub>131</sub>H<sub>163</sub>N<sub>24</sub>O<sub>28</sub>S<sub>3</sub>Zn [M + H]<sup>+</sup>, 2680.0517; found, 2680.0521. HRMS (MALDI-TOF) of <b>6</b>: <i>m</i>/<i>z</i> calcd for C<sub>111</sub>H<sub>138</sub>N<sub>23</sub>O<sub>23</sub>S<sub>3</sub>Zn [M + H]<sup>+</sup>, 2320.8784; found, 2320.8809. HRMS (MALDI-TOF) of <b>7</b>: <i>m</i>/<i>z</i> calcd for C<sub>112</sub>H<sub>129</sub>N<sub>22</sub>O<sub>23</sub>S<sub>2</sub>Zn [M + H]<sup>+</sup>, 2277.8328; found, 2277.8291.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Determination of Fluorescence Quantum Yields</h3><div class="NLM_p last">To minimize reabsorption of the radiation by the ground-state species, fluorescence spectra were recorded in very dilute solutions (2 μM in DMF). The fluorescence quantum yields (Φ<sub>F</sub>) of the samples in DMF were determined using the equation<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_m001.gif" alt="" id="_i22" /></img></span>where <i>F</i>, <i>A</i>, and <i>n</i> are the measured fluorescence (area under the emission peak), the absorbance at the excitation wavelength (610 nm), and the refractive index of the solvent, respectively.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> ZnPc in DMF was used as the reference [Φ<sub>F<sub>(ref)</sub></sub> = 0.28].<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Determination of Singlet Oxygen Quantum Yields</h3><div class="NLM_p last">The singlet oxygen quantum yields (Φ<sub>Δ</sub>) were calculated using DPBF as the singlet oxygen scavenger and ZnPc in DMF as the reference [Φ<sub>Δ</sub>(ref) = 0.56].<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> A solution of DPBF (30 μM) and the photosensitizer (2 μM) in DMF was irradiated with red light from a 100 W halogen lamp after passing through a water tank for cooling and a color glass filter with a cut-on wavelength at 610 nm (Newport). The absorbance of DPBF at 415 nm was monitored along with the irradiation time. The Φ<sub>Δ</sub> values (in DMF) were calculated using the equation<span class="NLM_disp-formula" id="ueq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_m002.gif" alt="" id="_i24" /></img></span>where <i>W</i> and <i>I</i><sub>abs</sub> are the photobleaching rate of DPBF and the rate of light absorption, respectively.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Study of Stability in Serum</h3><div class="NLM_p last">Conjugate <b>5</b> or the linear EBP peptide was incubated in DMEM (ThermoFisher Scientific, cat. no. 12100-046) with FBS (ThermoFisher Scientific, cat. no. 10270-106) (20% v/v) and DMSO (5% v/v) at 37 °C. An aliquot of the solution was drawn at different time points and precipitated with an equal volume of cold methanol. The mixture was centrifuged, and the supernatant was collected for HPLC analysis. The peak areas of <b>5</b> or EBP at different time points were compared.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Cell Lines and Culture Conditions</h3><div class="NLM_p last">HT29 (ATCC, no. HTB-38) and HeLa (ATCC, no. CCL-2) cells were maintained in Roswell Park Memorial Institute (RPMI) 1640 medium (Invitrogen, cat. no. 23400-021) supplemented with FBS (10%) and penicillin–streptomycin (100 units mL<sup>–1</sup> and 100 μg mL<sup>–1</sup>, respectively). HCT116 (ATCC, no. CCL-247) and HEK293 (ATCC, no. CRL-1573) cells were maintained in DMEM supplemented with FBS (10%) and penicillin–streptomycin (100 units mL<sup>–1</sup> and 100 μg mL<sup>–1</sup>, respectively). All the cells were grown at 37 °C in a humidified 5% CO<sub>2</sub> atmosphere.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Confocal Fluorescence Microscopic Studies</h3><div class="NLM_p last">Approximately 2 × 10<sup>5</sup> cells in RPMI 1640 medium or DMEM (2 mL) were seeded on a confocal dish and incubated overnight at 37 °C in a humidified 5% CO<sub>2</sub> atmosphere. Compounds <b>5</b> and <b>2</b> (20 nmol) were first dissolved in DMSO (25 μL) to prepare stock solutions of 800 μM. The solutions were further diluted with a serum-free medium to 2 μM. The cells, after being rinsed with PBS, were incubated with these solutions (2 μM) at 37 °C for 2 h. The solutions were then removed, and the cells were rinsed with PBS twice before being examined with a Leica TCS SP8 high-speed confocal microscope equipped with a solid-state 638 nm laser. The compound was excited at 638 nm and its fluorescence was monitored at 650–750 nm. The images were digitized and analyzed using a Leica Application Suite X software.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Flow Cytometric Studies</h3><div class="NLM_p last">Approximately 2 × 10<sup>5</sup> cells per well in RPMI 1640 medium or DMEM were seeded on a 6-multiwell plate and incubated overnight at 37 °C in a humidified 5% CO<sub>2</sub> atmosphere. Compounds <b>5</b>, <b>6</b>, <b>7</b>, and <b>2</b> (20 nmol) were first dissolved in DMSO (25 μL) to prepare stock solutions of 800 μM. The solutions were then diluted with a serum-free medium to 2 μM. The cells, after being rinsed with PBS, were incubated with these solutions (2 μM) at 37 °C for 2 h. For the competition assay, HT29 cells were preincubated with <b>3</b> at various concentrations (100 and 400 μM) for 30 min at 37 °C, followed by coincubation with <b>5</b> (2 μM) for further 2 h. The solutions were then removed, and the cells were rinsed with PBS twice and harvested by 0.25% trypsin-ethylenediaminetetraacetic acid (Invitrogen, 0.2 mL) for 5 min. The activity of trypsin was quenched with a serum-containing medium (0.5 mL), and the mixture was centrifuged at 1500 rpm for 3 min at room temperature. The pellet was then washed with PBS (1.0 mL) and then subjected to centrifugation. The cells were suspended in PBS (1.0 mL) and the intracellular fluorescence intensities were measured using a BD FACSVerse flow cytometer (Becton Dickinson) with 10<sup>4</sup> cells counted in each sample. The compounds were excited by an argon laser at 640 nm, and the emitted fluorescence was monitored at 720–840 nm. The data collected were analyzed using the BD FAC-Suite. All experiments were performed in triplicate.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Subcellular Localization Studies</h3><div class="NLM_p last">Approximately 2 × 10<sup>5</sup> HT29 cells in RPMI 1640 medium (2 mL) were seeded on a confocal dish and incubated overnight at 37 °C in a humidified 5% CO<sub>2</sub> atmosphere. A stock solution of <b>5</b> (800 μM) was prepared as described above, which was then diluted with a serum-free medium to 2 μM. The cells, after being rinsed with PBS, were incubated with the solution (2 μM) at 37 °C for 2 h. After being washed twice with PBS, the cells were stained with LysoTracker Green DND-26 (Thermo Fisher Scientific Inc., L7526) (2 μM), MitoTracker Green FM (Thermo Fisher Scientific Inc., M7514) (0.2 μM), or ER-Tracker Green (Thermo Fisher Scientific Inc., E34251) (1 μM) in a serum-free medium at 37 °C for 30, 15, and 15 min, respectively. The solutions were then removed, and the cells were rinsed with PBS twice before being examined with a Leica TCS SP8 high-speed confocal microscope equipped with a 488 nm laser and a 638 nm laser. All the trackers were excited at 488 nm, and their fluorescence was monitored at 500–570 nm, while <b>5</b> was excited at 638 nm and its fluorescence was monitored at 650–750 nm. The images were digitized and analyzed using a Leica Application Suite X software.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Photocytotoxicity Assay</h3><div class="NLM_p last">Approximately 2 × 10<sup>4</sup> cells per well in RPMI 1640 medium or DMEM were inoculated in 96-multiwell plates and incubated overnight at 37 °C in a humidified 5% CO<sub>2</sub> atmosphere. A stock solution of <b>5</b> (800 μM) was prepared as described above, which was then diluted with a serum-free medium to the respective concentrations. The cells, after being rinsed with PBS twice, were incubated with 100 μL of the phthalocyanine solutions for 2 h at 37 °C under 5% CO<sub>2</sub>. The cells were then rinsed again with PBS and refed with 100 μL of the culture medium before being illuminated at ambient temperature. The light source consisted of a 300 W halogen lamp, a water tank for cooling, and a color glass filter (Newport) cut-on at λ = 610 nm. The fluence rate (λ > 610 nm) was 23 mW cm<sup>–2</sup>. Illumination for 20 min led to a total fluence of 28 J cm<sup>–2</sup>. Cell viability was determined by means of a colorimetric MTT assay.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> After illumination, the cells were incubated at 37 °C under 5% CO<sub>2</sub> overnight. An MTT (Sigma) solution in PBS (3 mg mL<sup>–1</sup>, 50 μL) was added to each well followed by incubation for 4 h under the same environment. DMSO (100 μL) was then added to each well. Solutions in all wells were mixed until homogeneous. The absorbance at 490 nm of each well on the plate was taken using a microplate reader (Tecan Spark 10M) at ambient temperature. The average absorbance of the blank wells, which did not contain the cells, was subtracted from the readings of the other wells. The cell viability was then determined using the equation<span class="NLM_disp-formula" id="ueq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_m003.gif" alt="" id="_i31" /></img></span>where <i>A</i><sub><i>i</i></sub> is the absorbance of the <i>i</i>th data (<i>i</i> = 1, 2, ...;, <i>n</i>), <i>A</i><sub>control</sub> is the average absorbance of the control wells in which the compound was absent, and <i>n</i> (=4) is the number of data points.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> In Vivo Imaging</h3><div class="NLM_p last">Female Balb/c nude mice (20–25 g) were obtained from the Laboratory Animal Services Centre at The Chinese University of Hong Kong. All animal experiments were approved by the Animal Experimentation Ethics Committee of the University. The mice were kept under pathogen-free conditions with free access to food and water. HT29 cells (1 × 10<sup>7</sup> cells in 200 μL) were inoculated subcutaneously at the back of the mice. Once the tumors had grown to a size of 80–100 mm<sup>3</sup>, <b>5</b> or <b>2</b> (20 nmol) dissolved in 200 μL distilled water containing 2.5% DMSO and 0.1% Tween 80 was injected to the tumor-bearing mice through tail intravenous injection. In vivo fluorescence imaging was performed before and after the injection at different time points up to 24 h with an Odyssey infrared imaging system (excitation wavelength = 680 nm, emission wavelength ≥700 nm). The images were digitized and analyzed using the Odyssey imaging system software (no. 9201-500). After the in vivo imaging studies, the animals were euthanized at 24 h postinjection. The tumors and various organs were then harvested and their fluorescence intensities were measured with the Odyssey infrared imaging system again. Four mice were used for each compound.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> In Vivo Photodynamic Therapy</h3><div class="NLM_p last">HT29 tumor-bearing nude mice were prepared as described above. The length and width of the tumor were measured using a micrometer digital caliper (SCITOP Systems). The tumor volume (mm<sup>3</sup>) was calculated using the formula: tumor volume = (length × width<sup>2</sup>)/2. Once the tumors had grown to a size of 80–100 mm<sup>3</sup>, <b>5</b> (40 nmol) dissolved in 200 μL of distilled water containing 2.5% DMSO and 0.1% Tween 80 was injected to the tumor-bearing mice through tail intravenous injection. Five mice were used for this group. At 24 h postinjection, the tumor was illuminated by a diode laser (Biolitec Ceralas) at 680 nm operated at 0.24 W. Illumination on a circular spot with a 1.0 cm diameter for 10 min led to a total fluence of 180 J cm<sup>–2</sup>. The tumor sizes of the nude mice were monitored periodically for the next 14 days. The tumor volumes were compared with a PBS control group of mice without light treatment. Three mice were used for the control. After 14 days of the PDT treatment, the mice were sacrificed, and the tumor and major organs were harvested. The tissues were fixed with 4% paraformaldehyde, dehydrated in an alcohol series, mixed with solutions of xylene and paraffin, and embedded in paraffin. The tissue sections were prepared by Leica microtome RM2235. After H&E staining, the tissues were examined with a Carl Zeiss PALM inverted microscope.</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Statistical Analysis</h3><div class="NLM_p last">Data shown on figures were presented as the means with the SEM or SD. The data were analyzed using the Student’s <i>t</i>-test with <i>p</i> values <0.05 considered as significant; *<i>p</i> < 0.05; **<i>p</i> < 0.01; and ***<i>p</i> < 0.001. Statistical calculations were performed using a Microsoft Excel spreadsheet (Microsoft Corporation, Redmond, WA, USA).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01677" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01677?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01677</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">HPLC chromatograms, MALDI-TOF mass spectra, additional spectra, and in vitro results (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf">jm0c01677_si_001.pdf (1.42 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_002.csv">jm0c01677_si_002.csv (1.96 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01677" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68187" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68187" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clarence T. T. Wong</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, The Chinese University of
Hong Kong, Shatin, N.T., Hong Kong, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5d3e313c2f38333e38702929732a32333a1d2d3231242873383928733536"><span class="__cf_email__" data-cfemail="a2c1cec3d0c7ccc1c78fd6d68cd5cdccc5e2d2cdcedbd78cc7c6d78ccac9">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis K. P. Ng</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, The Chinese University of
Hong Kong, Shatin, N.T., Hong Kong, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9087-960X" title="Orcid link">http://orcid.org/0000-0001-9087-960X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#036768736d4360766b682d6667762d6b68"><span class="__cf_email__" data-cfemail="c1a5aab1af81a2b4a9aaefa4a5b4efa9aa">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacky C. H. Chu</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, The Chinese University of
Hong Kong, Shatin, N.T., Hong Kong, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wing-Ping Fong</span> - <span class="hlFld-Affiliation affiliation">School
of Life Sciences, The Chinese University
of Hong Kong, Shatin, N.T., Hong
Kong, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0468-9883" title="Orcid link">http://orcid.org/0000-0002-0468-9883</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10635" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10635" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by a General Research Fund from the Research Grants Council of the Hong Kong Special Administrative Region, China (project no. 14304817).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle’s medium</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">DPBF</td><td class="NLM_def"><p class="first last">1,3-diphenylisobenzofuran</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">Fmoc</td><td class="NLM_def"><p class="first last">9-fluorenylmethoxycarbonyl</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">dye concentration required to kill 50% of the cells</p></td></tr><tr><td class="NLM_term">MALDI-TOF</td><td class="NLM_def"><p class="first last">matrix-assisted laser desorption/ionization time-of-flight</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate-buffered saline</p></td></tr><tr><td class="NLM_term">PDT</td><td class="NLM_def"><p class="first last">photodynamic therapy</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">RPMI</td><td class="NLM_def"><p class="first last">Roswell Park Memorial Institute</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">ZnPc</td><td class="NLM_def"><p class="first last">zinc(II) phthalocyanine</p></td></tr><tr><td class="NLM_term">Φ<sub>F</sub></td><td class="NLM_def"><p class="first last">fluorescence quantum yield</p></td></tr><tr><td class="NLM_term">Φ<sub>Δ</sub></td><td class="NLM_def"><p class="first last">singlet oxygen quantum yield</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82828" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82828" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 49 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolmans, D. E. J. G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumura, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R. K.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy for cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">380</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1038/nrc1071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1038%2Fnrc1071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=12724736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlals74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=380-387&author=D.+E.+J.+G.+J.+Dolmansauthor=D.+Fukumuraauthor=R.+K.+Jain&title=Photodynamic+therapy+for+cancer&doi=10.1038%2Fnrc1071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">TIMELINE: Photodynamic therapy for cancer</span></div><div class="casAuthors">Dolmans, Dennis E. J. G. J.; Fukumura, Dai; Jain, Rakesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">380-387</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, on the mechanism of photodynamic therapy of cancer and other diseases.  The therapeutic properties of light have been known for thousands of years, but it was only in the last century that photodynamic therapy (PDT) was developed.  At present, PDT is being tested in the clinic for use in oncol. - to treat cancers of the head and neck, brain, lung, pancreas, i.p. cavity, breast, prostate and skin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzy17bVUKi07Vg90H21EOLACvtfcHk0lhm3zDZD5M8ZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlals74%253D&md5=06663e65f0f3e313f828234220efcf3c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc1071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1071%26sid%3Dliteratum%253Aachs%26aulast%3DDolmans%26aufirst%3DD.%2BE.%2BJ.%2BG.%2BJ.%26aulast%3DFukumura%26aufirst%3DD.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DPhotodynamic%2520therapy%2520for%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D380%26epage%3D387%26doi%3D10.1038%2Fnrc1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, I.</span></span> <span> </span><span class="NLM_article-title">The Present and future role of photodynamic therapy in cancer treatment</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">508</span>, <span class="refDoi"> DOI: 10.1016/s1470-2045(04)01529-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2FS1470-2045%2804%2901529-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=15288239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Kjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=497-508&author=S.+B.+Brownauthor=E.+A.+Brownauthor=I.+Walker&title=The+Present+and+future+role+of+photodynamic+therapy+in+cancer+treatment&doi=10.1016%2Fs1470-2045%2804%2901529-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The present and future role of photodynamic therapy in cancer treatment</span></div><div class="casAuthors">Brown, Stanley B.; Brown, Elizabeth A.; Walker, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">497-508</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Lancet Publishing Group</span>)
        </div><div class="casAbstract">A review.  It is more than 25 yr since photodynamic therapy (PDT) was proposed as a useful tool in oncol., but the approach is only now being used more widely in the clinic.  The understanding of the biol. of PDT has advanced, and efficient, convenient, and inexpensive systems of light delivery are now available.  Results from well-controlled, randomized phase III trials are also becoming available, esp. for treatment of non-melanoma skin cancer and Barrett's esophagus, and improved photosensitizing drugs are in development.  PDT has several potential advantages over surgery and radiotherapy; i.e., it is comparatively non-invasive, it can be targeted accurately, repeated doses can be given without the total-dose limitations assocd. with radiotherapy, and the healing process results in little or no scarring.  PDT can usually be done in an outpatient or day-case setting, is convenient for the patient, and has no side-effects.  Two photosensitizing drugs, porfirmer sodium and temoporfin, have now been approved for systemic administration, and aminolevulinic acid and Me aminolevulinate have been approved for topical use.  Here, we review current use of PDT in oncol. and look at its future potential as more selective photosensitizing drugs become available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPHiTvIl3SMLVg90H21EOLACvtfcHk0lgWzh5wH7eqXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Kjsrw%253D&md5=f5aa46f85ba792703e55cb9c67c6cccd</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2804%2901529-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252804%252901529-3%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%2BB.%26aulast%3DBrown%26aufirst%3DE.%2BA.%26aulast%3DWalker%26aufirst%3DI.%26atitle%3DThe%2520Present%2520and%2520future%2520role%2520of%2520photodynamic%2520therapy%2520in%2520cancer%2520treatment%26jtitle%3DLancet%2520Oncol.%26date%3D2004%26volume%3D5%26spage%3D497%26epage%3D508%26doi%3D10.1016%2Fs1470-2045%2804%2901529-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Straten, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashayekhi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bruijn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D.</span></span> <span> </span><span class="NLM_article-title">Oncologic photodynamic therapy: basic principles, current clinical status and future directions</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">19</span>, <span class="refDoi"> DOI: 10.3390/cancers9020019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.3390%2Fcancers9020019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=19&author=D.+van%0AStratenauthor=V.+Mashayekhiauthor=H.+de+Bruijnauthor=S.+Oliveiraauthor=D.+Robinson&title=Oncologic+photodynamic+therapy%3A+basic+principles%2C+current+clinical+status+and+future+directions&doi=10.3390%2Fcancers9020019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3390%2Fcancers9020019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers9020019%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BStraten%26aufirst%3DD.%26aulast%3DMashayekhi%26aufirst%3DV.%26aulast%3Dde%2BBruijn%26aufirst%3DH.%26aulast%3DOliveira%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DD.%26atitle%3DOncologic%2520photodynamic%2520therapy%253A%2520basic%2520principles%252C%2520current%2520clinical%2520status%2520and%2520future%2520directions%26jtitle%3DCancers%26date%3D2017%26volume%3D9%26spage%3D19%26doi%3D10.3390%2Fcancers9020019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.-H.</span></span> <span> </span><span class="NLM_article-title">Advanced smart-photosensitizers for more effective cancer treatment</span>. <i>Biomater. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1039/c7bm00872d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1039%2FC7BM00872D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=70-90&author=W.+Parkauthor=S.+Choauthor=J.+Hanauthor=H.+Shinauthor=K.+Naauthor=B.+Leeauthor=D.-H.+Kim&title=Advanced+smart-photosensitizers+for+more+effective+cancer+treatment&doi=10.1039%2Fc7bm00872d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1039%2FC7BM00872D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7BM00872D%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DW.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DShin%26aufirst%3DH.%26aulast%3DNa%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DD.-H.%26atitle%3DAdvanced%2520smart-photosensitizers%2520for%2520more%2520effective%2520cancer%2520treatment%26jtitle%3DBiomater.%2520Sci.%26date%3D2018%26volume%3D6%26spage%3D70%26epage%3D90%26doi%3D10.1039%2Fc7bm00872d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span> <span> </span><span class="NLM_article-title">Photosensitizers for photodynamic therapy</span>. <i>Adv. Healthcare Mater.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1900132</span>, <span class="refDoi"> DOI: 10.1002/adhm.201900132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1002%2Fadhm.201900132" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=1900132&author=M.+Lanauthor=S.+Zhaoauthor=W.+Liuauthor=C.-S.+Leeauthor=W.+Zhangauthor=P.+Wang&title=Photosensitizers+for+photodynamic+therapy&doi=10.1002%2Fadhm.201900132"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fadhm.201900132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadhm.201900132%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DC.-S.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DP.%26atitle%3DPhotosensitizers%2520for%2520photodynamic%2520therapy%26jtitle%3DAdv.%2520Healthcare%2520Mater.%26date%3D2019%26volume%3D8%26spage%3D1900132%26doi%3D10.1002%2Fadhm.201900132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colón, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roque, J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gujar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thummel, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, S. A.</span></span> <span> </span><span class="NLM_article-title">Transition metal complexes and photodynamic therapy from a tumor-centered approach: challenges, opportunities, and highlights from the development of TLD1433</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">828</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.8b00211</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.8b00211" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGmtrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2019&pages=797-828&author=S.+Monroauthor=K.+L.+Col%C3%B3nauthor=H.+Yinauthor=J.+Roqueauthor=P.+Kondaauthor=S.+Gujarauthor=R.+P.+Thummelauthor=L.+Lilgeauthor=C.+G.+Cameronauthor=S.+A.+McFarland&title=Transition+metal+complexes+and+photodynamic+therapy+from+a+tumor-centered+approach%3A+challenges%2C+opportunities%2C+and+highlights+from+the+development+of+TLD1433&doi=10.1021%2Facs.chemrev.8b00211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433</span></div><div class="casAuthors">Monro, Susan; Colon, Katsuya L.; Yin, Huimin; Roque, John; Konda, Prathyusha; Gujar, Shashi; Thummel, Randolph P.; Lilge, Lothar; Cameron, Colin G.; McFarland, Sherri A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">797-828</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Transition metal complexes are of increasing interest as photosensitizers in photodynamic therapy (PDT) and, more recently, for photochemotherapy (PCT).  In recent years, Ru(II) polypyridyl complexes have emerged as promising systems for both PDT and PCT.  Their rich photochem. and photophys. properties derive from a variety of excited-state electronic configurations accessible with visible and near-IR light, and these properties can be exploited for both energy- and electron-transfer processes that can yield highly potent oxygen-dependent and/or oxygen-independent photobiol. activity.  Selected examples highlight the use of rational design in coordination chem. to control the lowest-energy triplet excited-state configurations for eliciting a particular type of photoreactivity for PDT and/or PCT effects.  These principles are also discussed in the context of the development of TLD1433, the first Ru(II)-based photosensitizer for PDT to enter a human clin. trial.  The design of TLD1433 arose from a tumor-centered approach, as part of a complete PDT package that includes the light component and the protocol for treating non-muscle invasive bladder cancer.  Briefly, this review summarizes the challenges to bringing PDT into mainstream cancer therapy.  It considers the chem. and photophys. solns. that transition metal complexes offer, and it puts into context the multidisciplinary effort needed to bring a new drug to clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvMiOuSE20lbVg90H21EOLACvtfcHk0ljx98btWCFfqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGmtrjK&md5=73b333b327b1f83a6146b321dfe80ba9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.8b00211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.8b00211%26sid%3Dliteratum%253Aachs%26aulast%3DMonro%26aufirst%3DS.%26aulast%3DCol%25C3%25B3n%26aufirst%3DK.%2BL.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DRoque%26aufirst%3DJ.%26aulast%3DKonda%26aufirst%3DP.%26aulast%3DGujar%26aufirst%3DS.%26aulast%3DThummel%26aufirst%3DR.%2BP.%26aulast%3DLilge%26aufirst%3DL.%26aulast%3DCameron%26aufirst%3DC.%2BG.%26aulast%3DMcFarland%26aufirst%3DS.%2BA.%26atitle%3DTransition%2520metal%2520complexes%2520and%2520photodynamic%2520therapy%2520from%2520a%2520tumor-centered%2520approach%253A%2520challenges%252C%2520opportunities%252C%2520and%2520highlights%2520from%2520the%2520development%2520of%2520TLD1433%26jtitle%3DChem.%2520Rev.%26date%3D2019%26volume%3D119%26spage%3D797%26epage%3D828%26doi%3D10.1021%2Facs.chemrev.8b00211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo, P.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Morgade, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, D. K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumoulin, F.</span></span> <span> </span><span class="NLM_article-title">The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1041</span>– <span class="NLM_lpage">1056</span>, <span class="refDoi"> DOI: 10.1039/c9cs00129h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1039%2FC9CS00129H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=31845688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSnu77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2020&pages=1041-1056&author=P.-C.+Loauthor=M.+S.+Rodr%C3%ADguez-Morgadeauthor=R.+K.+Pandeyauthor=D.+K.+P.+Ngauthor=T.+Torresauthor=F.+Dumoulin&title=The+unique+features+and+promises+of+phthalocyanines+as+advanced+photosensitisers+for+photodynamic+therapy+of+cancer&doi=10.1039%2Fc9cs00129h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer</span></div><div class="casAuthors">Lo, Pui-Chi; Rodriguez-Morgade, M. Salome; Pandey, Ravindra K.; Ng, Dennis K. P.; Torres, Tomas; Dumoulin, Fabienne</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1041-1056</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Phthalocyanines exhibit superior photoproperties that make them a surely attractive class of photosensitizers for photodynamic therapy of cancer.  Several derivs. are at various phases of clin. trials, and efforts have been put continuously to improve their photodynamic efficacy.  To this end, various strategies have been applied to develop advanced phthalocyanines with optimized photoproperties, dual therapeutic actions, tumor-targeting properties and/or specific activation at tumor sites.  The advantageous properties and potential of phthalocyanines as advanced photosensitizers for photodynamic therapy of cancer are highlighted in this tutorial review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyq_GPDCHKSLVg90H21EOLACvtfcHk0ljx98btWCFfqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVSnu77I&md5=f600e873a969140fd13ef35efafbca81</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1039%2FC9CS00129H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9CS00129H%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DP.-C.%26aulast%3DRodr%25C3%25ADguez-Morgade%26aufirst%3DM.%2BS.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DNg%26aufirst%3DD.%2BK.%2BP.%26aulast%3DTorres%26aufirst%3DT.%26aulast%3DDumoulin%26aufirst%3DF.%26atitle%3DThe%2520unique%2520features%2520and%2520promises%2520of%2520phthalocyanines%2520as%2520advanced%2520photosensitisers%2520for%2520photodynamic%2520therapy%2520of%2520cancer%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2020%26volume%3D49%26spage%3D1041%26epage%3D1056%26doi%3D10.1039%2Fc9cs00129h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almeida-Marrero, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Winckel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anaya-Plaza, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Escosura, A.</span></span> <span> </span><span class="NLM_article-title">Porphyrinoid biohybrid materials as an emerging toolbox for biomedical light management</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">7369</span>– <span class="NLM_lpage">7400</span>, <span class="refDoi"> DOI: 10.1039/c7cs00554g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1039%2FC7CS00554G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=30152500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsF2lsbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=7369-7400&author=V.+Almeida-Marreroauthor=E.+van+de+Winckelauthor=E.+Anaya-Plazaauthor=T.+Torresauthor=A.+de+la+Escosura&title=Porphyrinoid+biohybrid+materials+as+an+emerging+toolbox+for+biomedical+light+management&doi=10.1039%2Fc7cs00554g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Porphyrinoid biohybrid materials as an emerging toolbox for biomedical light management</span></div><div class="casAuthors">Almeida-Marrero, Veronica; van de Winckel, Eveline; Anaya-Plaza, Eduardo; Torres, Tomas; de la Escosura, Andres</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7369-7400</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The development of photoactive and biocompatible nanomaterials is a current major challenge of materials science and nanotechnol., as they will contribute to promoting current and future biomedical applications.  A growing strategy in this direction consists of using biol. inspired hybrid materials to maintain or even enhance the optical properties of chromophores and fluorophores in biol. media.  Within this area, porphyrinoids constitute the most important family of org. photosensitizers.  The following extensive review will cover their incorporation into different kinds of photosensitizing biohybrid materials, as a fundamental research effort toward the management of light for biomedical use, including technologies such as photochem. internalization (PCI), photoimmunotherapy (PIT), and theranostic combinations of fluorescence imaging and photodynamic therapy (PDT) or photodynamic inactivation (PDI) of microorganisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq747ZDCy9A6LVg90H21EOLACvtfcHk0ljx5mcyoHWNUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsF2lsbfP&md5=d5330d33a1261b685b33206702f6b3a7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1039%2FC7CS00554G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CS00554G%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida-Marrero%26aufirst%3DV.%26aulast%3Dvan%2Bde%2BWinckel%26aufirst%3DE.%26aulast%3DAnaya-Plaza%26aufirst%3DE.%26aulast%3DTorres%26aufirst%3DT.%26aulast%3Dde%2Bla%2BEscosura%26aufirst%3DA.%26atitle%3DPorphyrinoid%2520biohybrid%2520materials%2520as%2520an%2520emerging%2520toolbox%2520for%2520biomedical%2520light%2520management%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2018%26volume%3D47%26spage%3D7369%26epage%3D7400%26doi%3D10.1039%2Fc7cs00554g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, R. W.</span></span> <span> </span><span class="NLM_article-title">Photosensitizer antibody-drug conjugates: past, present, and future</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">993</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.9b00055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.9b00055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFCqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=975-993&author=J.+Sandlandauthor=R.+W.+Boyle&title=Photosensitizer+antibody-drug+conjugates%3A+past%2C+present%2C+and+future&doi=10.1021%2Facs.bioconjchem.9b00055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Photosensitizer Antibody-Drug Conjugates: Past, Present, and Future</span></div><div class="casAuthors">Sandland, Jordon; Boyle, Ross W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">975-993</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This Review aims to highlight key aspects of tetrapyrrole-based antibody-drug conjugates (ADCs) and significant developments in the field since 2010.  Many new conjugation methods have been developed and employed in the past decade, and assocd. with this, there has been a rising interest in theranostic conjugates.  We have investigated the physicochem. properties that tetrapyrroles need to possess in order to be viable photosensitizers for conjugation to antibodies.  Differences in conjugation strategies are discussed, and structure-activity relationships of tetrapyrrole-antibody conjugates are reported, where available.  As the elegance of bioconjugation techniques has increased, it has paved the way for exceptionally phototoxic, yet highly selective, tetrapyrrole-antibody conjugates, with photocytotoxicities in the nanomolar range, to be synthesized and biol. evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRa8MnnISHn7Vg90H21EOLACvtfcHk0ljx5mcyoHWNUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFCqur0%253D&md5=09989d6e2a37e2b715c399035b03a160</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.9b00055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.9b00055%26sid%3Dliteratum%253Aachs%26aulast%3DSandland%26aufirst%3DJ.%26aulast%3DBoyle%26aufirst%3DR.%2BW.%26atitle%3DPhotosensitizer%2520antibody-drug%2520conjugates%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DBioconjugate%2520Chem.%26date%3D2019%26volume%3D30%26spage%3D975%26epage%3D993%26doi%3D10.1021%2Facs.bioconjchem.9b00055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Peptide-based cancer therapy: opportunity and challenge</span>. <i>Canc. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2014.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.canlet.2014.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=24836189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC2cXoslCks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2014&pages=13-22&author=D.+Wuauthor=Y.+Gaoauthor=Y.+Qiauthor=L.+Chenauthor=Y.+Maauthor=Y.+Li&title=Peptide-based+cancer+therapy%3A+opportunity+and+challenge&doi=10.1016%2Fj.canlet.2014.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide-based cancer therapy: Opportunity and challenge</span></div><div class="casAuthors">Wu, Dongdong; Gao, Yanfeng; Qi, Yuanming; Chen, Lixiang; Ma, Yuanfang; Li, Yanzhang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-22</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Cancer is one of the leading causes of death worldwide.  Conventional cancer therapies mainly focus on mass cell killing without high specificity and often cause severe side effects and toxicities.  Peptides are a novel class of anticancer agents that could specifically target cancer cells with lower toxicity to normal tissues, which will offer new opportunities for cancer prevention and treatment.  Anticancer peptides face several therapeutic challenges.  In this review, we present the sources and mechanisms of anticancer peptides and further discuss modification strategies to improve the anticancer effects of bioactive peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfTvF05vTMi7Vg90H21EOLACvtfcHk0ljx5mcyoHWNUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXoslCks74%253D&md5=c438f9714fb43545691d594a9aa775e6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DQi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DPeptide-based%2520cancer%2520therapy%253A%2520opportunity%2520and%2520challenge%26jtitle%3DCanc.%2520Lett.%26date%3D2014%26volume%3D351%26spage%3D13%26epage%3D22%26doi%3D10.1016%2Fj.canlet.2014.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruoslahti, E.</span></span> <span> </span><span class="NLM_article-title">Tumor penetrating peptides for improved drug delivery</span>. <i>Adv. Drug Deliv. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>110–111</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2016.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.addr.2016.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=27040947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC28XlslCjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110%E2%80%93111&publication_year=2017&pages=3-12&author=E.+Ruoslahti&title=Tumor+penetrating+peptides+for+improved+drug+delivery&doi=10.1016%2Fj.addr.2016.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor penetrating peptides for improved drug delivery</span></div><div class="casAuthors">Ruoslahti, Erkki</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">110-111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3-12</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In vivo screening of phage libraries in tumor-bearing mice has been used to identify peptides that direct phage homing to a tumor.  The power of in vivo phage screening is illustrated by the recent discovery of peptides with unique tumor-penetrating properties.  These peptides activate an endocytic transport pathway related to but distinct from macropinocytosis.  They do so through a complex process that involves binding to a primary, tumor-specific receptor, followed by a proteolytic cleavage, and binding to a second receptor.  The second receptor, neuropilin-1 (or neuropilin-2) activates the transport pathway.  This trans-tissue pathway, dubbed the C-end Rule (CendR) pathway, mediates the extravasation transport through extravascular tumor tissue of payloads ranging from small mol. drugs to nanoparticles.  The CendR technol. provides a soln. to a major problem in tumor therapy, poor penetration of drugs into tumors.  Targeted delivery with tumor-penetrating peptides has been shown to specifically increase the accumulation of drugs, antibodies and nanotherapeutics in exptl. tumors in vivo, and in human tumors ex vivo.  Remarkably the payload does not have to be coupled to the peptide; the peptide activates a bulk transport system that sweeps along a drug present in the blood.  Treatment studies in mice have shown improved anti-tumor efficacy and less damage to normal tissues with drugs ranging from traditional chemotherapeutics to antibodies, and to nanoparticle drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGcd2TTUqzLrVg90H21EOLACvtfcHk0ljJUr77xsgEEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlslCjsrY%253D&md5=83c52c1ec16224278feafb06c8522a1e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2016.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2016.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DRuoslahti%26aufirst%3DE.%26atitle%3DTumor%2520penetrating%2520peptides%2520for%2520improved%2520drug%2520delivery%26jtitle%3DAdv.%2520Drug%2520Deliv.%2520Rev.%26date%3D2017%26volume%3D110%25E2%2580%2593111%26spage%3D3%26epage%3D12%26doi%3D10.1016%2Fj.addr.2016.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, W. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Z.</span></span> <span> </span><span class="NLM_article-title">Peptide-based multifunctional nanomaterials for tumor imaging and therapy</span>. <i>Adv. Funct. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1804492</span>, <span class="refDoi"> DOI: 10.1002/adfm.201804492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1002%2Fadfm.201804492" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=1804492&author=C.+Zhangauthor=W.+Wuauthor=R.+Q.+Liauthor=W.+X.+Qiuauthor=Z.+N.+Zhuangauthor=S.+X.+Chengauthor=X.+Z.+Zhang&title=Peptide-based+multifunctional+nanomaterials+for+tumor+imaging+and+therapy&doi=10.1002%2Fadfm.201804492"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fadfm.201804492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadfm.201804492%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DR.%2BQ.%26aulast%3DQiu%26aufirst%3DW.%2BX.%26aulast%3DZhuang%26aufirst%3DZ.%2BN.%26aulast%3DCheng%26aufirst%3DS.%2BX.%26aulast%3DZhang%26aufirst%3DX.%2BZ.%26atitle%3DPeptide-based%2520multifunctional%2520nanomaterials%2520for%2520tumor%2520imaging%2520and%2520therapy%26jtitle%3DAdv.%2520Funct.%2520Mater.%26date%3D2018%26volume%3D28%26spage%3D1804492%26doi%3D10.1002%2Fadfm.201804492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span> <span> </span><span class="NLM_article-title">Functional peptide-based drug delivery systems</span>. <i>J. Mater. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">6517</span>– <span class="NLM_lpage">6529</span>, <span class="refDoi"> DOI: 10.1039/d0tb00713g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1039%2FD0TB00713G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=32350489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntlensr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2020&pages=6517-6529&author=Z.+Lianauthor=T.+Ji&title=Functional+peptide-based+drug+delivery+systems&doi=10.1039%2Fd0tb00713g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Functional peptide-based drug delivery systems</span></div><div class="casAuthors">Lian, Zheng; Ji, Tianjiao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry B: Materials for Biology and Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">6517-6529</span>CODEN:
                <span class="NLM_cas:coden">JMCBDV</span>;
        ISSN:<span class="NLM_cas:issn">2050-7518</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Peptides are one of the most important functional motifs for constructing smart drug delivery systems (DDSs).  Functional peptides can be conjugated with drugs or carriers via covalent bonds, or assembled into DDSs via supramol. forces, which enables the DDSs to acquire desired functions such as targeting and/or environmental responsiveness.  In this mini review, we first introduce the different types of functional peptides that are commonly used for constructing DDSs, and we highlight representative strategies for designing smart DDSs by using functional peptides in the past few years.  We also state the challenges of peptide-based DDSs and come up with prospects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGHNf0dwKztbVg90H21EOLACvtfcHk0ljJUr77xsgEEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntlensr0%253D&md5=960a3f689456b6d0c62c6900c1f1467a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1039%2FD0TB00713G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FD0TB00713G%26sid%3Dliteratum%253Aachs%26aulast%3DLian%26aufirst%3DZ.%26aulast%3DJi%26aufirst%3DT.%26atitle%3DFunctional%2520peptide-based%2520drug%2520delivery%2520systems%26jtitle%3DJ.%2520Mater.%2520Chem.%2520B%26date%3D2020%26volume%3D8%26spage%3D6517%26epage%3D6529%26doi%3D10.1039%2Fd0tb00713g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, K. S.</span></span> <span> </span><span class="NLM_article-title">Tumor-targeting peptides from combinatorial libraries</span>. <i>Adv. Drug Deliv. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>110–111</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2016.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.addr.2016.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=27210583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC28XosFSrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110%E2%80%93111&publication_year=2017&pages=13-37&author=R.+Liuauthor=X.+Liauthor=W.+Xiaoauthor=K.+S.+Lam&title=Tumor-targeting+peptides+from+combinatorial+libraries&doi=10.1016%2Fj.addr.2016.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-targeting peptides from combinatorial libraries</span></div><div class="casAuthors">Liu, Ruiwu; Li, Xiaocen; Xiao, Wenwu; Lam, Kit S.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">110-111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-37</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cancer is one of the major and leading causes of death worldwide.  Two of the greatest challenges in fighting cancer are early detection and effective treatments with no or min. side effects.  Widespread use of targeted therapies and mol. imaging in clinics requires high affinity, tumor-specific agents as effective targeting vehicles to deliver therapeutics and imaging probes to the primary or metastatic tumor sites.  Combinatorial libraries such as phage-display and one-bead one-compd. (OBOC) peptide libraries are powerful approaches in discovering tumor-targeting peptides.  This review gives an overview of different combinatorial library technologies that have been used for the discovery of tumor-targeting peptides.  Examples of tumor-targeting peptides identified from each combinatorial library method will be discussed.  Published tumor-targeting peptide ligands and their applications will also be summarized by the combinatorial library methods and their corresponding binding receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9KQ2kv9PcBbVg90H21EOLACvtfcHk0lhHsr-mNcyLOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosFSrt7s%253D&md5=45a83d99dc3bf88e649662ee031835bc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2016.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2016.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXiao%26aufirst%3DW.%26aulast%3DLam%26aufirst%3DK.%2BS.%26atitle%3DTumor-targeting%2520peptides%2520from%2520combinatorial%2520libraries%26jtitle%3DAdv.%2520Drug%2520Deliv.%2520Rev.%26date%3D2017%26volume%3D110%25E2%2580%2593111%26spage%3D13%26epage%3D37%26doi%3D10.1016%2Fj.addr.2016.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoppenz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Els-Heindl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span> <span> </span><span class="NLM_article-title">Peptide-drug conjugates and their targets in advanced cancer therapies</span>. <i>Front. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">571</span>, <span class="refDoi"> DOI: 10.3389/fchem.2020.00571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.3389%2Ffchem.2020.00571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=32733853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFWhsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2020&pages=571&author=P.+Hoppenzauthor=S.+Els-Heindlauthor=A.+G.+Beck-Sickinger&title=Peptide-drug+conjugates+and+their+targets+in+advanced+cancer+therapies&doi=10.3389%2Ffchem.2020.00571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide-drug conjugates and their targets in advanced cancer therapies</span></div><div class="casAuthors">Hoppenz, Paul; Els-Heindl, Sylvia; Beck-Sickinger, Annette G.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Chemistry (Lausanne, Switzerland)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">571</span>CODEN:
                <span class="NLM_cas:coden">FCLSAA</span>;
        ISSN:<span class="NLM_cas:issn">2296-2646</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Cancer became recently the leading cause of death in industrialized countries.  Even though std. treatments achieve significant effects in growth inhibition and tumor elimination, they cause severe side effects as most of the applied drugs exhibit only minor selectivity for the malignant tissue.  Hence, specific addressing of tumor cells without affecting healthy tissue is currently a major desire in cancer therapy.  Cell surface receptors, which bind peptides are frequently overexpressed on cancer cells and can therefore be considered as promising targets for selective tumor therapy.  In this review, the benefits of peptides as tumor homing agents are presented and an overview of the most commonly addressed peptide receptors is given.  A special focus was set on the bombesin receptor family and the neuropeptide Y receptor family.  In the second part, the specific requirements of peptide-drug conjugates (PDC) and intelligent linker structures as an essential component of PDC are outlined.  Furthermore, different drug cargos are presented including classical and recent toxic agents as well as radionuclides for diagnostic and therapeutic approaches.  In the last part, boron neutron capture therapy as advanced targeted cancer therapy is introduced and past and recent developments are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxlD6eRupScLVg90H21EOLACvtfcHk0lhHsr-mNcyLOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFWhsrnK&md5=8ae3c54d1f171273e4684afb17298f22</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3389%2Ffchem.2020.00571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffchem.2020.00571%26sid%3Dliteratum%253Aachs%26aulast%3DHoppenz%26aufirst%3DP.%26aulast%3DEls-Heindl%26aufirst%3DS.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26atitle%3DPeptide-drug%2520conjugates%2520and%2520their%2520targets%2520in%2520advanced%2520cancer%2520therapies%26jtitle%3DFront.%2520Chem.%26date%3D2020%26volume%3D8%26spage%3D571%26doi%3D10.3389%2Ffchem.2020.00571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yewale, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baradia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vhora, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, A.</span></span> <span> </span><span class="NLM_article-title">Epidermal growth factor receptor targeting in cancer: a review of trends and strategies</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">8690</span>– <span class="NLM_lpage">8707</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2013.07.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.biomaterials.2013.07.100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=23953842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Kgu7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=8690-8707&author=C.+Yewaleauthor=D.+Baradiaauthor=I.+Vhoraauthor=S.+Patilauthor=A.+Misra&title=Epidermal+growth+factor+receptor+targeting+in+cancer%3A+a+review+of+trends+and+strategies&doi=10.1016%2Fj.biomaterials.2013.07.100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal growth factor receptor targeting in cancer: A review of trends and strategies</span></div><div class="casAuthors">Yewale, Chetan; Baradia, Dipesh; Vhora, Imran; Patil, Sushilkumar; Misra, Ambikanandan</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">8690-8707</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The epidermal growth factor receptor (EGFR) is a cell-surface receptor belonging to ErbB family of tyrosine kinase and it plays a vital role in the regulation of cell proliferation, survival and differentiation.  However; EGFR is aberrantly activated by various mechanisms like receptor overexpression, mutation, ligand-dependent receptor dimerization, ligand-independent activation and is assocd. with development of variety of tumors.  Therefore, specific EGFR inhibition is one of the key targets for cancer therapy.  Two major approaches have been developed and demonstrated benefits in clin. trials for targeting EGFR; monoclonal antibodies (mAbs) and tyrosine kinase inhibitors (TKIs).  EGFR inhibitors like, cetuximab, panitumumab, etc. (mAbs) and gefitinib, erlotinib, lapatinib, etc. (TKIs) are now com. available for treatment of variety of cancers.  Recently, many other agents like peptides, nanobodies, affibodies and antisense oligonucleotide have also shown better efficacy in targeting and inhibiting EGFR.  Now a days, efforts are being focused to identify mol. markers that can predict patients more likely to respond to anti-EGFR therapy; to find out combinatorial approaches with EGFR inhibitors and to bring new therapeutic agents with clin. efficacy.  In this review we have outlined the role of EGFR in cancer, different types of EGFR inhibitors, preclin. and clin. status of EGFR inhibitors as well as summarized the recent efforts made in the field of mol. EGFR targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP89tYD6VDorVg90H21EOLACvtfcHk0liJKmXgEJ42tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Kgu7bL&md5=e7ca806ebdfe6a6f48962cf3c8620468</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2013.07.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2013.07.100%26sid%3Dliteratum%253Aachs%26aulast%3DYewale%26aufirst%3DC.%26aulast%3DBaradia%26aufirst%3DD.%26aulast%3DVhora%26aufirst%3DI.%26aulast%3DPatil%26aufirst%3DS.%26aulast%3DMisra%26aufirst%3DA.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520targeting%2520in%2520cancer%253A%2520a%2520review%2520of%2520trends%2520and%2520strategies%26jtitle%3DBiomaterials%26date%3D2013%26volume%3D34%26spage%3D8690%26epage%3D8707%26doi%3D10.1016%2Fj.biomaterials.2013.07.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luwor, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, A. W.</span></span> <span> </span><span class="NLM_article-title">Epidermal growth factor receptor: structure-function informing the design of anticancer therapeutics</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2018.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.yexcr.2018.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=30098332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFWgsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2018&pages=1-19&author=R.+A.+Mitchellauthor=R.+B.+Luworauthor=A.+W.+Burgess&title=Epidermal+growth+factor+receptor%3A+structure-function+informing+the+design+of+anticancer+therapeutics&doi=10.1016%2Fj.yexcr.2018.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal growth factor receptor: Structure-function informing the design of anticancer therapeutics</span></div><div class="casAuthors">Mitchell, Ruth A.; Luwor, Rodney B.; Burgess, Antony W.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-19</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Research on the epidermal growth factor (EGF) family and the family of receptors (EGFR) has progressed rapidly in recent times.  New crystal structures of the ectodomains with different ligands, the activation of the kinase domain through oligomerisation and the use of fluorescence techniques have revealed profound conformational changes on ligand binding.  The control of cell signaling from the EGFR-family is complex, with heterodimerization, ligand affinity and signaling cross-talk influencing cellular outcomes.  Anal. of tissue homeostasis indicates that the control of pro-ligand processing is likely to be as important as receptor activation events.  Several members of the EGFR-family are overexpressed and/or mutated in cancer cells.  The perturbation of EGFR-family signaling drives the malignant phenotype of many cancers and both inhibitors and antagonists of signaling from these receptors have already produced therapeutic benefits for patients.  The design of affibodies, antibodies, small mol. inhibitors and even immunotherapeutic drugs targeting the EGFR-family has yielded promising new approaches to improving outcomes for cancer patients.  In this review, we describe recent discoveries which have increased our understanding of the structure and dynamics of signaling from the EGFR-family, the roles of ligand processing and receptor cross-talk.  We discuss the relevance of these studies to the development of strategies for designing more effective targeted treatments for cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWV1XU_yns2LVg90H21EOLACvtfcHk0liJKmXgEJ42tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFWgsLnI&md5=b14b21439986169ea8b55c525b70b9ed</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2018.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2018.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DMitchell%26aufirst%3DR.%2BA.%26aulast%3DLuwor%26aufirst%3DR.%2BB.%26aulast%3DBurgess%26aufirst%3DA.%2BW.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%253A%2520structure-function%2520informing%2520the%2520design%2520of%2520anticancer%2520therapeutics%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2018%26volume%3D371%26spage%3D1%26epage%3D19%26doi%3D10.1016%2Fj.yexcr.2018.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ongarora, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontenot, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehgal, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satyanarayana-Jois, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicente, M. G. H.</span></span> <span> </span><span class="NLM_article-title">Phthalocyanine–peptide conjugates for epidermal growth factor receptor targeting</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3725</span>– <span class="NLM_lpage">3738</span>, <span class="refDoi"> DOI: 10.1021/jm201544y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201544y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFOnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3725-3738&author=B.+G.+Ongaroraauthor=K.+R.+Fontenotauthor=X.+Huauthor=I.+Sehgalauthor=S.+D.+Satyanarayana-Joisauthor=M.+G.+H.+Vicente&title=Phthalocyanine%E2%80%93peptide+conjugates+for+epidermal+growth+factor+receptor+targeting&doi=10.1021%2Fjm201544y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Phthalocyanine-Peptide Conjugates for Epidermal Growth Factor Receptor Targeting</span></div><div class="casAuthors">Ongarora, Benson G.; Fontenot, Krystal R.; Hu, Xiaoke; Sehgal, Inder; Satyanarayana-Jois, Seetharama D.; Vicente, M. Graca H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3725-3738</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Four phthalocyanine (Pc)-peptide conjugates designed to target the epidermal growth factor receptor (EGFR) were synthesized and evaluated in vitro using four cell lines: human carcinoma A431 and HEp2, human colorectal HT-29, and kidney Vero (neg. control) cells.  Two peptide ligands for EGFR were studied: EGFR-L1 and -L2, bearing 6 and 13 amino acid residues, resp.  The peptides and Pc-conjugates bind to EGFR using both theor. (Autodock) and exptl. (SPR) studies.  The Pc-EGFR-L1 conjugates 5a and 5b efficiently targeted EGFR and were internalized, in part due to their cationic charge, whereas the uncharged Pc-EGFR-L2 conjugates 4b and 6a poorly targeted EGFR maybe due to their low aq. soly.  All conjugates were nontoxic (IC50 > 100 μM) to HT-29 cells, both in the dark and upon light activation (1 J/cm2).  I.v. administration of conjugate 5b into nude mice bearing A431 and HT-29 human tumor xenografts resulted in a near-IR fluorescence signal at ∼700 nm, 24 h after administration.  The authors' studies show that Pc-EGFR-L1 conjugates are promising near-IR fluorescent contrast agents for CRC and potentially other EGFR overexpressing cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUApGztjQQE7Vg90H21EOLACvtfcHk0liJKmXgEJ42tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFOnsLk%253D&md5=db3ce964fe894d433712cd9062bd0192</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm201544y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201544y%26sid%3Dliteratum%253Aachs%26aulast%3DOngarora%26aufirst%3DB.%2BG.%26aulast%3DFontenot%26aufirst%3DK.%2BR.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DSehgal%26aufirst%3DI.%26aulast%3DSatyanarayana-Jois%26aufirst%3DS.%2BD.%26aulast%3DVicente%26aufirst%3DM.%2BG.%2BH.%26atitle%3DPhthalocyanine%25E2%2580%2593peptide%2520conjugates%2520for%2520epidermal%2520growth%2520factor%2520receptor%2520targeting%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3725%26epage%3D3738%26doi%3D10.1021%2Fjm201544y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xue, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, R. C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, W.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, D. K. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of an epidermal growth factor receptor-targeted peptide-conjugated phthalocyanine-based photosensitiser</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">20652</span>– <span class="NLM_lpage">20662</span>, <span class="refDoi"> DOI: 10.1039/c9ra03911b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1039%2FC9RA03911B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1yku7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=20652-20662&author=E.+Y.+Xueauthor=R.+C.+H.+Wongauthor=C.+T.+T.+Wongauthor=W.-P.+Fongauthor=D.+K.+P.+Ng&title=Synthesis+and+biological+evaluation+of+an+epidermal+growth+factor+receptor-targeted+peptide-conjugated+phthalocyanine-based+photosensitiser&doi=10.1039%2Fc9ra03911b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of an epidermal growth factor receptor-targeted peptide-conjugated phthalocyanine-based photosensitiser</span></div><div class="casAuthors">Xue, Evelyn Y.; Wong, Roy C. H.; Wong, Clarence T. T.; Fong, Wing-Ping; Ng, Dennis K. P.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">20652-20662</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A peptide-conjugated zinc(II) phthalocyanine contg. the epidermal growth factor receptor-targeted heptapeptide QRHKPRE has been prepd.  The conjugate labeled as ZnPc-QRH* can selectively bind to the cell membrane of HT29 human colorectal adenocarcinoma cells in 10 min followed by internalisation upon prolonged incubation via receptor-mediated endocytosis, leading to localisation in lysosomes eventually.  By manipulating the incubation time, the subcellular localisation of the conjugate can be varied and the cell-death pathways induced upon irradn. can also be altered.  It has been found that photosensitization initiated at the cell membrane and in the lysosomes would trigger cell death mainly through necrosis and apoptosis resp.  I.v. administration of the conjugate into HT29 tumor-bearing nude mice resulted in higher accumulation in the tumor than in most major organs.  The selective binding of this conjugate to tumor has also been demonstrated by comparing the results with those of the analog with a scrambled peptide sequence (EPRQRHK).  The overall results indicate that ZnPc-QRH* is a promising EGFR-targeted photosensitizer for photodynamic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3mVFouidkOLVg90H21EOLACvtfcHk0lifhUboCz452Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1yku7nO&md5=d4c4c1f3fdc76928b6a576d562c93586</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1039%2FC9RA03911B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9RA03911B%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DE.%2BY.%26aulast%3DWong%26aufirst%3DR.%2BC.%2BH.%26aulast%3DWong%26aufirst%3DC.%2BT.%2BT.%26aulast%3DFong%26aufirst%3DW.-P.%26aulast%3DNg%26aufirst%3DD.%2BK.%2BP.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520an%2520epidermal%2520growth%2520factor%2520receptor-targeted%2520peptide-conjugated%2520phthalocyanine-based%2520photosensitiser%26jtitle%3DRSC%2520Adv.%26date%3D2019%26volume%3D9%26spage%3D20652%26epage%3D20662%26doi%3D10.1039%2Fc9ra03911b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, R. C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, D. K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, P.-C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of phthalocyanine-peptide conjugate for EGFR-targeted photodynamic therapy and bioimaging</span>. <i>Dyes Pigm.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1016/j.dyepig.2018.11.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.dyepig.2018.11.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVyhtrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2019&pages=197-203&author=L.+Yuauthor=Q.+Wangauthor=R.+C.-H.+Wongauthor=S.+Zhaoauthor=D.+K.+P.+Ngauthor=P.-C.+Lo&title=Synthesis+and+biological+evaluation+of+phthalocyanine-peptide+conjugate+for+EGFR-targeted+photodynamic+therapy+and+bioimaging&doi=10.1016%2Fj.dyepig.2018.11.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of phthalocyanine-peptide conjugate for EGFR-targeted photodynamic therapy and bioimaging</span></div><div class="casAuthors">Yu, Ligang; Wang, Qiong; Wong, Roy C.-H.; Zhao, Shirui; Ng, Dennis K. P.; Lo, Pui-Chi</div><div class="citationInfo"><span class="NLM_cas:title">Dyes and Pigments</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">197-203</span>CODEN:
                <span class="NLM_cas:coden">DYPIDX</span>;
        ISSN:<span class="NLM_cas:issn">0143-7208</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">To improve the biocompatibility and tumor selectivity, we employed an epidermal growth factor receptor (EGFR) binding peptide (namely GE11, with a sequence of Tyr-His-Trp-Tyr-Gly-Tyr-Thr-Pro-Gln-Asn-Val-Ile) as a tumor directing vector for the delivery of zinc(II) phthalocyanine for targeted photodynamic therapy and bioimaging.  The photophys. properties, cellular uptake, in vitro cytotoxicity, and in vivo biodistribution of this phthalocyanine-peptide conjugate (namely Pc-GE11) have been evaluated.  Pc-GE11 exhibited higher cellular uptake on EGFR-overexpressing epidermoid carcinoma A431 cells when compared with that on human breast adenocarcinoma MCF7 cells (low EGFR expression).  Moreover, pretreatment of A431 cells with GE11 peptide inhibited the cellular uptake of Pc-GE11 significantly and it exhibited exclusive light-activated cytotoxicity toward A431 cells.  Furthermore, Pc-GE11 showed much higher tumor accumulation than the non-targeted control compd. contg. a random peptide sequence (Tyr-Trp-Gly-Pro-Asn-Ile-His-Tyr-Tyr-Thr-Gln-Val) after i.v. administration in A431-tumor bearing mice, indicating the potential application of this GE11 peptide-conjugated photosensitizer for targeted photodynamic therapy and bioimaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2GVl6-CurgLVg90H21EOLACvtfcHk0lifhUboCz452Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVyhtrfL&md5=11b2967d14d3a24dccff91dcdb38481f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.dyepig.2018.11.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dyepig.2018.11.055%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWong%26aufirst%3DR.%2BC.-H.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DNg%26aufirst%3DD.%2BK.%2BP.%26aulast%3DLo%26aufirst%3DP.-C.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520phthalocyanine-peptide%2520conjugate%2520for%2520EGFR-targeted%2520photodynamic%2520therapy%2520and%2520bioimaging%26jtitle%3DDyes%2520Pigm.%26date%3D2019%26volume%3D163%26spage%3D197%26epage%3D203%26doi%3D10.1016%2Fj.dyepig.2018.11.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gentilucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerisoli, L.</span></span> <span> </span><span class="NLM_article-title">Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3185</span>– <span class="NLM_lpage">3203</span>, <span class="refDoi"> DOI: 10.2174/138161210793292555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.2174%2F138161210793292555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=20687878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKlurvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=3185-3203&author=L.+Gentilucciauthor=R.+De+Marcoauthor=L.+Cerisoli&title=Chemical+modifications+designed+to+improve+peptide+stability%3A+incorporation+of+non-natural+amino+acids%2C+pseudo-peptide+bonds%2C+and+cyclization&doi=10.2174%2F138161210793292555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization</span></div><div class="casAuthors">Gentilucci, Luca; De Marco, Rossella; Cerisoli, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3185-3203</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Functions and properties of native peptides vary from highly specific antibiotics or cytotoxic antitumor drugs, to hormones, neurotransmitters, immunomodulators, etc.  Despite their potential utility as therapeutic agents, there are problems connected with the use of natural peptides, due to the low stability against proteolysis, resulting in a short duration of in vivo activity, and in a low bioavailability.  One way to overcome these disadvantages is the use of modified peptides, the so called peptidomimetics.  Overall, the less peptide character in a drug candidate, the more stable it is towards protease cleavage.  A huge no. of non-peptidic scaffolds have been reported in the literature; nevertheless, several cases have failed to reproduce the activity of the precursor peptide when the scaffold itself contains relevant pharmacophore elements.  Therefore, quasi-peptides still maintain their appeal for applications in medicinal chem.  For the large no. of different unnatural amino acids and peptidomimetics, the overview cannot be all-inclusive.  This review focuses on modified peptides in which the peptide character is still preponderant, with particular emphasis on the chem. methodologies utilized to introduce the modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKqrcss8C63rVg90H21EOLACvtfcHk0lifhUboCz452Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKlurvN&md5=415952939a1fad8af38d117812205853</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F138161210793292555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210793292555%26sid%3Dliteratum%253Aachs%26aulast%3DGentilucci%26aufirst%3DL.%26aulast%3DDe%2BMarco%26aufirst%3DR.%26aulast%3DCerisoli%26aufirst%3DL.%26atitle%3DChemical%2520modifications%2520designed%2520to%2520improve%2520peptide%2520stability%253A%2520incorporation%2520of%2520non-natural%2520amino%2520acids%252C%2520pseudo-peptide%2520bonds%252C%2520and%2520cyclization%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D3185%26epage%3D3203%26doi%3D10.2174%2F138161210793292555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, R. K.</span></span> <span> </span><span class="NLM_article-title">Cyclic cell-penetrating peptides as efficient intracellular drug delivery tools</span>. <i>Mol. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3727</span>– <span class="NLM_lpage">3743</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.9b00633</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.9b00633" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVSqtrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=3727-3743&author=S.+E.+Parkauthor=M.+I.+Sajidauthor=K.+Parangauthor=R.+K.+Tiwari&title=Cyclic+cell-penetrating+peptides+as+efficient+intracellular+drug+delivery+tools&doi=10.1021%2Facs.molpharmaceut.9b00633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools</span></div><div class="casAuthors">Park, Shang Eun; Sajid, Muhammad Imran; Parang, Keykavous; Tiwari, Rakesh Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3727-3743</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic cell-penetrating peptides are relatively a newer class of peptides that have a huge potential for the intracellular delivery of therapeutic agents aimed at treating challenging ailments like multidrug resistance bacterial diseases, cancer, and HIV infection.  Although, cell-penetrating peptides (CPPs) have been extensively explored as intracellular delivery vehicles, however, they have some inherent limitations like poor stability, endosomal entrapment, toxicity, and suboptimal cell penetration.  Owing to their favorable properties that avoid these limitations, cyclic CPPs can provide a good alternative to linear CPPs.  Several reviews have been published in the last decade that cover CPPs and cyclic peptides independently.  To the best of our knowledge, this is one of the first reviews that covers cyclic CPPs comprehensively in the light of studies published so far.  In this review, we have detailed examples of cyclic CPPs, their structures, cyclization strategies followed by a detailed account of their advantages over their linear counterparts.  A hot area in cyclic CPPs is the exploration of cell penetration mechanisms; this review highlights this topic in detail.  Finally, we will review the applications of cyclic CPPs, followed by conclusions and future prospects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFdQDLeWoz2LVg90H21EOLACvtfcHk0liLBl94RC3A8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVSqtrbE&md5=10c81e465de1faf0be041b93a7a73bab</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.9b00633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.9b00633%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BE.%26aulast%3DSajid%26aufirst%3DM.%2BI.%26aulast%3DParang%26aufirst%3DK.%26aulast%3DTiwari%26aufirst%3DR.%2BK.%26atitle%3DCyclic%2520cell-penetrating%2520peptides%2520as%2520efficient%2520intracellular%2520drug%2520delivery%2520tools%26jtitle%3DMol.%2520Pharm.%26date%3D2019%26volume%3D16%26spage%3D3727%26epage%3D3743%26doi%3D10.1021%2Facs.molpharmaceut.9b00633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roxin, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span> <span> </span><span class="NLM_article-title">Flexible or fixed: a comparative review of linear and cyclic cancer-targeting peptides</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1601</span>– <span class="NLM_lpage">1618</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.75</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.4155%2Ffmc.12.75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=22917248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Gjtb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1601-1618&author=%C3%81.+Roxinauthor=G.+Zheng&title=Flexible+or+fixed%3A+a+comparative+review+of+linear+and+cyclic+cancer-targeting+peptides&doi=10.4155%2Ffmc.12.75"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Flexible or fixed: a comparative review of linear and cyclic cancer-targeting peptides</span></div><div class="casAuthors">Roxin, Aron; Zheng, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1601-1618</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Peptides can serve as versatile cancer-targeting ligands and have been used for clin. relevant applications such as cancer imaging and therapy.  A current and long-standing focus within peptide research is the creation of structurally constrained peptides generated through cyclization.  Cyclization is envisioned to enhance the selective binding, uptake, potency and stability of linear precursors.  This review compares closely related linear and cyclic peptides in these respects.  Peptide cyclization generally improves the selective binding and stability of linear precursors; however, not all cyclization strategies and constrained geometries enhance these properties to the same extent.  In some instances, linear analogs actually have better cancer-targeting properties compared with their cyclic counterparts.  Although cyclization does not necessarily improve the cancer-targeting properties of linear analogs, cyclic peptides may obtain properties that allow them to be used for addnl. applications.  This review aims to convey the advantages and limitations of cyclic cancer-targeting peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrViWuXjsVdQbVg90H21EOLACvtfcHk0liLBl94RC3A8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Gjtb3M&md5=9b5af6d0c7dbbb926cb5a4f4d89dc06f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.75%26sid%3Dliteratum%253Aachs%26aulast%3DRoxin%26aufirst%3D%25C3%2581.%26aulast%3DZheng%26aufirst%3DG.%26atitle%3DFlexible%2520or%2520fixed%253A%2520a%2520comparative%2520review%2520of%2520linear%2520and%2520cyclic%2520cancer-targeting%2520peptides%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D1601%26epage%3D1618%26doi%3D10.4155%2Ffmc.12.75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zorzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deyle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinis, C.</span></span> <span> </span><span class="NLM_article-title">Cyclic peptide therapeutics: past, present and future</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2017.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.cbpa.2017.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=28249193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsFGksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=24-29&author=A.+Zorziauthor=K.+Deyleauthor=C.+Heinis&title=Cyclic+peptide+therapeutics%3A+past%2C+present+and+future&doi=10.1016%2Fj.cbpa.2017.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic peptide therapeutics: past, present and future</span></div><div class="casAuthors">Zorzi, Alessandro; Deyle, Kaycie; Heinis, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-29</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cyclic peptides combine several favorable properties such as good binding affinity, target selectivity and low toxicity that make them an attractive modality for the development of therapeutics.  Over 40 cyclic peptide drugs are currently in clin. use and around one new cyclic peptide drug enters the market every year on av.  The vast majority of clin. approved cyclic peptides are derived from natural products, such as antimicrobials or human peptide hormones.  New powerful techniques based on rational design and in vitro evolution have enabled the de novo development of cyclic peptide ligands to targets for which nature does not offer solns.  A look at the cyclic peptides currently under clin. evaluation shows that several have been developed using such techniques.  This new source for cyclic peptide ligands introduces a freshness to the field, and it is likely that de novo developed cyclic peptides will be in clin. use in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwchcMOj1bSbVg90H21EOLACvtfcHk0liLBl94RC3A8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsFGksLg%253D&md5=4b9581365b92b649dad8c7b22c5bd9c3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2017.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2017.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DZorzi%26aufirst%3DA.%26aulast%3DDeyle%26aufirst%3DK.%26aulast%3DHeinis%26aufirst%3DC.%26atitle%3DCyclic%2520peptide%2520therapeutics%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D38%26spage%3D24%26epage%3D29%26doi%3D10.1016%2Fj.cbpa.2017.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span> <span> </span><span class="NLM_article-title">Radiolabeled multimeric cyclic RGD peptides as integrin α<sub>v</sub>β<sub>3</sub> targeted radiotracers for tumor imaging</span>. <i>Mol. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">472</span>– <span class="NLM_lpage">487</span>, <span class="refDoi"> DOI: 10.1021/mp060049x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp060049x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVKgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=472-487&author=S.+Liu&title=Radiolabeled+multimeric+cyclic+RGD+peptides+as+integrin+%CE%B1v%CE%B23+targeted+radiotracers+for+tumor+imaging&doi=10.1021%2Fmp060049x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabeled Multimeric Cyclic RGD Peptides as Integrin αvβ3 Targeted Radiotracers for Tumor Imaging</span></div><div class="casAuthors">Liu, Shuang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">472-487</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Integrin αvβ3 plays a significant role in tumor angiogenesis and is a receptor for the extracellular matrix proteins with the exposed arginine-glycine-aspartic (RGD) tripeptide sequence.  These include vitronectin, fibronectin, fibrinogen, lamin, collagen, Von Willibrand's factor, osteoponin, and adenovirus particles.  Integrin αvβ3 is expressed at low levels on epithelial cells and mature endothelial cells, but it is overexpressed on the activated endothelial cells of tumor neovasculature and some tumor cells.  The highly restricted expression of integrin αvβ3 during tumor growth, invasion, and metastasis presents an interesting mol. target for both early detection and treatment of rapidly growing solid tumors.  In the past decade, many radiolabeled linear and cyclic RGD peptide antagonists have been evaluated as the integrin αvβ3 targeted radiotracers.  Significant progress has been made on their use for imaging tumors of different origin by single photon emission computed tomog. (SPECT) or positron emission tomog. (PET) in several tumor-bearing animal models.  [18F]Galacto-RGD is under clin. investigation as the first integrin αvβ3 targeted radiotracer for noninvasive visualization of the activated integrin αvβ3 in cancer patients.  This review will focus on the radiolabeled multimeric cyclic RGD peptides (dimers and tetramers) useful as radiotracers to image the tumor integrin αvβ3 expression by SPECT and PET, and some fundamental aspects for the development of integrin αvβ3 targeted radiotracers.  These include the choice of radionuclide and bifunctional chelators, selection of targeting biomols., and factors influencing the integrin αvβ3 binding affinity and tumor uptake, as well as different approaches for modification of radiotracer pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVh1R-qDKmQ7Vg90H21EOLACvtfcHk0lhtGExNdExAnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVKgtr8%253D&md5=129f12ebcb72a9210f907715e5964657</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fmp060049x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp060049x%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26atitle%3DRadiolabeled%2520multimeric%2520cyclic%2520RGD%2520peptides%2520as%2520integrin%2520%25CE%25B1v%25CE%25B23%2520targeted%2520radiotracers%2520for%2520tumor%2520imaging%26jtitle%3DMol.%2520Pharm.%26date%3D2006%26volume%3D3%26spage%3D472%26epage%3D487%26doi%3D10.1021%2Fmp060049x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deyle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinis, C.</span></span> <span> </span><span class="NLM_article-title">Phage selection of cyclic peptides for application in research and drug development</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1866</span>– <span class="NLM_lpage">1874</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.7b00184</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.7b00184" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOqt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2017&pages=1866-1874&author=K.+Deyleauthor=X.-D.+Kongauthor=C.+Heinis&title=Phage+selection+of+cyclic+peptides+for+application+in+research+and+drug+development&doi=10.1021%2Facs.accounts.7b00184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Phage Selection of Cyclic Peptides for Application in Research and Drug Development</span></div><div class="casAuthors">Deyle, Kaycie; Kong, Xu-Dong; Heinis, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1866-1874</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic peptides can bind to protein targets with high affinities and selectivities, which makes them an attractive modality for the development of research reagents and therapeutics.  Addnl. properties, including low inherent toxicity, efficient chem. synthesis, and facile modification with labels or immobilization reagents, increase their attractiveness.  Cyclic peptide ligands against a wide range of protein targets have been isolated from natural sources such as bacteria, fungi, plants, and animals.  Many of them are currently used as research tools, and several have found application as therapeutics, such as the peptide hormones oxytocin and vasopressin and the antibiotics vancomycin and daptomycin, proving the utility of cyclic peptides in research and medicine.With the advent of phage display and other in vitro evolution techniques, it has become possible to generate cyclic peptide binders to diverse protein targets for which no natural peptides have been discovered.  A highly robust and widely applied approach is based on the cyclization of peptides displayed on phage via a disulfide bridge.  Disulfide-cyclized peptide ligands to more than a hundred different proteins have been reported in the literature.  Technol. advances achieved over the last three decades, including methods for generating larger phage display libraries, improved phage panning protocols, new cyclic peptide formats, and high-throughput sequencing, have enabled the generation of cyclic peptides with ever better binding affinities to more challenging targets.A relatively new cyclic peptide format developed using phage display involves bicyclic peptides.  These mols. consist of two macrocyclic peptide rings cyclized through a chem. linker.  Compared to monocyclic peptides of comparable mol. mass, bicyclic peptides are more constrained in their conformation.  As a result, they can bind to their targets with a higher affinity and are more resistant to proteolytic degrdn.  Phage-encoded bicyclic peptides are generated by chem. cyclizing random peptide libraries on phage.  Binders are identified by conventional phage panning and DNA sequencing.  Next-generation sequencing and new sequence alignment tools have enabled the rapid identification of bicyclic peptides.Bicyclic peptide ligands were developed against a range of diverse target classes including enzymes, receptors, and cytokines.  Most ligands bind with nanomolar affinities, with some reaching the picomolar range.  To date, several bicyclic peptides have been pos. evaluated in preclin. studies, and the first clin. tests are in sight.  While bicyclic peptide phage display was developed with therapeutic applications in mind, these peptides are increasingly used as research tools for target evaluation or as basic research probes as well.  Given the efficient development method, the ease of synthesis and handling, and the favorable binding and biophys. properties, bicyclic peptides are being developed against more and more targets, ever increasing their potential applications in research and medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtQln3dL6wo7Vg90H21EOLACvtfcHk0lhtGExNdExAnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOqt7zP&md5=416350a497d5f8811ac0a52cc441a03e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.7b00184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.7b00184%26sid%3Dliteratum%253Aachs%26aulast%3DDeyle%26aufirst%3DK.%26aulast%3DKong%26aufirst%3DX.-D.%26aulast%3DHeinis%26aufirst%3DC.%26atitle%3DPhage%2520selection%2520of%2520cyclic%2520peptides%2520for%2520application%2520in%2520research%2520and%2520drug%2520development%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2017%26volume%3D50%26spage%3D1866%26epage%3D1874%26doi%3D10.1021%2Facs.accounts.7b00184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">Understanding cell penetration of cyclic peptides</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">10241</span>– <span class="NLM_lpage">10287</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.9b00008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.9b00008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlCksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2019&pages=10241-10287&author=P.+G.+Doughertyauthor=A.+Sahniauthor=D.+Pei&title=Understanding+cell+penetration+of+cyclic+peptides&doi=10.1021%2Facs.chemrev.9b00008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding Cell Penetration of Cyclic Peptides</span></div><div class="casAuthors">Dougherty, Patrick G.; Sahni, Ashweta; Pei, Dehua</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">10241-10287</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Approx. 75% of all disease-relevant human proteins, including those involved in intracellular protein-protein interactions (PPIs), are undruggable with the current drug modalities (i.e., small mols. and biologics).  Macrocyclic peptides provide a potential soln. to these undruggable targets because their larger sizes (relative to conventional small mols.) endow them the capability of binding to flat PPI interfaces with antibody-like affinity and specificity.  Powerful combinatorial library technologies have been developed to routinely identify cyclic peptides as potent, specific inhibitors against proteins including PPI targets.  However, with the exception of a very small set of sequences, the vast majority of cyclic peptides are impermeable to the cell membrane, preventing their application against intracellular targets.  This Review examines common structural features that render most cyclic peptides membrane impermeable, as well as the unique features that allow the minority of sequences to enter the cell interior by passive diffusion, endocytosis/endosomal escape, or other mechanisms.  We also present the current state of knowledge about the mol. mechanisms of cell penetration, the various strategies for designing cell-permeable, biol. active cyclic peptides against intracellular targets, and the assay methods available to quantify their cell-permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0NDA9U7-1YrVg90H21EOLACvtfcHk0lhtGExNdExAnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlCksLs%253D&md5=65f68a9b69f3f7f33641b6a91835b1dd</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.9b00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.9b00008%26sid%3Dliteratum%253Aachs%26aulast%3DDougherty%26aufirst%3DP.%2BG.%26aulast%3DSahni%26aufirst%3DA.%26aulast%3DPei%26aufirst%3DD.%26atitle%3DUnderstanding%2520cell%2520penetration%2520of%2520cyclic%2520peptides%26jtitle%3DChem.%2520Rev.%26date%3D2019%26volume%3D119%26spage%3D10241%26epage%3D10287%26doi%3D10.1021%2Facs.chemrev.9b00008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, S. J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qvit, N.</span></span> <span> </span><span class="NLM_article-title">Backbone-cyclized peptides: a critical review</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">555</span>, <span class="refDoi"> DOI: 10.2174/1568026618666180518092333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.2174%2F1568026618666180518092333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=29773062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlCqsbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=526-555&author=S.+J.+S.+Rubinauthor=N.+Qvit&title=Backbone-cyclized+peptides%3A+a+critical+review&doi=10.2174%2F1568026618666180518092333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Backbone-Cyclized Peptides: A Critical Review</span></div><div class="casAuthors">Rubin, Samuel J. S.; Qvit, Nir</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">526-555</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Backbone-cyclized peptides and peptidomimetics integrate the biol. activity and pharmacol. features necessary for successful research tools and therapeutics.  In general, these structures demonstrate improved maintenance of bioactive conformation, stability and cell permeability compared to their linear counterparts, while maintaining support for a variety of side chain chemistries.  We explain how backbone cyclization and cycloscan techniques allow scientists to cyclize linear peptides with retained or enhanced biol. activity and improved drug-like features.  We discuss head-to-tail (Cterminus to N-terminus), building unit-to-tail, building unit-to-side chain, building unit-to-building unit, and building unit-to-head backbone cyclization, with examples of building blocks, such as Nα-(ω- thioalkylene), Nα-(ω-aminoalkylene) and Nα-(ω-carboxyalkylene) units.  We also present several methods for recombinant expression of backbone-cyclized peptides, including backbone cyclic peptide synthesis using recombinant elements (bcPURE), phage display and induced peptidyl-tRNA drop-off.  Moreover, natural backbone-cyclized peptides are also produced by cyanobacteria, plants and other organisms; several of these compds. have been developed and commercialized for therapeutic applications, which we .</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppeP4DJ9pFV7Vg90H21EOLACvtfcHk0ljYW7DhGX9zvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlCqsbrP&md5=5632ba35249befab43e0998afe51979a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F1568026618666180518092333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026618666180518092333%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DS.%2BJ.%2BS.%26aulast%3DQvit%26aufirst%3DN.%26atitle%3DBackbone-cyclized%2520peptides%253A%2520a%2520critical%2520review%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2018%26volume%3D18%26spage%3D526%26epage%3D555%26doi%3D10.2174%2F1568026618666180518092333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. T. T.</span></span> <span> </span><span class="NLM_article-title">Chemical synthesis of circular proteins</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">27020</span>– <span class="NLM_lpage">27025</span>, <span class="refDoi"> DOI: 10.1074/jbc.r111.323568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1074%2Fjbc.R111.323568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=22700959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFaqtr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=27020-27025&author=J.+P.+Tamauthor=C.+T.+T.+Wong&title=Chemical+synthesis+of+circular+proteins&doi=10.1074%2Fjbc.r111.323568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Synthesis of Circular Proteins</span></div><div class="casAuthors">Tam, James P.; Wong, Clarence T. T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">27020-27025</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Circular proteins, once thought to be rare, are now commonly found in plants.  Their chem. synthesis, once thought to be difficult, is now readily achievable.  The enabling methodol. is largely due to the advances in entropic chem. ligation to overcome the entropy barrier in coupling the N- and C-terminal ends of large peptide segments for either intermol. ligation or intramol. ligation in end-to-end cyclization.  Key elements of an entropic chem. ligation consist of a chemoselective capture step merging the N and C termini as a covalently linked O/S-ester intermediate to permit the subsequent step of an intramol. O/S-N acyl shift to form an amide.  Many ligation methods exploit the supernucleophilicity of a thiol side chain at the N terminus for the capture reaction, which makes cysteine-rich peptides ideal candidates for the entropy-driven macrocyclization.  Advances in desulfurization and modification of the thiol-contg. amino acids at the ligation sites to other amino acids add extra dimensions to the entropy-driven ligation methods.  This minireview describes recent advances of entropy-driven ligation to prep. circular proteins with or without a cysteinyl side chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF9-dNb_Q-abVg90H21EOLACvtfcHk0ljYW7DhGX9zvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFaqtr3F&md5=0f3a72634d8e812369ffcadb12e5342f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R111.323568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R111.323568%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DJ.%2BP.%26aulast%3DWong%26aufirst%3DC.%2BT.%2BT.%26atitle%3DChemical%2520synthesis%2520of%2520circular%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D27020%26epage%3D27025%26doi%3D10.1074%2Fjbc.r111.323568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yudin, A. K.</span></span> <span> </span><span class="NLM_article-title">Contemporary strategies for peptide macrocyclization</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">509</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1038/nchem.1062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1038%2Fnchem.1062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=21697871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFWjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=509-524&author=C.+J.+Whiteauthor=A.+K.+Yudin&title=Contemporary+strategies+for+peptide+macrocyclization&doi=10.1038%2Fnchem.1062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Contemporary strategies for peptide macrocyclization</span></div><div class="casAuthors">White, Christopher J.; Yudin, Andrei K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">509-524</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Peptide macrocycles have found applications that range from drug discovery to nanomaterials.  These ring-shaped mols. have shown remarkable capacity for functional fine-tuning.  Such capacity is enabled by the possibility of adjusting the peptide conformation using the techniques of chem. synthesis.  Cyclic peptides have been difficult, and often impossible, to prep. using traditional synthetic methods.  For macrocyclization to occur, the activated peptide must adopt an entropically disfavored pre-cyclization conformation before forming the desired product.  Here, recent solns. to some of the major challenges in this important area of contemporary synthesis were reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUTda6OkfQprVg90H21EOLACvtfcHk0ljYW7DhGX9zvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFWjtrc%253D&md5=32dfd94692ca20901dc8828bcd27ae8c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1062%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DC.%2BJ.%26aulast%3DYudin%26aufirst%3DA.%2BK.%26atitle%3DContemporary%2520strategies%2520for%2520peptide%2520macrocyclization%26jtitle%3DNat.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D509%26epage%3D524%26doi%3D10.1038%2Fnchem.1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, G. K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. T. T.</span></span> <span> </span><span class="NLM_article-title">Making circles: recent advance in chemical and enzymatic approaches in peptide macrocyclization</span>. <i>J. Biochem. Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.29199/bccs.101011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.29199%2Fbccs.101011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2017&pages=1-13&author=G.+K.+T.+Nguyenauthor=C.+T.+T.+Wong&title=Making+circles%3A+recent+advance+in+chemical+and+enzymatic+approaches+in+peptide+macrocyclization&doi=10.29199%2Fbccs.101011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.29199%2Fbccs.101011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.29199%252Fbccs.101011%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DG.%2BK.%2BT.%26aulast%3DWong%26aufirst%3DC.%2BT.%2BT.%26atitle%3DMaking%2520circles%253A%2520recent%2520advance%2520in%2520chemical%2520and%2520enzymatic%2520approaches%2520in%2520peptide%2520macrocyclization%26jtitle%3DJ.%2520Biochem.%2520Chem.%2520Sci.%26date%3D2017%26volume%3D1%26spage%3D1%26epage%3D13%26doi%3D10.29199%2Fbccs.101011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chow, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matheson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Ligation technologies for the synthesis of cyclic peptides</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">9971</span>– <span class="NLM_lpage">10001</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.8b00657</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.8b00657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlylsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2019&pages=9971-10001&author=H.+Y.+Chowauthor=Y.+Zhangauthor=E.+Mathesonauthor=X.+Li&title=Ligation+technologies+for+the+synthesis+of+cyclic+peptides&doi=10.1021%2Facs.chemrev.8b00657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Ligation technologies for the synthesis of cyclic peptides</span></div><div class="casAuthors">Chow, Hoi Yee; Zhang, Yue; Matheson, Eilidh; Li, Xuechen</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9971-10001</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Cyclic peptides have been attracting a lot of attention in recent decades, esp. in the area of drug discovery, as more and more naturally occurring cyclic peptides with diverse biol. activities have been discovered.  Chem. synthesis of cyclic peptides is essential when studying their structure-activity relationships.  Conventional peptide cyclization methods via direct coupling have inherent limitations, like the susceptibility to epimerization at the C-terminus, poor soly. of fully protected peptide precursors, and low yield caused by oligomerization.  In this regard, chemoselective ligation-mediated cyclization methods have emerged as effective strategies for cyclic peptide synthesis.  The toolbox for cyclic peptide synthesis has been expanded substantially in the past two decades, allowing more efficient synthesis of cyclic peptides with various scaffolds and modifications.  This review will explore different chemoselective ligation technologies used for cyclic peptide synthesis that generate both native and unnatural peptide linkages.  The practical issues and limitations of different methods will be discussed.  The advance in cyclic peptide synthesis will benefit the biol. and medicinal study of cyclic peptides, an important class of macrocycles with potentials in numerous fields, notably in therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog_6f0UHYktLVg90H21EOLACvtfcHk0lhIApeFldAiGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlylsLrE&md5=f7df3ecfe31680fa58f6c58f7cdd7265</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.8b00657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.8b00657%26sid%3Dliteratum%253Aachs%26aulast%3DChow%26aufirst%3DH.%2BY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMatheson%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DLigation%2520technologies%2520for%2520the%2520synthesis%2520of%2520cyclic%2520peptides%26jtitle%3DChem.%2520Rev.%26date%3D2019%26volume%3D119%26spage%3D9971%26epage%3D10001%26doi%3D10.1021%2Facs.chemrev.8b00657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kale, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villequey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deyle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinis, C.</span></span> <span> </span><span class="NLM_article-title">Cyclization of peptides with two chemical bridges affords large scaffold diversities</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1038/s41557-018-0042-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1038%2Fs41557-018-0042-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=29713035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVCkurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=715-723&author=S.+S.+Kaleauthor=C.+Villequeyauthor=X.-D.+Kongauthor=A.+Zorziauthor=K.+Deyleauthor=C.+Heinis&title=Cyclization+of+peptides+with+two+chemical+bridges+affords+large+scaffold+diversities&doi=10.1038%2Fs41557-018-0042-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclization of peptides with two chemical bridges affords large scaffold diversities</span></div><div class="casAuthors">Kale, Sangram S.; Villequey, Camille; Kong, Xu-Dong; Zorzi, Alessandro; Deyle, Kaycie; Heinis, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">715-723</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Successful screening campaigns depend on large and structurally diverse collections of compds.  In macrocycle screening, variation of the mol. scaffold is important for structural diversity, but so far it has been challenging to diversify this aspect in large combinatorial libraries.  Here, the authors report the cyclization of peptides with two chem. bridges to provide rapid access to thousands of different macrocyclic scaffolds in libraries that are easy to synthesize, screen and decode.  Application of this strategy to phage-encoded libraries allowed for the screening of an unprecedented structural diversity of macrocycles against plasma kallikrein, which is important in the swelling disorder hereditary angioedema.  These libraries yielded inhibitors with remarkable binding properties (subnanomolar Ki, >1000-fold selectivity) despite the small mol. mass (∼1200 Da).  An interlaced bridge format characteristic of this strategy provided high proteolytic stability (t1/2 in plasma of >3 days), making double-bridged peptides potentially amenable to topical or oral delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmZOAVFLZRH7Vg90H21EOLACvtfcHk0lhIApeFldAiGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVCkurg%253D&md5=66161a855b4d8317fb456a36765d9766</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fs41557-018-0042-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41557-018-0042-7%26sid%3Dliteratum%253Aachs%26aulast%3DKale%26aufirst%3DS.%2BS.%26aulast%3DVillequey%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DX.-D.%26aulast%3DZorzi%26aufirst%3DA.%26aulast%3DDeyle%26aufirst%3DK.%26aulast%3DHeinis%26aufirst%3DC.%26atitle%3DCyclization%2520of%2520peptides%2520with%2520two%2520chemical%2520bridges%2520affords%2520large%2520scaffold%2520diversities%26jtitle%3DNat.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D715%26epage%3D723%26doi%3D10.1038%2Fs41557-018-0042-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chu, J. C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, P.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, D. K. P.</span></span> <span> </span><span class="NLM_article-title">One-pot synthesis of a cyclic antimicrobial peptide-conjugated phthalocyanine for synergistic chemo-photodynamic killing of multidrug-resistant bacteria</span>. <i>Adv. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2000204</span>, <span class="refDoi"> DOI: 10.1002/adtp.202000204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1002%2Fadtp.202000204" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2021&pages=2000204&author=J.+C.+H.+Chuauthor=M.+L.+Chinauthor=C.+T.+T.+Wongauthor=M.+Huiauthor=P.-C.+Loauthor=D.+K.+P.+Ng&title=One-pot+synthesis+of+a+cyclic+antimicrobial+peptide-conjugated+phthalocyanine+for+synergistic+chemo-photodynamic+killing+of+multidrug-resistant+bacteria&doi=10.1002%2Fadtp.202000204"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fadtp.202000204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadtp.202000204%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DJ.%2BC.%2BH.%26aulast%3DChin%26aufirst%3DM.%2BL.%26aulast%3DWong%26aufirst%3DC.%2BT.%2BT.%26aulast%3DHui%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DP.-C.%26aulast%3DNg%26aufirst%3DD.%2BK.%2BP.%26atitle%3DOne-pot%2520synthesis%2520of%2520a%2520cyclic%2520antimicrobial%2520peptide-conjugated%2520phthalocyanine%2520for%2520synergistic%2520chemo-photodynamic%2520killing%2520of%2520multidrug-resistant%2520bacteria%26jtitle%3DAdv.%2520Ther.%26date%3D2021%26volume%3D4%26spage%3D2000204%26doi%3D10.1002%2Fadtp.202000204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics, 2016</span>. <i>CA-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.3322/caac.21332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.3322%2Fcaac.21332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=26742998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A280%3ADC%252BC28rot1Kjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2016&pages=7-30&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2016&doi=10.3322%2Fcaac.21332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2016</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries.  Mortality data were collected by the National Center for Health Statistics.  In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are projected to occur in the United States.  Overall cancer incidence trends (13 oldest SEER registries) are stable in women, but declining by 3.1% per year in men (from 2009-2012), much of which is because of recent rapid declines in prostate cancer diagnoses.  The cancer death rate has dropped by 23% since 1991, translating to more than 1.7 million deaths averted through 2012.  Despite this progress, death rates are increasing for cancers of the liver, pancreas, and uterine corpus, and cancer is now the leading cause of death in 21 states, primarily due to exceptionally large reductions in death from heart disease.  Among children and adolescents (aged birth-19 years), brain cancer has surpassed leukemia as the leading cause of cancer death because of the dramatic therapeutic advances against leukemia.  Accelerating progress against cancer requires both increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKAn5ROFAaRS86Js-BCLiifW6udTcc2eZip7148o99iLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rot1Kjug%253D%253D&md5=2d4030a531945c5ebaaab181bfd80457</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21332%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202016%26jtitle%3DCA-Cancer%2520J.%2520Clin.%26date%3D2016%26volume%3D66%26spage%3D7%26epage%3D30%26doi%3D10.3322%2Fcaac.21332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. A.</span></span> <span> </span><span class="NLM_article-title">Isolation of a colon tumor specific binding peptide using phage display selection</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1016/s1476-5586(03)80046-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2FS1476-5586%2803%2980046-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=14670181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvVehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=437-444&author=K.+A.+Kellyauthor=D.+A.+Jones&title=Isolation+of+a+colon+tumor+specific+binding+peptide+using+phage+display+selection&doi=10.1016%2Fs1476-5586%2803%2980046-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a colon tumor specific binding peptide using phage display selection</span></div><div class="casAuthors">Kelly, Kimberly A.; Jones, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (Wilton, CT, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">437-444</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Neoplasia Press Inc.</span>)
        </div><div class="casAbstract">Colorectal cancer is the third most common malignancy in the United States.  Improved detection sensitivity of early colorectal neoplasms would have important clin. applications.  Herein, we report on using phage display to generate peptide libraries that detect colon carcinoma tissues.  To accomplish this, we employed pos. selection of a peptide-bearing phage library on poorly differentiated colon carcinoma cells (HT29) and combined this with neg. selection of the phage library on well-differentiated colon carcinoma cells (HCT116).  Anal. of the resulting library identified a nine-amino-acid, disulfide-constrained peptide, CPIEDRPMC (RPMrel), that stained HT29 colon carcinoma cells.  Immunohistochem. staining using FITC-conjugated RPMrel peptide also showed binding of RPMrel to colon tumor tissues from four patients.  We saw no binding of RPMrel to normal colon tissues.  In addn., RPMrel failed to stain a panel of noncolon tissues including the lungs, liver, and stomach.  We further demonstrated that RPMrel coupled to the mitochondrial toxin (KLAKLAK)2 killed HT29 cells.  These studies suggest that RPMrel may be a promising lead candidate in the development of a useful colon tumor diagnostic and targeted drug delivery agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTd-mnPukB17Vg90H21EOLACvtfcHk0lgIKeM2Lww36Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvVehtg%253D%253D&md5=3d5653fd836a1a254a37efc1d0763d1a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS1476-5586%2803%2980046-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1476-5586%252803%252980046-5%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DK.%2BA.%26aulast%3DJones%26aufirst%3DD.%2BA.%26atitle%3DIsolation%2520of%2520a%2520colon%2520tumor%2520specific%2520binding%2520peptide%2520using%2520phage%2520display%2520selection%26jtitle%3DNeoplasia%26date%3D2003%26volume%3D5%26spage%3D437%26epage%3D444%26doi%3D10.1016%2Fs1476-5586%2803%2980046-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W. K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S. S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, C. H.</span></span> <span> </span><span class="NLM_article-title">A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">292</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2010.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.jconrel.2010.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=20854857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFSqtb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2010&pages=292-302&author=Z.+J.+Liauthor=W.+K.+K.+Wuauthor=S.+S.+M.+Ngauthor=L.+Yuauthor=H.+T.+Liauthor=C.+C.+M.+Wongauthor=Y.+C.+Wuauthor=L.+Zhangauthor=S.+X.+Renauthor=X.+G.+Sunauthor=K.+M.+Chanauthor=C.+H.+Cho&title=A+novel+peptide+specifically+targeting+the+vasculature+of+orthotopic+colorectal+cancer+for+imaging+detection+and+drug+delivery&doi=10.1016%2Fj.jconrel.2010.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery</span></div><div class="casAuthors">Li, Zhi Jie; Wu, William Ka Kei; Ng, Simon Siu Man; Yu, Le; Li, Hai Tao; Wong, Clover Ching Man; Wu, Ya Chun; Zhang, Lin; Ren, Shun Xiang; Sun, Xue Gang; Chan, Kam Ming; Cho, Chi Hin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">292-302</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Colorectal cancer (CRC) is the third most common malignancy and the fourth most frequent cause of cancer deaths worldwide.  Ligand-mediated diagnosis and targeted therapy would have vital clin. applications in cancer treatment.  In this study, an orthotopic model of colorectal cancer was established in mice.  In vivo phage library selection was then utilized to isolate peptides specifically recognizing the vasculature of colorectal cancer tissues.  A phage (termed TCP-1 phage) was isolated by this manner and it homed to the colorectal cancer tissues by 11- to 94-fold more than other organs.  Chem. synthetic peptide (CTPSPFSHC, termed TCP-1) displayed by TCP-1 phage inhibited the homing ability of the phage to the tumor mass when co-injected i.v. with the TCP-1 phage into mice with colon cancer.  Meanwhile, immunostaining anal. indicated that TCP-1 phage and peptide localized in the vasculature of the colorectal cancer tissue, but not of normal tissues.  Moreover, TCP-1 peptide bound to blood vessels of surgical tissue samples of human colorectal cancer.  After i.v. injection of FITC-labeled TCP-1 into the tumor-bearing mice for 20 h, there was a strong fluorescent signal in the tumors but not other tissues when obsd. under blue light.  In addn., TCP-1 conjugated with a pro-apoptotic peptide specifically induced apoptosis of tumor-assocd. blood vessels in vivo.  The data define a novel peptide TCP-1 as an effective agent for imaging detection and drug delivery for colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_WXoajF6pC7Vg90H21EOLACvtfcHk0lip-tr5rvxXbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFSqtb7L&md5=650c2f678aaadb98fd098dd296ce58a8</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2010.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2010.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%2BJ.%26aulast%3DWu%26aufirst%3DW.%2BK.%2BK.%26aulast%3DNg%26aufirst%3DS.%2BS.%2BM.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DH.%2BT.%26aulast%3DWong%26aufirst%3DC.%2BC.%2BM.%26aulast%3DWu%26aufirst%3DY.%2BC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DRen%26aufirst%3DS.%2BX.%26aulast%3DSun%26aufirst%3DX.%2BG.%26aulast%3DChan%26aufirst%3DK.%2BM.%26aulast%3DCho%26aufirst%3DC.%2BH.%26atitle%3DA%2520novel%2520peptide%2520specifically%2520targeting%2520the%2520vasculature%2520of%2520orthotopic%2520colorectal%2520cancer%2520for%2520imaging%2520detection%2520and%2520drug%2520delivery%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2010%26volume%3D148%26spage%3D292%26epage%3D302%26doi%3D10.1016%2Fj.jconrel.2010.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span> <span> </span><span class="NLM_article-title">Biological evaluation of a novel doxorubicin-peptide conjugate for targeted delivery to EGF receptor-overexpressing tumor cells</span>. <i>Mol. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1021/mp100243j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp100243j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=375-386&author=S.+Aiauthor=J.+Duanauthor=X.+Liuauthor=S.+Bockauthor=Y.+Tianauthor=Z.+Huang&title=Biological+evaluation+of+a+novel+doxorubicin-peptide+conjugate+for+targeted+delivery+to+EGF+receptor-overexpressing+tumor+cells&doi=10.1021%2Fmp100243j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Biological Evaluation of a Novel Doxorubicin-Peptide Conjugate for Targeted Delivery to EGF Receptor-Overexpressing Tumor Cells</span></div><div class="casAuthors">Ai, Shibin; Duan, Jianli; Liu, Xin; Bock, Stephanie; Tian, Yuan; Huang, Zebo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">375-386</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) is overexpressed in a variety of epithelial malignancies and thus can be used for EGFR-targeted therapy to improve antitumor efficacy.  Therefore we synthesized a novel conjugate of doxorubicin (DOX) with an EGFR-binding peptide (NH2-CMYIEALDKYAC-COOH; EBP) via an ester bond at position 14 of DOX through a glutarate spacer.  To confirm that the DOX-EBP conjugate is capable of targeting tumor cells overexpressing EGFR, we compared the cellular accumulation, intracellular distribution and in vitro cytotoxicity of DOX-EBP and free DOX.  After treating with equimolar concn. of DOX-EBP or free DOX, the conjugate accumulated at significantly higher levels in EGFR-overexpressing cells than in non-EGFR-overexpressing cells, while the intracellular accumulation of free DOX was almost the same in all the cells.  However, the intracellular accumulation of DOX-EBP was significantly reduced in EGFR-overexpressing cells preincubated with inhibitory anti-EGFR monoclonal antibody, demonstrating the involvement of EGFR pathway in the transport of the conjugate.  Confocal fluorescence microscopy reveals that the conjugate was distributed in cytoplasmic and perinuclear areas during the first 30 min, whereas the free DOX was accumulated in both cytoplasm and nuclei.  After 24 h, however, the DOX signal in the cells treated with DOX-EBP was also distributed in the nuclei, suggesting the release of DOX from the conjugate and entry into the nuclei.  Biodistribution and in vivo antitumor expts., together with in vitro cytotoxicity, indicate that the therapeutic competence of DOX-EBP was due to its increased accumulation in EGFR-expressing tumor cells.  Furthermore, the survival of tumor-bearing mice treated with DOX-EBP was significantly higher than that with free DOX.  These data demonstrate the enhanced anticancer efficacy and reduced systemic toxicity of DOX-EBP conjugate with targeting ability to EGFR-overexpressing tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVSrJQxo4pvbVg90H21EOLACvtfcHk0lip-tr5rvxXbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSitLw%253D&md5=dced6f94494c99afd91e8e3e7481b21f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fmp100243j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp100243j%26sid%3Dliteratum%253Aachs%26aulast%3DAi%26aufirst%3DS.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBock%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DBiological%2520evaluation%2520of%2520a%2520novel%2520doxorubicin-peptide%2520conjugate%2520for%2520targeted%2520delivery%2520to%2520EGF%2520receptor-overexpressing%2520tumor%2520cells%26jtitle%3DMol.%2520Pharm.%26date%3D2011%26volume%3D8%26spage%3D375%26epage%3D386%26doi%3D10.1021%2Fmp100243j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">St.
Amant, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florinas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazenbaker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Alaniz, J. R.</span></span> <span> </span><span class="NLM_article-title">Tuning the Diels-Alder reaction for bioconjugation to maleimide drug-linkers</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2406</span>– <span class="NLM_lpage">2414</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.8b00320</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.8b00320" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFOqsr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=2406-2414&author=A.+H.+St.%0AAmantauthor=D.+Lemenauthor=S.+Florinasauthor=S.+Maoauthor=C.+Fazenbakerauthor=H.+Zhongauthor=H.+Wuauthor=C.+Gaoauthor=R.+J.+Christieauthor=J.+R.+de+Alaniz&title=Tuning+the+Diels-Alder+reaction+for+bioconjugation+to+maleimide+drug-linkers&doi=10.1021%2Facs.bioconjchem.8b00320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tuning the Diels-Alder Reaction for Bioconjugation to Maleimide Drug-Linkers</span></div><div class="casAuthors">St. Amant, Andre H.; Lemen, Daniel; Florinas, Stelios; Mao, Shenlan; Fazenbaker, Christine; Zhong, Haihong; Wu, Herren; Gao, Changshou; Christie, R. James; Read de Alaniz, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2406-2414</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The thiol-maleimide linkage is widely used for antibody-drug conjugate (ADC) prodn.; however, conjugation of maleimide-drugs could be improved by simplified procedures and reliable conjugate stability.  Here, we report the evaluation of electron-rich and cyclic dienes that can be appended to antibodies and reacted with maleimide-contg. drugs through the Diels-Alder (DA) reaction.  Drug conjugation is fast and quant. due to reaction acceleration in water, and the linkage is more stable in serum than in the corresponding thiol-maleimide adduct with the same drug.  ADCs produced using the DA reaction (DAADCs) are effective in vitro and in vivo, demonstrating the utility of this reaction in producing effective biotherapeutics.  Given the large no. of com. available maleimide compds., this conjugation approach could be readily applied to the prodn. of a wide range of antibody (or protein) conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNcpT6Rr87XrVg90H21EOLACvtfcHk0lhZfzsq190lQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFOqsr7O&md5=6dcd7ac21f0c021215a18ea8429fe36b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.8b00320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.8b00320%26sid%3Dliteratum%253Aachs%26aulast%3DSt.%2BAmant%26aufirst%3DA.%2BH.%26aulast%3DLemen%26aufirst%3DD.%26aulast%3DFlorinas%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DFazenbaker%26aufirst%3DC.%26aulast%3DZhong%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DR.%2BJ.%26aulast%3Dde%2BAlaniz%26aufirst%3DJ.%2BR.%26atitle%3DTuning%2520the%2520Diels-Alder%2520reaction%2520for%2520bioconjugation%2520to%2520maleimide%2520drug-linkers%26jtitle%3DBioconjugate%2520Chem.%26date%3D2018%26volume%3D29%26spage%3D2406%26epage%3D2414%26doi%3D10.1021%2Facs.bioconjchem.8b00320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mielert, A.</span></span> <span> </span><span class="NLM_article-title">The order of reactivity of dienes towards maleic anhydride in the Diels-Alder reaction</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1962</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1002/anie.196202683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1002%2Fanie.196202683" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1962&pages=268-269&author=J.+Sauerauthor=D.+Langauthor=A.+Mielert&title=The+order+of+reactivity+of+dienes+towards+maleic+anhydride+in+the+Diels-Alder+reaction&doi=10.1002%2Fanie.196202683"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fanie.196202683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.196202683%26sid%3Dliteratum%253Aachs%26aulast%3DSauer%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DD.%26aulast%3DMielert%26aufirst%3DA.%26atitle%3DThe%2520order%2520of%2520reactivity%2520of%2520dienes%2520towards%2520maleic%2520anhydride%2520in%2520the%2520Diels-Alder%2520reaction%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1962%26volume%3D1%26spage%3D268%26epage%3D269%26doi%3D10.1002%2Fanie.196202683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, B.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raab, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhakta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons-Reponte, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tibbitts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baudys, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saad, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scales, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hass, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solis, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flagella, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khawli, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebens, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandlen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sliwkowski, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheller, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junutula, J. R.</span></span> <span> </span><span class="NLM_article-title">Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1038/nbt.2108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1038%2Fnbt.2108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=22267010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=184-189&author=B.-Q.+Shenauthor=K.+Xuauthor=L.+Liuauthor=H.+Raabauthor=S.+Bhaktaauthor=M.+Kenrickauthor=K.+L.+Parsons-Reponteauthor=J.+Tienauthor=S.-F.+Yuauthor=E.+Maiauthor=D.+Liauthor=J.+Tibbittsauthor=J.+Baudysauthor=O.+M.+Saadauthor=S.+J.+Scalesauthor=P.+J.+McDonaldauthor=P.+E.+Hassauthor=C.+Eigenbrotauthor=T.+Nguyenauthor=W.+A.+Solisauthor=R.+N.+Fujiauthor=K.+M.+Flagellaauthor=D.+Patelauthor=S.+D.+Spencerauthor=L.+A.+Khawliauthor=A.+Ebensauthor=W.+L.+Wongauthor=R.+Vandlenauthor=S.+Kaurauthor=M.+X.+Sliwkowskiauthor=R.+H.+Schellerauthor=P.+Polakisauthor=J.+R.+Junutula&title=Conjugation+site+modulates+the+in+vivo+stability+and+therapeutic+activity+of+antibody-drug+conjugates&doi=10.1038%2Fnbt.2108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates</span></div><div class="casAuthors">Shen, Ben-Quan; Xu, Keyang; Liu, Luna; Raab, Helga; Bhakta, Sunil; Kenrick, Margaret; Parsons-Reponte, Kathryn L.; Tien, Janet; Yu, Shang-Fan; Mai, Elaine; Li, Dongwei; Tibbitts, Jay; Baudys, Jakub; Saad, Ola M.; Scales, Suzie J.; McDonald, Paul J.; Hass, Philip E.; Eigenbrot, Charles; Nguyen, Trung; Solis, Willy A.; Fuji, Reina N.; Flagella, Kelly M.; Patel, Darshana; Spencer, Susan D.; Khawli, Leslie A.; Ebens, Allen; Wong, Wai Lee; Vandlen, Richard; Kaur, Surinder; Sliwkowski, Mark X.; Scheller, Richard H.; Polakis, Paul; Junutula, Jagath R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-189</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The reactive thiol in cysteine is used for coupling maleimide linkers in the generation of antibody conjugates.  To assess the impact of the conjugation site, we engineered cysteines into a therapeutic HER2/neu antibody at three sites differing in solvent accessibility and local charge.  The highly solvent-accessible site rapidly lost conjugated thiol-reactive linkers in plasma owing to maleimide exchange with reactive thiols in albumin, free cysteine or glutathione.  In contrast, a partially accessible site with a pos. charged environment promoted hydrolysis of the succinimide ring in the linker, thereby preventing this exchange reaction.  The site with partial solvent-accessibility and neutral charge displayed both properties.  In a mouse mammary tumor model, the stability and therapeutic activity of the antibody conjugate were affected pos. by succinimide ring hydrolysis and neg. by maleimide exchange with thiol-reactive constituents in plasma.  Thus, the chem. and structural dynamics of the conjugation site can influence antibody conjugate performance by modulating the stability of the antibody-linker interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkINkMwQTMFrVg90H21EOLACvtfcHk0lhZfzsq190lQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGqtLg%253D&md5=c647fc5bdfe93dfdabb15ca40934837f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2108%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DB.-Q.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DRaab%26aufirst%3DH.%26aulast%3DBhakta%26aufirst%3DS.%26aulast%3DKenrick%26aufirst%3DM.%26aulast%3DParsons-Reponte%26aufirst%3DK.%2BL.%26aulast%3DTien%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DS.-F.%26aulast%3DMai%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DTibbitts%26aufirst%3DJ.%26aulast%3DBaudys%26aufirst%3DJ.%26aulast%3DSaad%26aufirst%3DO.%2BM.%26aulast%3DScales%26aufirst%3DS.%2BJ.%26aulast%3DMcDonald%26aufirst%3DP.%2BJ.%26aulast%3DHass%26aufirst%3DP.%2BE.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DSolis%26aufirst%3DW.%2BA.%26aulast%3DFuji%26aufirst%3DR.%2BN.%26aulast%3DFlagella%26aufirst%3DK.%2BM.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DSpencer%26aufirst%3DS.%2BD.%26aulast%3DKhawli%26aufirst%3DL.%2BA.%26aulast%3DEbens%26aufirst%3DA.%26aulast%3DWong%26aufirst%3DW.%2BL.%26aulast%3DVandlen%26aufirst%3DR.%26aulast%3DKaur%26aufirst%3DS.%26aulast%3DSliwkowski%26aufirst%3DM.%2BX.%26aulast%3DScheller%26aufirst%3DR.%2BH.%26aulast%3DPolakis%26aufirst%3DP.%26aulast%3DJunutula%26aufirst%3DJ.%2BR.%26atitle%3DConjugation%2520site%2520modulates%2520the%2520in%2520vivo%2520stability%2520and%2520therapeutic%2520activity%2520of%2520antibody-drug%2520conjugates%26jtitle%3DNat.%2520Biotechnol.%26date%3D2012%26volume%3D30%26spage%3D184%26epage%3D189%26doi%3D10.1038%2Fnbt.2108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Entradas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldron, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volk, M.</span></span> <span> </span><span class="NLM_article-title">The detection sensitivity of commonly used singlet oxygen probes in aqueous environments</span>. <i>J. Photochem. Photobiol., B</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>204</i></span>,  <span class="NLM_fpage">111787</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2020.111787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.jphotobiol.2020.111787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=31958676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFOjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2020&pages=111787&author=T.+Entradasauthor=S.+Waldronauthor=M.+Volk&title=The+detection+sensitivity+of+commonly+used+singlet+oxygen+probes+in+aqueous+environments&doi=10.1016%2Fj.jphotobiol.2020.111787"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The detection sensitivity of commonly used singlet oxygen probes in aqueous environments</span></div><div class="casAuthors">Entradas, Tiago; Waldron, Sarah; Volk, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111787</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The sensitivity for singlet oxygen (1O2) of two convenient 1O2 probes, 1,3-diphenylisobenzofuran (DPBF) and 9,10-Anthracenediyl-bis(methylene)dimalonic acid (ABDA), has been investigated in different aq. environments.  Both probes are com. available at reasonable cost and can be used with std. UV-vis spectrometers.  Although DPBF is not sol. in neat water and is not specific to the detection of 1O2, it has very high, essentially diffusion-limited, reactivity towards 1O2; it can trap up to 50% of all 1O2 created in alc./water or micellar soln., and even more when replacing H2O by D2O, which makes it highly useful when the process under investigation does not yield much 1O2.  On the other hand, ABDA has a much lower reactivity, reacting with only 2% of the singlet oxygen generated in H2O, as well as a smaller extinction coeff., resulting in a much smaller spectroscopic response, but is sol. in neat water and is specific for 1O2, allowing for discrimination from other reactive oxygen species.  The results presented here not only allow a comparative assessment of the usefulness of the two 1O2 probes, but also provide a ref. for an accurate abs. quantification of the amt. of 1O2 generated in an expt. from the obsd. absorbance bleach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIjDnr9MT9BrVg90H21EOLACvtfcHk0lgpOPm5BliQWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFOjt7Y%253D&md5=0a5e1df32543ac54e2af2287206f7bab</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2020.111787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2020.111787%26sid%3Dliteratum%253Aachs%26aulast%3DEntradas%26aufirst%3DT.%26aulast%3DWaldron%26aufirst%3DS.%26aulast%3DVolk%26aufirst%3DM.%26atitle%3DThe%2520detection%2520sensitivity%2520of%2520commonly%2520used%2520singlet%2520oxygen%2520probes%2520in%2520aqueous%2520environments%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%252C%2520B%26date%3D2020%26volume%3D204%26spage%3D111787%26doi%3D10.1016%2Fj.jphotobiol.2020.111787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, W.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, D. K. P.</span></span> <span> </span><span class="NLM_article-title">Highly photocytotoxic 1,4-dipegylated zinc(II) phthalocyanines. Effects of the chain length on the in vitro photodynamic activities</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">4560</span>– <span class="NLM_lpage">4566</span>, <span class="refDoi"> DOI: 10.1039/b814627f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1039%2Fb814627f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=19039364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVChtb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=4560-4566&author=J.-Y.+Liuauthor=X.-J.+Jiangauthor=W.-P.+Fongauthor=D.+K.+P.+Ng&title=Highly+photocytotoxic+1%2C4-dipegylated+zinc%28II%29+phthalocyanines.+Effects+of+the+chain+length+on+the+in+vitro+photodynamic+activities&doi=10.1039%2Fb814627f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Highly photocytotoxic 1,4-dipegylated zinc(ii) phthalocyanines. Effects of the chain length on the in vitro photodynamic activities</span></div><div class="casAuthors">Liu, Jian-Yong; Jiang, Xiong-Jie; Fong, Wing-Ping; Ng, Dennis K. P.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4560-4566</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A new series of 1,4-dipegylated zinc(ii) phthalocyanines have been synthesized and spectroscopically characterised.  The derivs. ZnPc[O(CH2CH2O)nMe]2 (n = 2, 4, ca. 12) have been prepd. by mixed cyclisation of the corresponding disubstituted phthalonitriles with an excess of unsubstituted phthalonitrile in the presence of Zn(OAc)2·2H2O and 1,8-diazabicyclo[5.4.0]undec-7-ene.  The other two analogs ZnPc[O(CH2CH2O)nMe]2 (n = 6, 8) have been prepd. by chain elongation reaction of ZnPc[O(CH2CH2O)4H]2.  These macrocycles are highly sol. and remain non-aggregated in DMF as shown by the sharp Q-band absorption.  Compared with the unsubstituted zinc(ii) phthalocyanine, these di-α-substituted analogs have a red-shifted Q band (at 689 vs. 670 nm) and exhibit a relatively weaker fluorescence emission and a higher efficiency at generating singlet oxygen.  Upon illumination, these compds. are highly cytotoxic toward HT29 human colorectal carcinoma and HepG2 human hepatocarcinoma cells.  The compds. with medium-length substituents are particularly potent, having IC50 values as low as 0.02 μM.  The high photodynamic activity of these compds. can be attributed to their high cellular uptake and low aggregation tendency in the biol. media, which promote the generation of reactive oxygen species inside the cells.  The effects of the chain length on the aggregation behavior, photophys. properties, cellular uptake and in vitro photodynamic activities of this series of compds. have also been examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1prlVcKgYRrVg90H21EOLACvtfcHk0lgpOPm5BliQWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVChtb%252FE&md5=013f54d31c4495f606a1d1379f0439cc</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1039%2Fb814627f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb814627f%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.-Y.%26aulast%3DJiang%26aufirst%3DX.-J.%26aulast%3DFong%26aufirst%3DW.-P.%26aulast%3DNg%26aufirst%3DD.%2BK.%2BP.%26atitle%3DHighly%2520photocytotoxic%25201%252C4-dipegylated%2520zinc%2528II%2529%2520phthalocyanines.%2520Effects%2520of%2520the%2520chain%2520length%2520on%2520the%2520in%2520vitro%2520photodynamic%2520activities%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2008%26volume%3D6%26spage%3D4560%26epage%3D4566%26doi%3D10.1039%2Fb814627f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishizuka, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, G.</span></span> <span> </span><span class="NLM_article-title">Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models</span>. <i>BMC Res. Notes</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">140</span>, <span class="refDoi"> DOI: 10.1186/1756-0500-4-140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1186%2F1756-0500-4-140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=21554739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsV2gs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=140&author=T.+Matsuoauthor=S.+S.+Nishizukaauthor=K.+Ishidaauthor=T.+Iwayaauthor=M.+Ikedaauthor=G.+Wakabayashi&title=Analysis+of+the+anti-tumor+effect+of+cetuximab+using+protein+kinetics+and+mouse+xenograft+models&doi=10.1186%2F1756-0500-4-140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models</span></div><div class="casAuthors">Matsuo, Teppei; Nishizuka, Satoshi S.; Ishida, Kazushige; Iwaya, Takeshi; Ikeda, Miyuki; Wakabayashi, Go</div><div class="citationInfo"><span class="NLM_cas:title">BMC Research Notes</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">140</span>CODEN:
                <span class="NLM_cas:coden">BRNMAT</span>;
        ISSN:<span class="NLM_cas:issn">1756-0500</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The binding of EGFR and its ligands leads to autophosphorylation of receptor tyrosine kinase as well as subsequent activation of signal transduction pathways that are involved in regulating cellular proliferation, differentiation, and survival.  An EGFR inhibitor, cetuximab, binds to EGFR and consequently blocks a variety of cellular processes.  KRAS/BRAF mutations are known to be assocd. with a low response rate to cetuximab.  In the present study, to clarify the anti-tumor mechanisms of cetuximab, we evaluated the KRAS/BRAF status, phosphorylation level of the EGFR pathway, and the tumor suppression effect in vivo, using a human colon cancer cell line HT29, which exhibited the highest EGFR expression in response to the cetuximab therapy among the 6 colorectal cancer cell lines tested.  Findings: The conventional growth suppression assay did not work efficiently with cetuximab EGF, TGF-α, and IGF activated the EGFR/MAPK cell signaling pathway by initiating the phosphorylation of EGFR.  Cetuximab partially inhibited the EGFR/MAPK pathway induced by EGF, TGF-α, and IGF.  However, cetuximab exposure induced the EGFR, MEK, and ERK1/2 phosphorylation by itself.  Mouse xenograft tumor growth was significantly inhibited by cetuximab and both cetuximab-treated and -untreated xenograft specimens exhibited phosphorylations of the EGFR pathway proteins.  Conclusions: We have confirmed that cetuximab inhibited the EGFR/MAPK pathway and reduced tumor growth in the xenografts while the remaining tumor showed EGFR pathway activation.  These results suggest that: (i) The effect of cetuximab in growth signaling is not sufficient to induce complete growth suppression in vitro; (ii) time-course monitoring may be necessary to evaluate the effect of cetuximab because EGFR signaling is transmitted in a minute order; and (iii) cetuximab treatment may have cells acquired resistant selectively survived in the heterogeneous cancer population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo16h67f82FkLVg90H21EOLACvtfcHk0lgpOPm5BliQWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsV2gs7c%253D&md5=83957fe9f4e1e9d7a7ee222b6938043e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1186%2F1756-0500-4-140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-0500-4-140%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuo%26aufirst%3DT.%26aulast%3DNishizuka%26aufirst%3DS.%2BS.%26aulast%3DIshida%26aufirst%3DK.%26aulast%3DIwaya%26aufirst%3DT.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DWakabayashi%26aufirst%3DG.%26atitle%3DAnalysis%2520of%2520the%2520anti-tumor%2520effect%2520of%2520cetuximab%2520using%2520protein%2520kinetics%2520and%2520mouse%2520xenograft%2520models%26jtitle%3DBMC%2520Res.%2520Notes%26date%3D2011%26volume%3D4%26spage%3D140%26doi%3D10.1186%2F1756-0500-4-140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.-M.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of PCNA by EGFR inhibits mismatch repair and promotes misincorporation during DNA synthesis</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">5667</span>– <span class="NLM_lpage">5672</span>, <span class="refDoi"> DOI: 10.1073/pnas.1417711112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1073%2Fpnas.1417711112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=25825764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVOnsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=5667-5672&author=J.+Ortegaauthor=J.+Y.+Liauthor=S.+Leeauthor=D.+Tongauthor=L.+Guauthor=G.-M.+Li&title=Phosphorylation+of+PCNA+by+EGFR+inhibits+mismatch+repair+and+promotes+misincorporation+during+DNA+synthesis&doi=10.1073%2Fpnas.1417711112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of PCNA by EGFR inhibits mismatch repair and promotes misincorporation during DNA synthesis</span></div><div class="casAuthors">Ortega, Janice; Li, Jessie Y.; Lee, Sanghee; Tong, Dan; Gu, Liya; Li, Guo-Min</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5667-5672</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Proliferating cell nuclear antigen (PCNA) plays essential roles in eukaryotic cells during DNA replication, DNA mismatch repair (MMR), and other events at the replication fork.  Earlier studies show that PCNA is regulated by post-translational modifications, including phosphorylation of Tyr-211 (Y211) by epidermal growth factor receptor (EGFR) kinase (EGFRK).  However, the functional significance of Y211-phosphorylated PCNA remains unknown.  Here, the authors show that PCNA phosphorylation by EGFRK alters its interaction with mismatch-recognition proteins MutSα and MutSβ and interferes with PCNA-dependent activation of MutLα endonuclease, thereby inhibiting MMR at the initiation step.  Evidence is also provided that Y211-phosphorylated PCNA induces nucleotide misincorporation during DNA synthesis.  Thus, these findings reveal a novel mechanism by which Y211-phosphorylated PCNA promotes cancer development and progression via facilitating error-prone DNA replication and suppressing the MMR function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_i7H-3LEUm7Vg90H21EOLACvtfcHk0ljd8LhxtxsPpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVOnsL4%253D&md5=d2c8d751e3603118a46eddfbfef177f5</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1417711112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1417711112%26sid%3Dliteratum%253Aachs%26aulast%3DOrtega%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DTong%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DG.-M.%26atitle%3DPhosphorylation%2520of%2520PCNA%2520by%2520EGFR%2520inhibits%2520mismatch%2520repair%2520and%2520promotes%2520misincorporation%2520during%2520DNA%2520synthesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2015%26volume%3D112%26spage%3D5667%26epage%3D5672%26doi%3D10.1073%2Fpnas.1417711112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, T.</span></span> <span> </span><span class="NLM_article-title">The functions and applications of RGD in tumor therapy and tissue engineering</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">13447</span>– <span class="NLM_lpage">13462</span>, <span class="refDoi"> DOI: 10.3390/ijms140713447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.3390%2Fijms140713447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=23807504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1GlurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=13447-13462&author=F.+Wangauthor=Y.+Liauthor=Y.+Shenauthor=A.+Wangauthor=S.+Wangauthor=T.+Xie&title=The+functions+and+applications+of+RGD+in+tumor+therapy+and+tissue+engineering&doi=10.3390%2Fijms140713447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The functions and applications of RGD in tumor therapy and tissue engineering</span></div><div class="casAuthors">Wang, Fen; Li, Yuanyuan; Shen, Yingqiang; Wang, Anming; Wang, Shuling; Xie, Tian</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">13447-13462, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Arginine-Glycine-Aspartic (RGD), is the specific recognition site of integrins with theirs ligands and regulates cell-cell and cell-extracellular matrix interactions.  The RGD motif can be combined with integrins overexpressed on the tumor neovasculature and tumor cells with a certain affinity, becoming the new target for imaging agents and drugs and gene delivery for tumor treatment.  Further, RGD as a biomimetic peptide can also promote cell adherence to the matrix, prevent cell apoptosis and accelerate new tissue regeneration.  Functionalizing material surfaces with RGD can improve cell/biomaterial interactions, which facilitates the generation of tissue-engineered constructs.  This paper reviews the main functions and advantages of RGD, describes the applications of RGD in imaging agents, drugs, gene delivery for tumor therapy and highlights the role of RGD in promoting the development of tissue engineering (bone regeneration, cornea repair, artificial neovascularization) in recent years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp_ftvayY6XLVg90H21EOLACvtfcHk0ljd8LhxtxsPpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1GlurvL&md5=fc7f335ac589ff88e25e21f5ae4e4458</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3390%2Fijms140713447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms140713447%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DT.%26atitle%3DThe%2520functions%2520and%2520applications%2520of%2520RGD%2520in%2520tumor%2520therapy%2520and%2520tissue%2520engineering%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26spage%3D13447%26epage%3D13462%26doi%3D10.3390%2Fijms140713447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, D. F.</span></span> <span> </span><span class="NLM_article-title">Reference materials for fluorescence measurement</span>. <i>Pure Appl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1107</span>– <span class="NLM_lpage">1114</span>, <span class="refDoi"> DOI: 10.1351/pac198860071107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1351%2Fpac198860071107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADyaL1cXlsFyrtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1988&pages=1107-1114&author=D.+F.+Eaton&title=Reference+materials+for+fluorescence+measurement&doi=10.1351%2Fpac198860071107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Reference materials for fluorescence measurement</span></div><div class="casAuthors">Eaton, David F.</div><div class="citationInfo"><span class="NLM_cas:title">Pure and Applied Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1107-14</span>CODEN:
                <span class="NLM_cas:coden">PACHAS</span>;
        ISSN:<span class="NLM_cas:issn">0033-4545</span>.
    </div><div class="casAbstract">A review with 19 refs. is given on std. practices and materials for fluorescence measurements and the avoidance of exptl. inadequacies attendant on their application in practical use.  Appropriate methods are discussed which strike a balance between ease of application, generality of use, and reliability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDXpSTvcElrLVg90H21EOLACvtfcHk0lhSkWE_Su5IAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXlsFyrtL0%253D&md5=51ba5738e8da49584e6393251022a47f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1351%2Fpac198860071107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252Fpac198860071107%26sid%3Dliteratum%253Aachs%26aulast%3DEaton%26aufirst%3DD.%2BF.%26atitle%3DReference%2520materials%2520for%2520fluorescence%2520measurement%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D1988%26volume%3D60%26spage%3D1107%26epage%3D1114%26doi%3D10.1351%2Fpac198860071107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maree, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyokong, T.</span></span> <span> </span><span class="NLM_article-title">Syntheses and photochemical properties of octasubstituted phthalocyaninato zinc complexes</span>. <i>J. Porphyrins Phthalocyanines</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">782</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1002/jpp.388</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1002%2Fjpp.388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotVSlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2001&pages=782-792&author=S.+E.+Mareeauthor=T.+Nyokong&title=Syntheses+and+photochemical+properties+of+octasubstituted+phthalocyaninato+zinc+complexes&doi=10.1002%2Fjpp.388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses and photochemical properties of octasubstituted phthalocyaninato zinc complexes</span></div><div class="casAuthors">Maree, Suzanne E.; Nyokong, Tebello</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Porphyrins and Phthalocyanines</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">782-792</span>CODEN:
                <span class="NLM_cas:coden">JPPHFZ</span>;
        ISSN:<span class="NLM_cas:issn">1088-4246</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A selection of octasubstituted phthalocyaninato Zn complexes were synthesized and their photochem. studied.  The substituents included cholesterol, estrone, naphthol and phenoxy groups substituted with CH3, di-CMe3, CMe3, NO2, NH2, CHO, COOH and H.  In general, complexes contg. electron-donating groups (di-CMe3 and CMe3) attached to the phenoxy ring are photochem. unstable with photobleaching quantum yields of the order of 10-3.  In the presence of electron-withdrawing groups (NO2, CHO, and CO2H) the photobleaching quantum yields were of the order of 10-6 to 10-5.  Singlet O quantum yields (ΦΔ) ranged from 0.01 to 0.73.  The lowest ΦΔ was obsd. for the highly aggregated complex with naphthol.  All the complexes showed aggregation at high concns.  Electrochem. redn. using a thin-layer spectroelectrochem. cell showed that the complexes become more monomeric following redn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO-LcmDUP2xbVg90H21EOLACvtfcHk0lhSkWE_Su5IAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotVSlsL0%253D&md5=c4e9ed5d01b0e94e6a5e169a8e81a703</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fjpp.388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjpp.388%26sid%3Dliteratum%253Aachs%26aulast%3DMaree%26aufirst%3DS.%2BE.%26aulast%3DNyokong%26aufirst%3DT.%26atitle%3DSyntheses%2520and%2520photochemical%2520properties%2520of%2520octasubstituted%2520phthalocyaninato%2520zinc%2520complexes%26jtitle%3DJ.%2520Porphyrins%2520Phthalocyanines%26date%3D2001%26volume%3D5%26spage%3D782%26epage%3D792%26doi%3D10.1002%2Fjpp.388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiho, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroshima, K.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, K.</span></span> <span> </span><span class="NLM_article-title">An improved colorimetric assay for interleukin 2</span>. <i>J. Immunol. Methods</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1016/0022-1759(86)90183-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2F0022-1759%2886%2990183-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=3490518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADyaL2sXjtFSjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1986&pages=157-165&author=H.+Tadaauthor=O.+Shihoauthor=K.-i.+Kuroshimaauthor=M.+Koyamaauthor=K.+Tsukamoto&title=An+improved+colorimetric+assay+for+interleukin+2&doi=10.1016%2F0022-1759%2886%2990183-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">An improved colorimetric assay for interleukin 2</span></div><div class="casAuthors">Tada, Hiroko; Shiho, Osamu; Kuroshima, Kenichi; Koyama, Masaru; Tsukamoto, Kyozo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-65</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">Mosmann's method for measuring the no. of viable cells with a tetrazolium salt, 3-(4,5-dimethyl-thiazol-2-yl)-2,5-di-phenyltetrazolium bromide (MTT), was modified to make it possible to measure a large no. of interleukin 2 (IL-2) samples at one time with less labor and more accuracy.  Each step of the method was examd. in detail and modified (the modified MTT method).  An IL-2-dependent mouse natural killer cell line, NKC3, was used as an indicator cell line.  The incubation period before adding MTT was reduced to 24 h.  A soln. of 10% SDS-0.01 N HCl was used to dissolve the MTT formazan produced.  The authors compared the value obtained by the modified MTT method and the conventional [3H]thymidine method, and confirmed that the ests. of IL-2 content were almost equal.  The variation of IL-2 content measured by both methods was within 5% in terms of the std. error.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz6JaDrAXBbrVg90H21EOLACvtfcHk0lgt7yPZaCnqmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXjtFSjtw%253D%253D&md5=0208ea4486aca20fcc30ed18d065dd2d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2886%2990183-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252886%252990183-3%26sid%3Dliteratum%253Aachs%26aulast%3DTada%26aufirst%3DH.%26aulast%3DShiho%26aufirst%3DO.%26aulast%3DKuroshima%26aufirst%3DK.-i.%26aulast%3DKoyama%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DK.%26atitle%3DAn%2520improved%2520colorimetric%2520assay%2520for%2520interleukin%25202%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1986%26volume%3D93%26spage%3D157%26epage%3D165%26doi%3D10.1016%2F0022-1759%2886%2990183-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. One-pot synthesis of cyclic peptide–phthalocyanine conjugates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Monitoring the course of the formation of <b>5</b> using HPLC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Molecular structures of conjugates <b>6</b> and <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Electronic absorption and (b) fluorescence (excited at 610 nm) spectra of <b>5</b> and <b>2</b> (both at 2 μM) in DMF and PBS with Tween 80 (0.1% v/v).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Relative percentages of <b>5</b> and EBP in DMEM with FBS (20% v/v) at different time points as determined by integrating the peak areas in the HPLC chromatograms. Data are expressed as the mean value ± standard deviation (SD) of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Bright-field, fluorescence, and the merged images of HT29, HCT116, HeLa, and HEK293 cells after incubation with <b>5</b> or <b>2</b> (both at 2 μM) for 2 h. (b) Fluorescence intensity profiles of the four cell lines after incubation with <b>5</b> or <b>2</b> (both at 2 μM) for 2 h and the corresponding mean intracellular fluorescence intensities as determined by flow cytometry. (c) Fluorescence intensity profiles of HT29 cells after preincubation with <b>3</b> (100 or 400 μM) for 30 min at 37 °C, followed by coincubation with <b>5</b> (2 μM) for further 2 h and the corresponding mean intracellular fluorescence intensities as determined by flow cytometry. Data are expressed as the mean value ± standard error of the mean (SEM) of three independent experiments. **<i>p</i> < 0.01 and ***<i>p</i> < 0.001 as calculated by the Student’s <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Visualization of the intracellular fluorescence of <b>5</b> and various subcellular trackers in HT29 cells. The corresponding bright-field and merged images are given in column 1 and 4, respectively. The figures on the right show the fluorescence intensity profiles of <b>5</b> and the different trackers traced along the lines in the corresponding images on the left.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Cell viability of <b>5</b> on HT29, HCT116, HeLa, and HEK293 cells after drug incubation for 2 h in the (a) absence or (b) presence of light irradiation (λ > 610 nm, 23 mW cm<sup>–2</sup>, 28 J cm<sup>–2</sup>). Data are expressed as the mean value ± SEM of three independent experiments, each performed in quadruplicate. ***<i>p</i> < 0.001 as calculated by the Student’s <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (a) Fluorescence images of HT29 tumor-bearing nude mice before and after intravenous injection of <b>5</b> or <b>2</b> over a period of 24 h (excitation wavelength = 680 nm, emission wavelength ≥700 nm). (b) Ex vivo distribution of <b>5</b> and <b>2</b> in the tumor and different organs of the mice at 24 h postinjection. (c) Fluorescence intensities of the tumor and different organs in HT29 tumor-bearing nude mice at 24 h after intravenous injection of <b>5</b> or <b>2</b>. Data are expressed as the mean value ± SD for <i>n</i> = 4. ***<i>p</i> < 0.001 as calculated by the Student’s <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/medium/jm0c01677_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (a) Photographs of the HT29 tumor-bearing nude mice before and after the treatment with <b>5</b> with light irradiation (680 nm, 0.3 W cm<sup>–2</sup>, 180 J cm<sup>–2</sup>) or PBS without light irradiation. (b) Tumor-growth curves for HT29 tumor-bearing nude mice after intravenous injection with <b>5</b> and illuminated with a diode laser at 680 nm for 10 min (0.3 W cm<sup>–2</sup>, 180 J cm<sup>–2</sup>) at 24 h postinjection (<i>n</i> = 5) or PBS in the absence of light (<i>n</i> = 3). (c) Body weights of the mice being injected with <b>5</b> or PBS on different days. Data are expressed as the mean value ± SD for <i>n</i> = 5 (for <b>5</b>) or 3 (for the PBS control). (d) H&E-stained slices of the tumor and major organs of the mice after 14 days of the treatment with <b>5</b> with light irradiation or PBS without light irradiation. ***<i>p</i> < 0.001 as calculated by the Student’s <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01677/20210218/images/large/jm0c01677_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01677&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i39">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62051" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62051" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 49 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolmans, D. E. J. G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumura, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, R. K.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy for cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">380</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1038/nrc1071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1038%2Fnrc1071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=12724736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlals74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=380-387&author=D.+E.+J.+G.+J.+Dolmansauthor=D.+Fukumuraauthor=R.+K.+Jain&title=Photodynamic+therapy+for+cancer&doi=10.1038%2Fnrc1071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">TIMELINE: Photodynamic therapy for cancer</span></div><div class="casAuthors">Dolmans, Dennis E. J. G. J.; Fukumura, Dai; Jain, Rakesh K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">380-387</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, on the mechanism of photodynamic therapy of cancer and other diseases.  The therapeutic properties of light have been known for thousands of years, but it was only in the last century that photodynamic therapy (PDT) was developed.  At present, PDT is being tested in the clinic for use in oncol. - to treat cancers of the head and neck, brain, lung, pancreas, i.p. cavity, breast, prostate and skin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzy17bVUKi07Vg90H21EOLACvtfcHk0lgtt3-AjCqgCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlals74%253D&md5=06663e65f0f3e313f828234220efcf3c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrc1071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1071%26sid%3Dliteratum%253Aachs%26aulast%3DDolmans%26aufirst%3DD.%2BE.%2BJ.%2BG.%2BJ.%26aulast%3DFukumura%26aufirst%3DD.%26aulast%3DJain%26aufirst%3DR.%2BK.%26atitle%3DPhotodynamic%2520therapy%2520for%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2003%26volume%3D3%26spage%3D380%26epage%3D387%26doi%3D10.1038%2Fnrc1071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, I.</span></span> <span> </span><span class="NLM_article-title">The Present and future role of photodynamic therapy in cancer treatment</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">508</span>, <span class="refDoi"> DOI: 10.1016/s1470-2045(04)01529-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2FS1470-2045%2804%2901529-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=15288239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmt1Kjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=497-508&author=S.+B.+Brownauthor=E.+A.+Brownauthor=I.+Walker&title=The+Present+and+future+role+of+photodynamic+therapy+in+cancer+treatment&doi=10.1016%2Fs1470-2045%2804%2901529-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The present and future role of photodynamic therapy in cancer treatment</span></div><div class="casAuthors">Brown, Stanley B.; Brown, Elizabeth A.; Walker, Ian</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">497-508</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Lancet Publishing Group</span>)
        </div><div class="casAbstract">A review.  It is more than 25 yr since photodynamic therapy (PDT) was proposed as a useful tool in oncol., but the approach is only now being used more widely in the clinic.  The understanding of the biol. of PDT has advanced, and efficient, convenient, and inexpensive systems of light delivery are now available.  Results from well-controlled, randomized phase III trials are also becoming available, esp. for treatment of non-melanoma skin cancer and Barrett's esophagus, and improved photosensitizing drugs are in development.  PDT has several potential advantages over surgery and radiotherapy; i.e., it is comparatively non-invasive, it can be targeted accurately, repeated doses can be given without the total-dose limitations assocd. with radiotherapy, and the healing process results in little or no scarring.  PDT can usually be done in an outpatient or day-case setting, is convenient for the patient, and has no side-effects.  Two photosensitizing drugs, porfirmer sodium and temoporfin, have now been approved for systemic administration, and aminolevulinic acid and Me aminolevulinate have been approved for topical use.  Here, we review current use of PDT in oncol. and look at its future potential as more selective photosensitizing drugs become available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPHiTvIl3SMLVg90H21EOLACvtfcHk0lgtt3-AjCqgCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmt1Kjsrw%253D&md5=f5aa46f85ba792703e55cb9c67c6cccd</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2804%2901529-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252804%252901529-3%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DS.%2BB.%26aulast%3DBrown%26aufirst%3DE.%2BA.%26aulast%3DWalker%26aufirst%3DI.%26atitle%3DThe%2520Present%2520and%2520future%2520role%2520of%2520photodynamic%2520therapy%2520in%2520cancer%2520treatment%26jtitle%3DLancet%2520Oncol.%26date%3D2004%26volume%3D5%26spage%3D497%26epage%3D508%26doi%3D10.1016%2Fs1470-2045%2804%2901529-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Straten, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashayekhi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Bruijn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, D.</span></span> <span> </span><span class="NLM_article-title">Oncologic photodynamic therapy: basic principles, current clinical status and future directions</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">19</span>, <span class="refDoi"> DOI: 10.3390/cancers9020019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.3390%2Fcancers9020019" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=19&author=D.+van%0AStratenauthor=V.+Mashayekhiauthor=H.+de+Bruijnauthor=S.+Oliveiraauthor=D.+Robinson&title=Oncologic+photodynamic+therapy%3A+basic+principles%2C+current+clinical+status+and+future+directions&doi=10.3390%2Fcancers9020019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3390%2Fcancers9020019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers9020019%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BStraten%26aufirst%3DD.%26aulast%3DMashayekhi%26aufirst%3DV.%26aulast%3Dde%2BBruijn%26aufirst%3DH.%26aulast%3DOliveira%26aufirst%3DS.%26aulast%3DRobinson%26aufirst%3DD.%26atitle%3DOncologic%2520photodynamic%2520therapy%253A%2520basic%2520principles%252C%2520current%2520clinical%2520status%2520and%2520future%2520directions%26jtitle%3DCancers%26date%3D2017%26volume%3D9%26spage%3D19%26doi%3D10.3390%2Fcancers9020019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.-H.</span></span> <span> </span><span class="NLM_article-title">Advanced smart-photosensitizers for more effective cancer treatment</span>. <i>Biomater. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">70</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1039/c7bm00872d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1039%2FC7BM00872D" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2018&pages=70-90&author=W.+Parkauthor=S.+Choauthor=J.+Hanauthor=H.+Shinauthor=K.+Naauthor=B.+Leeauthor=D.-H.+Kim&title=Advanced+smart-photosensitizers+for+more+effective+cancer+treatment&doi=10.1039%2Fc7bm00872d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1039%2FC7BM00872D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7BM00872D%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DW.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DShin%26aufirst%3DH.%26aulast%3DNa%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DD.-H.%26atitle%3DAdvanced%2520smart-photosensitizers%2520for%2520more%2520effective%2520cancer%2520treatment%26jtitle%3DBiomater.%2520Sci.%26date%3D2018%26volume%3D6%26spage%3D70%26epage%3D90%26doi%3D10.1039%2Fc7bm00872d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span> <span> </span><span class="NLM_article-title">Photosensitizers for photodynamic therapy</span>. <i>Adv. Healthcare Mater.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1900132</span>, <span class="refDoi"> DOI: 10.1002/adhm.201900132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1002%2Fadhm.201900132" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=1900132&author=M.+Lanauthor=S.+Zhaoauthor=W.+Liuauthor=C.-S.+Leeauthor=W.+Zhangauthor=P.+Wang&title=Photosensitizers+for+photodynamic+therapy&doi=10.1002%2Fadhm.201900132"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fadhm.201900132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadhm.201900132%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLee%26aufirst%3DC.-S.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DP.%26atitle%3DPhotosensitizers%2520for%2520photodynamic%2520therapy%26jtitle%3DAdv.%2520Healthcare%2520Mater.%26date%3D2019%26volume%3D8%26spage%3D1900132%26doi%3D10.1002%2Fadhm.201900132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colón, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roque, J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gujar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thummel, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lilge, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McFarland, S. A.</span></span> <span> </span><span class="NLM_article-title">Transition metal complexes and photodynamic therapy from a tumor-centered approach: challenges, opportunities, and highlights from the development of TLD1433</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">828</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.8b00211</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.8b00211" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVGmtrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2019&pages=797-828&author=S.+Monroauthor=K.+L.+Col%C3%B3nauthor=H.+Yinauthor=J.+Roqueauthor=P.+Kondaauthor=S.+Gujarauthor=R.+P.+Thummelauthor=L.+Lilgeauthor=C.+G.+Cameronauthor=S.+A.+McFarland&title=Transition+metal+complexes+and+photodynamic+therapy+from+a+tumor-centered+approach%3A+challenges%2C+opportunities%2C+and+highlights+from+the+development+of+TLD1433&doi=10.1021%2Facs.chemrev.8b00211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433</span></div><div class="casAuthors">Monro, Susan; Colon, Katsuya L.; Yin, Huimin; Roque, John; Konda, Prathyusha; Gujar, Shashi; Thummel, Randolph P.; Lilge, Lothar; Cameron, Colin G.; McFarland, Sherri A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">797-828</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Transition metal complexes are of increasing interest as photosensitizers in photodynamic therapy (PDT) and, more recently, for photochemotherapy (PCT).  In recent years, Ru(II) polypyridyl complexes have emerged as promising systems for both PDT and PCT.  Their rich photochem. and photophys. properties derive from a variety of excited-state electronic configurations accessible with visible and near-IR light, and these properties can be exploited for both energy- and electron-transfer processes that can yield highly potent oxygen-dependent and/or oxygen-independent photobiol. activity.  Selected examples highlight the use of rational design in coordination chem. to control the lowest-energy triplet excited-state configurations for eliciting a particular type of photoreactivity for PDT and/or PCT effects.  These principles are also discussed in the context of the development of TLD1433, the first Ru(II)-based photosensitizer for PDT to enter a human clin. trial.  The design of TLD1433 arose from a tumor-centered approach, as part of a complete PDT package that includes the light component and the protocol for treating non-muscle invasive bladder cancer.  Briefly, this review summarizes the challenges to bringing PDT into mainstream cancer therapy.  It considers the chem. and photophys. solns. that transition metal complexes offer, and it puts into context the multidisciplinary effort needed to bring a new drug to clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvMiOuSE20lbVg90H21EOLACvtfcHk0liI8OjJWf9bpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVGmtrjK&md5=73b333b327b1f83a6146b321dfe80ba9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.8b00211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.8b00211%26sid%3Dliteratum%253Aachs%26aulast%3DMonro%26aufirst%3DS.%26aulast%3DCol%25C3%25B3n%26aufirst%3DK.%2BL.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DRoque%26aufirst%3DJ.%26aulast%3DKonda%26aufirst%3DP.%26aulast%3DGujar%26aufirst%3DS.%26aulast%3DThummel%26aufirst%3DR.%2BP.%26aulast%3DLilge%26aufirst%3DL.%26aulast%3DCameron%26aufirst%3DC.%2BG.%26aulast%3DMcFarland%26aufirst%3DS.%2BA.%26atitle%3DTransition%2520metal%2520complexes%2520and%2520photodynamic%2520therapy%2520from%2520a%2520tumor-centered%2520approach%253A%2520challenges%252C%2520opportunities%252C%2520and%2520highlights%2520from%2520the%2520development%2520of%2520TLD1433%26jtitle%3DChem.%2520Rev.%26date%3D2019%26volume%3D119%26spage%3D797%26epage%3D828%26doi%3D10.1021%2Facs.chemrev.8b00211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo, P.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Morgade, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, D. K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumoulin, F.</span></span> <span> </span><span class="NLM_article-title">The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1041</span>– <span class="NLM_lpage">1056</span>, <span class="refDoi"> DOI: 10.1039/c9cs00129h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1039%2FC9CS00129H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=31845688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSnu77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2020&pages=1041-1056&author=P.-C.+Loauthor=M.+S.+Rodr%C3%ADguez-Morgadeauthor=R.+K.+Pandeyauthor=D.+K.+P.+Ngauthor=T.+Torresauthor=F.+Dumoulin&title=The+unique+features+and+promises+of+phthalocyanines+as+advanced+photosensitisers+for+photodynamic+therapy+of+cancer&doi=10.1039%2Fc9cs00129h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer</span></div><div class="casAuthors">Lo, Pui-Chi; Rodriguez-Morgade, M. Salome; Pandey, Ravindra K.; Ng, Dennis K. P.; Torres, Tomas; Dumoulin, Fabienne</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1041-1056</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Phthalocyanines exhibit superior photoproperties that make them a surely attractive class of photosensitizers for photodynamic therapy of cancer.  Several derivs. are at various phases of clin. trials, and efforts have been put continuously to improve their photodynamic efficacy.  To this end, various strategies have been applied to develop advanced phthalocyanines with optimized photoproperties, dual therapeutic actions, tumor-targeting properties and/or specific activation at tumor sites.  The advantageous properties and potential of phthalocyanines as advanced photosensitizers for photodynamic therapy of cancer are highlighted in this tutorial review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyq_GPDCHKSLVg90H21EOLACvtfcHk0liI8OjJWf9bpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVSnu77I&md5=f600e873a969140fd13ef35efafbca81</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1039%2FC9CS00129H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9CS00129H%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DP.-C.%26aulast%3DRodr%25C3%25ADguez-Morgade%26aufirst%3DM.%2BS.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DNg%26aufirst%3DD.%2BK.%2BP.%26aulast%3DTorres%26aufirst%3DT.%26aulast%3DDumoulin%26aufirst%3DF.%26atitle%3DThe%2520unique%2520features%2520and%2520promises%2520of%2520phthalocyanines%2520as%2520advanced%2520photosensitisers%2520for%2520photodynamic%2520therapy%2520of%2520cancer%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2020%26volume%3D49%26spage%3D1041%26epage%3D1056%26doi%3D10.1039%2Fc9cs00129h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Almeida-Marrero, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Winckel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anaya-Plaza, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la Escosura, A.</span></span> <span> </span><span class="NLM_article-title">Porphyrinoid biohybrid materials as an emerging toolbox for biomedical light management</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">7369</span>– <span class="NLM_lpage">7400</span>, <span class="refDoi"> DOI: 10.1039/c7cs00554g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1039%2FC7CS00554G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=30152500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsF2lsbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2018&pages=7369-7400&author=V.+Almeida-Marreroauthor=E.+van+de+Winckelauthor=E.+Anaya-Plazaauthor=T.+Torresauthor=A.+de+la+Escosura&title=Porphyrinoid+biohybrid+materials+as+an+emerging+toolbox+for+biomedical+light+management&doi=10.1039%2Fc7cs00554g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Porphyrinoid biohybrid materials as an emerging toolbox for biomedical light management</span></div><div class="casAuthors">Almeida-Marrero, Veronica; van de Winckel, Eveline; Anaya-Plaza, Eduardo; Torres, Tomas; de la Escosura, Andres</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7369-7400</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The development of photoactive and biocompatible nanomaterials is a current major challenge of materials science and nanotechnol., as they will contribute to promoting current and future biomedical applications.  A growing strategy in this direction consists of using biol. inspired hybrid materials to maintain or even enhance the optical properties of chromophores and fluorophores in biol. media.  Within this area, porphyrinoids constitute the most important family of org. photosensitizers.  The following extensive review will cover their incorporation into different kinds of photosensitizing biohybrid materials, as a fundamental research effort toward the management of light for biomedical use, including technologies such as photochem. internalization (PCI), photoimmunotherapy (PIT), and theranostic combinations of fluorescence imaging and photodynamic therapy (PDT) or photodynamic inactivation (PDI) of microorganisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq747ZDCy9A6LVg90H21EOLACvtfcHk0liI8OjJWf9bpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsF2lsbfP&md5=d5330d33a1261b685b33206702f6b3a7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1039%2FC7CS00554G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC7CS00554G%26sid%3Dliteratum%253Aachs%26aulast%3DAlmeida-Marrero%26aufirst%3DV.%26aulast%3Dvan%2Bde%2BWinckel%26aufirst%3DE.%26aulast%3DAnaya-Plaza%26aufirst%3DE.%26aulast%3DTorres%26aufirst%3DT.%26aulast%3Dde%2Bla%2BEscosura%26aufirst%3DA.%26atitle%3DPorphyrinoid%2520biohybrid%2520materials%2520as%2520an%2520emerging%2520toolbox%2520for%2520biomedical%2520light%2520management%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2018%26volume%3D47%26spage%3D7369%26epage%3D7400%26doi%3D10.1039%2Fc7cs00554g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, R. W.</span></span> <span> </span><span class="NLM_article-title">Photosensitizer antibody-drug conjugates: past, present, and future</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">993</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.9b00055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.9b00055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFCqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=975-993&author=J.+Sandlandauthor=R.+W.+Boyle&title=Photosensitizer+antibody-drug+conjugates%3A+past%2C+present%2C+and+future&doi=10.1021%2Facs.bioconjchem.9b00055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Photosensitizer Antibody-Drug Conjugates: Past, Present, and Future</span></div><div class="casAuthors">Sandland, Jordon; Boyle, Ross W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">975-993</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This Review aims to highlight key aspects of tetrapyrrole-based antibody-drug conjugates (ADCs) and significant developments in the field since 2010.  Many new conjugation methods have been developed and employed in the past decade, and assocd. with this, there has been a rising interest in theranostic conjugates.  We have investigated the physicochem. properties that tetrapyrroles need to possess in order to be viable photosensitizers for conjugation to antibodies.  Differences in conjugation strategies are discussed, and structure-activity relationships of tetrapyrrole-antibody conjugates are reported, where available.  As the elegance of bioconjugation techniques has increased, it has paved the way for exceptionally phototoxic, yet highly selective, tetrapyrrole-antibody conjugates, with photocytotoxicities in the nanomolar range, to be synthesized and biol. evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRa8MnnISHn7Vg90H21EOLACvtfcHk0lgrw64dZxXHJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFCqur0%253D&md5=09989d6e2a37e2b715c399035b03a160</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.9b00055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.9b00055%26sid%3Dliteratum%253Aachs%26aulast%3DSandland%26aufirst%3DJ.%26aulast%3DBoyle%26aufirst%3DR.%2BW.%26atitle%3DPhotosensitizer%2520antibody-drug%2520conjugates%253A%2520past%252C%2520present%252C%2520and%2520future%26jtitle%3DBioconjugate%2520Chem.%26date%3D2019%26volume%3D30%26spage%3D975%26epage%3D993%26doi%3D10.1021%2Facs.bioconjchem.9b00055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span> <span> </span><span class="NLM_article-title">Peptide-based cancer therapy: opportunity and challenge</span>. <i>Canc. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.canlet.2014.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.canlet.2014.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=24836189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC2cXoslCks74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2014&pages=13-22&author=D.+Wuauthor=Y.+Gaoauthor=Y.+Qiauthor=L.+Chenauthor=Y.+Maauthor=Y.+Li&title=Peptide-based+cancer+therapy%3A+opportunity+and+challenge&doi=10.1016%2Fj.canlet.2014.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide-based cancer therapy: Opportunity and challenge</span></div><div class="casAuthors">Wu, Dongdong; Gao, Yanfeng; Qi, Yuanming; Chen, Lixiang; Ma, Yuanfang; Li, Yanzhang</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-22</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Cancer is one of the leading causes of death worldwide.  Conventional cancer therapies mainly focus on mass cell killing without high specificity and often cause severe side effects and toxicities.  Peptides are a novel class of anticancer agents that could specifically target cancer cells with lower toxicity to normal tissues, which will offer new opportunities for cancer prevention and treatment.  Anticancer peptides face several therapeutic challenges.  In this review, we present the sources and mechanisms of anticancer peptides and further discuss modification strategies to improve the anticancer effects of bioactive peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfTvF05vTMi7Vg90H21EOLACvtfcHk0lgrw64dZxXHJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXoslCks74%253D&md5=c438f9714fb43545691d594a9aa775e6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2014.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2014.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DQi%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26atitle%3DPeptide-based%2520cancer%2520therapy%253A%2520opportunity%2520and%2520challenge%26jtitle%3DCanc.%2520Lett.%26date%3D2014%26volume%3D351%26spage%3D13%26epage%3D22%26doi%3D10.1016%2Fj.canlet.2014.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruoslahti, E.</span></span> <span> </span><span class="NLM_article-title">Tumor penetrating peptides for improved drug delivery</span>. <i>Adv. Drug Deliv. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>110–111</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2016.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.addr.2016.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=27040947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC28XlslCjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110%E2%80%93111&publication_year=2017&pages=3-12&author=E.+Ruoslahti&title=Tumor+penetrating+peptides+for+improved+drug+delivery&doi=10.1016%2Fj.addr.2016.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor penetrating peptides for improved drug delivery</span></div><div class="casAuthors">Ruoslahti, Erkki</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">110-111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3-12</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In vivo screening of phage libraries in tumor-bearing mice has been used to identify peptides that direct phage homing to a tumor.  The power of in vivo phage screening is illustrated by the recent discovery of peptides with unique tumor-penetrating properties.  These peptides activate an endocytic transport pathway related to but distinct from macropinocytosis.  They do so through a complex process that involves binding to a primary, tumor-specific receptor, followed by a proteolytic cleavage, and binding to a second receptor.  The second receptor, neuropilin-1 (or neuropilin-2) activates the transport pathway.  This trans-tissue pathway, dubbed the C-end Rule (CendR) pathway, mediates the extravasation transport through extravascular tumor tissue of payloads ranging from small mol. drugs to nanoparticles.  The CendR technol. provides a soln. to a major problem in tumor therapy, poor penetration of drugs into tumors.  Targeted delivery with tumor-penetrating peptides has been shown to specifically increase the accumulation of drugs, antibodies and nanotherapeutics in exptl. tumors in vivo, and in human tumors ex vivo.  Remarkably the payload does not have to be coupled to the peptide; the peptide activates a bulk transport system that sweeps along a drug present in the blood.  Treatment studies in mice have shown improved anti-tumor efficacy and less damage to normal tissues with drugs ranging from traditional chemotherapeutics to antibodies, and to nanoparticle drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGcd2TTUqzLrVg90H21EOLACvtfcHk0lgrw64dZxXHJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlslCjsrY%253D&md5=83c52c1ec16224278feafb06c8522a1e</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2016.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2016.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DRuoslahti%26aufirst%3DE.%26atitle%3DTumor%2520penetrating%2520peptides%2520for%2520improved%2520drug%2520delivery%26jtitle%3DAdv.%2520Drug%2520Deliv.%2520Rev.%26date%3D2017%26volume%3D110%25E2%2580%2593111%26spage%3D3%26epage%3D12%26doi%3D10.1016%2Fj.addr.2016.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, W. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuang, Z. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. Z.</span></span> <span> </span><span class="NLM_article-title">Peptide-based multifunctional nanomaterials for tumor imaging and therapy</span>. <i>Adv. Funct. Mater.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1804492</span>, <span class="refDoi"> DOI: 10.1002/adfm.201804492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1002%2Fadfm.201804492" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=1804492&author=C.+Zhangauthor=W.+Wuauthor=R.+Q.+Liauthor=W.+X.+Qiuauthor=Z.+N.+Zhuangauthor=S.+X.+Chengauthor=X.+Z.+Zhang&title=Peptide-based+multifunctional+nanomaterials+for+tumor+imaging+and+therapy&doi=10.1002%2Fadfm.201804492"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1002%2Fadfm.201804492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadfm.201804492%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DR.%2BQ.%26aulast%3DQiu%26aufirst%3DW.%2BX.%26aulast%3DZhuang%26aufirst%3DZ.%2BN.%26aulast%3DCheng%26aufirst%3DS.%2BX.%26aulast%3DZhang%26aufirst%3DX.%2BZ.%26atitle%3DPeptide-based%2520multifunctional%2520nanomaterials%2520for%2520tumor%2520imaging%2520and%2520therapy%26jtitle%3DAdv.%2520Funct.%2520Mater.%26date%3D2018%26volume%3D28%26spage%3D1804492%26doi%3D10.1002%2Fadfm.201804492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lian, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span> <span> </span><span class="NLM_article-title">Functional peptide-based drug delivery systems</span>. <i>J. Mater. Chem. B</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">6517</span>– <span class="NLM_lpage">6529</span>, <span class="refDoi"> DOI: 10.1039/d0tb00713g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1039%2FD0TB00713G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=32350489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntlensr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2020&pages=6517-6529&author=Z.+Lianauthor=T.+Ji&title=Functional+peptide-based+drug+delivery+systems&doi=10.1039%2Fd0tb00713g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Functional peptide-based drug delivery systems</span></div><div class="casAuthors">Lian, Zheng; Ji, Tianjiao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry B: Materials for Biology and Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">6517-6529</span>CODEN:
                <span class="NLM_cas:coden">JMCBDV</span>;
        ISSN:<span class="NLM_cas:issn">2050-7518</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Peptides are one of the most important functional motifs for constructing smart drug delivery systems (DDSs).  Functional peptides can be conjugated with drugs or carriers via covalent bonds, or assembled into DDSs via supramol. forces, which enables the DDSs to acquire desired functions such as targeting and/or environmental responsiveness.  In this mini review, we first introduce the different types of functional peptides that are commonly used for constructing DDSs, and we highlight representative strategies for designing smart DDSs by using functional peptides in the past few years.  We also state the challenges of peptide-based DDSs and come up with prospects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGHNf0dwKztbVg90H21EOLACvtfcHk0lgOBOjkDII9Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntlensr0%253D&md5=960a3f689456b6d0c62c6900c1f1467a</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1039%2FD0TB00713G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FD0TB00713G%26sid%3Dliteratum%253Aachs%26aulast%3DLian%26aufirst%3DZ.%26aulast%3DJi%26aufirst%3DT.%26atitle%3DFunctional%2520peptide-based%2520drug%2520delivery%2520systems%26jtitle%3DJ.%2520Mater.%2520Chem.%2520B%26date%3D2020%26volume%3D8%26spage%3D6517%26epage%3D6529%26doi%3D10.1039%2Fd0tb00713g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, K. S.</span></span> <span> </span><span class="NLM_article-title">Tumor-targeting peptides from combinatorial libraries</span>. <i>Adv. Drug Deliv. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>110–111</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1016/j.addr.2016.05.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.addr.2016.05.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=27210583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC28XosFSrt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110%E2%80%93111&publication_year=2017&pages=13-37&author=R.+Liuauthor=X.+Liauthor=W.+Xiaoauthor=K.+S.+Lam&title=Tumor-targeting+peptides+from+combinatorial+libraries&doi=10.1016%2Fj.addr.2016.05.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-targeting peptides from combinatorial libraries</span></div><div class="casAuthors">Liu, Ruiwu; Li, Xiaocen; Xiao, Wenwu; Lam, Kit S.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">110-111</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-37</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cancer is one of the major and leading causes of death worldwide.  Two of the greatest challenges in fighting cancer are early detection and effective treatments with no or min. side effects.  Widespread use of targeted therapies and mol. imaging in clinics requires high affinity, tumor-specific agents as effective targeting vehicles to deliver therapeutics and imaging probes to the primary or metastatic tumor sites.  Combinatorial libraries such as phage-display and one-bead one-compd. (OBOC) peptide libraries are powerful approaches in discovering tumor-targeting peptides.  This review gives an overview of different combinatorial library technologies that have been used for the discovery of tumor-targeting peptides.  Examples of tumor-targeting peptides identified from each combinatorial library method will be discussed.  Published tumor-targeting peptide ligands and their applications will also be summarized by the combinatorial library methods and their corresponding binding receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9KQ2kv9PcBbVg90H21EOLACvtfcHk0lgOBOjkDII9Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosFSrt7s%253D&md5=45a83d99dc3bf88e649662ee031835bc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2016.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2016.05.009%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXiao%26aufirst%3DW.%26aulast%3DLam%26aufirst%3DK.%2BS.%26atitle%3DTumor-targeting%2520peptides%2520from%2520combinatorial%2520libraries%26jtitle%3DAdv.%2520Drug%2520Deliv.%2520Rev.%26date%3D2017%26volume%3D110%25E2%2580%2593111%26spage%3D13%26epage%3D37%26doi%3D10.1016%2Fj.addr.2016.05.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoppenz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Els-Heindl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck-Sickinger, A. G.</span></span> <span> </span><span class="NLM_article-title">Peptide-drug conjugates and their targets in advanced cancer therapies</span>. <i>Front. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">571</span>, <span class="refDoi"> DOI: 10.3389/fchem.2020.00571</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.3389%2Ffchem.2020.00571" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=32733853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitFWhsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2020&pages=571&author=P.+Hoppenzauthor=S.+Els-Heindlauthor=A.+G.+Beck-Sickinger&title=Peptide-drug+conjugates+and+their+targets+in+advanced+cancer+therapies&doi=10.3389%2Ffchem.2020.00571"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide-drug conjugates and their targets in advanced cancer therapies</span></div><div class="casAuthors">Hoppenz, Paul; Els-Heindl, Sylvia; Beck-Sickinger, Annette G.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Chemistry (Lausanne, Switzerland)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">571</span>CODEN:
                <span class="NLM_cas:coden">FCLSAA</span>;
        ISSN:<span class="NLM_cas:issn">2296-2646</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Cancer became recently the leading cause of death in industrialized countries.  Even though std. treatments achieve significant effects in growth inhibition and tumor elimination, they cause severe side effects as most of the applied drugs exhibit only minor selectivity for the malignant tissue.  Hence, specific addressing of tumor cells without affecting healthy tissue is currently a major desire in cancer therapy.  Cell surface receptors, which bind peptides are frequently overexpressed on cancer cells and can therefore be considered as promising targets for selective tumor therapy.  In this review, the benefits of peptides as tumor homing agents are presented and an overview of the most commonly addressed peptide receptors is given.  A special focus was set on the bombesin receptor family and the neuropeptide Y receptor family.  In the second part, the specific requirements of peptide-drug conjugates (PDC) and intelligent linker structures as an essential component of PDC are outlined.  Furthermore, different drug cargos are presented including classical and recent toxic agents as well as radionuclides for diagnostic and therapeutic approaches.  In the last part, boron neutron capture therapy as advanced targeted cancer therapy is introduced and past and recent developments are reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxlD6eRupScLVg90H21EOLACvtfcHk0lgOBOjkDII9Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitFWhsrnK&md5=8ae3c54d1f171273e4684afb17298f22</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3389%2Ffchem.2020.00571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffchem.2020.00571%26sid%3Dliteratum%253Aachs%26aulast%3DHoppenz%26aufirst%3DP.%26aulast%3DEls-Heindl%26aufirst%3DS.%26aulast%3DBeck-Sickinger%26aufirst%3DA.%2BG.%26atitle%3DPeptide-drug%2520conjugates%2520and%2520their%2520targets%2520in%2520advanced%2520cancer%2520therapies%26jtitle%3DFront.%2520Chem.%26date%3D2020%26volume%3D8%26spage%3D571%26doi%3D10.3389%2Ffchem.2020.00571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yewale, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baradia, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vhora, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, A.</span></span> <span> </span><span class="NLM_article-title">Epidermal growth factor receptor targeting in cancer: a review of trends and strategies</span>. <i>Biomaterials</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">8690</span>– <span class="NLM_lpage">8707</span>, <span class="refDoi"> DOI: 10.1016/j.biomaterials.2013.07.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.biomaterials.2013.07.100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=23953842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Kgu7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=8690-8707&author=C.+Yewaleauthor=D.+Baradiaauthor=I.+Vhoraauthor=S.+Patilauthor=A.+Misra&title=Epidermal+growth+factor+receptor+targeting+in+cancer%3A+a+review+of+trends+and+strategies&doi=10.1016%2Fj.biomaterials.2013.07.100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal growth factor receptor targeting in cancer: A review of trends and strategies</span></div><div class="casAuthors">Yewale, Chetan; Baradia, Dipesh; Vhora, Imran; Patil, Sushilkumar; Misra, Ambikanandan</div><div class="citationInfo"><span class="NLM_cas:title">Biomaterials</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">8690-8707</span>CODEN:
                <span class="NLM_cas:coden">BIMADU</span>;
        ISSN:<span class="NLM_cas:issn">0142-9612</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The epidermal growth factor receptor (EGFR) is a cell-surface receptor belonging to ErbB family of tyrosine kinase and it plays a vital role in the regulation of cell proliferation, survival and differentiation.  However; EGFR is aberrantly activated by various mechanisms like receptor overexpression, mutation, ligand-dependent receptor dimerization, ligand-independent activation and is assocd. with development of variety of tumors.  Therefore, specific EGFR inhibition is one of the key targets for cancer therapy.  Two major approaches have been developed and demonstrated benefits in clin. trials for targeting EGFR; monoclonal antibodies (mAbs) and tyrosine kinase inhibitors (TKIs).  EGFR inhibitors like, cetuximab, panitumumab, etc. (mAbs) and gefitinib, erlotinib, lapatinib, etc. (TKIs) are now com. available for treatment of variety of cancers.  Recently, many other agents like peptides, nanobodies, affibodies and antisense oligonucleotide have also shown better efficacy in targeting and inhibiting EGFR.  Now a days, efforts are being focused to identify mol. markers that can predict patients more likely to respond to anti-EGFR therapy; to find out combinatorial approaches with EGFR inhibitors and to bring new therapeutic agents with clin. efficacy.  In this review we have outlined the role of EGFR in cancer, different types of EGFR inhibitors, preclin. and clin. status of EGFR inhibitors as well as summarized the recent efforts made in the field of mol. EGFR targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP89tYD6VDorVg90H21EOLACvtfcHk0lgOBOjkDII9Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Kgu7bL&md5=e7ca806ebdfe6a6f48962cf3c8620468</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.biomaterials.2013.07.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biomaterials.2013.07.100%26sid%3Dliteratum%253Aachs%26aulast%3DYewale%26aufirst%3DC.%26aulast%3DBaradia%26aufirst%3DD.%26aulast%3DVhora%26aufirst%3DI.%26aulast%3DPatil%26aufirst%3DS.%26aulast%3DMisra%26aufirst%3DA.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%2520targeting%2520in%2520cancer%253A%2520a%2520review%2520of%2520trends%2520and%2520strategies%26jtitle%3DBiomaterials%26date%3D2013%26volume%3D34%26spage%3D8690%26epage%3D8707%26doi%3D10.1016%2Fj.biomaterials.2013.07.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luwor, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, A. W.</span></span> <span> </span><span class="NLM_article-title">Epidermal growth factor receptor: structure-function informing the design of anticancer therapeutics</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1016/j.yexcr.2018.08.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.yexcr.2018.08.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=30098332" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFWgsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2018&pages=1-19&author=R.+A.+Mitchellauthor=R.+B.+Luworauthor=A.+W.+Burgess&title=Epidermal+growth+factor+receptor%3A+structure-function+informing+the+design+of+anticancer+therapeutics&doi=10.1016%2Fj.yexcr.2018.08.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal growth factor receptor: Structure-function informing the design of anticancer therapeutics</span></div><div class="casAuthors">Mitchell, Ruth A.; Luwor, Rodney B.; Burgess, Antony W.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-19</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Research on the epidermal growth factor (EGF) family and the family of receptors (EGFR) has progressed rapidly in recent times.  New crystal structures of the ectodomains with different ligands, the activation of the kinase domain through oligomerisation and the use of fluorescence techniques have revealed profound conformational changes on ligand binding.  The control of cell signaling from the EGFR-family is complex, with heterodimerization, ligand affinity and signaling cross-talk influencing cellular outcomes.  Anal. of tissue homeostasis indicates that the control of pro-ligand processing is likely to be as important as receptor activation events.  Several members of the EGFR-family are overexpressed and/or mutated in cancer cells.  The perturbation of EGFR-family signaling drives the malignant phenotype of many cancers and both inhibitors and antagonists of signaling from these receptors have already produced therapeutic benefits for patients.  The design of affibodies, antibodies, small mol. inhibitors and even immunotherapeutic drugs targeting the EGFR-family has yielded promising new approaches to improving outcomes for cancer patients.  In this review, we describe recent discoveries which have increased our understanding of the structure and dynamics of signaling from the EGFR-family, the roles of ligand processing and receptor cross-talk.  We discuss the relevance of these studies to the development of strategies for designing more effective targeted treatments for cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWV1XU_yns2LVg90H21EOLACvtfcHk0ljxJ5QmIE9Ieg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFWgsLnI&md5=b14b21439986169ea8b55c525b70b9ed</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.yexcr.2018.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexcr.2018.08.009%26sid%3Dliteratum%253Aachs%26aulast%3DMitchell%26aufirst%3DR.%2BA.%26aulast%3DLuwor%26aufirst%3DR.%2BB.%26aulast%3DBurgess%26aufirst%3DA.%2BW.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor%253A%2520structure-function%2520informing%2520the%2520design%2520of%2520anticancer%2520therapeutics%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2018%26volume%3D371%26spage%3D1%26epage%3D19%26doi%3D10.1016%2Fj.yexcr.2018.08.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ongarora, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontenot, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehgal, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satyanarayana-Jois, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicente, M. G. H.</span></span> <span> </span><span class="NLM_article-title">Phthalocyanine–peptide conjugates for epidermal growth factor receptor targeting</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3725</span>– <span class="NLM_lpage">3738</span>, <span class="refDoi"> DOI: 10.1021/jm201544y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201544y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFOnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3725-3738&author=B.+G.+Ongaroraauthor=K.+R.+Fontenotauthor=X.+Huauthor=I.+Sehgalauthor=S.+D.+Satyanarayana-Joisauthor=M.+G.+H.+Vicente&title=Phthalocyanine%E2%80%93peptide+conjugates+for+epidermal+growth+factor+receptor+targeting&doi=10.1021%2Fjm201544y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Phthalocyanine-Peptide Conjugates for Epidermal Growth Factor Receptor Targeting</span></div><div class="casAuthors">Ongarora, Benson G.; Fontenot, Krystal R.; Hu, Xiaoke; Sehgal, Inder; Satyanarayana-Jois, Seetharama D.; Vicente, M. Graca H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3725-3738</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Four phthalocyanine (Pc)-peptide conjugates designed to target the epidermal growth factor receptor (EGFR) were synthesized and evaluated in vitro using four cell lines: human carcinoma A431 and HEp2, human colorectal HT-29, and kidney Vero (neg. control) cells.  Two peptide ligands for EGFR were studied: EGFR-L1 and -L2, bearing 6 and 13 amino acid residues, resp.  The peptides and Pc-conjugates bind to EGFR using both theor. (Autodock) and exptl. (SPR) studies.  The Pc-EGFR-L1 conjugates 5a and 5b efficiently targeted EGFR and were internalized, in part due to their cationic charge, whereas the uncharged Pc-EGFR-L2 conjugates 4b and 6a poorly targeted EGFR maybe due to their low aq. soly.  All conjugates were nontoxic (IC50 > 100 μM) to HT-29 cells, both in the dark and upon light activation (1 J/cm2).  I.v. administration of conjugate 5b into nude mice bearing A431 and HT-29 human tumor xenografts resulted in a near-IR fluorescence signal at ∼700 nm, 24 h after administration.  The authors' studies show that Pc-EGFR-L1 conjugates are promising near-IR fluorescent contrast agents for CRC and potentially other EGFR overexpressing cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUApGztjQQE7Vg90H21EOLACvtfcHk0ljxJ5QmIE9Ieg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFOnsLk%253D&md5=db3ce964fe894d433712cd9062bd0192</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm201544y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201544y%26sid%3Dliteratum%253Aachs%26aulast%3DOngarora%26aufirst%3DB.%2BG.%26aulast%3DFontenot%26aufirst%3DK.%2BR.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DSehgal%26aufirst%3DI.%26aulast%3DSatyanarayana-Jois%26aufirst%3DS.%2BD.%26aulast%3DVicente%26aufirst%3DM.%2BG.%2BH.%26atitle%3DPhthalocyanine%25E2%2580%2593peptide%2520conjugates%2520for%2520epidermal%2520growth%2520factor%2520receptor%2520targeting%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3725%26epage%3D3738%26doi%3D10.1021%2Fjm201544y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xue, E. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, R. C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, W.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, D. K. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of an epidermal growth factor receptor-targeted peptide-conjugated phthalocyanine-based photosensitiser</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">20652</span>– <span class="NLM_lpage">20662</span>, <span class="refDoi"> DOI: 10.1039/c9ra03911b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1039%2FC9RA03911B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1yku7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=20652-20662&author=E.+Y.+Xueauthor=R.+C.+H.+Wongauthor=C.+T.+T.+Wongauthor=W.-P.+Fongauthor=D.+K.+P.+Ng&title=Synthesis+and+biological+evaluation+of+an+epidermal+growth+factor+receptor-targeted+peptide-conjugated+phthalocyanine-based+photosensitiser&doi=10.1039%2Fc9ra03911b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of an epidermal growth factor receptor-targeted peptide-conjugated phthalocyanine-based photosensitiser</span></div><div class="casAuthors">Xue, Evelyn Y.; Wong, Roy C. H.; Wong, Clarence T. T.; Fong, Wing-Ping; Ng, Dennis K. P.</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">20652-20662</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A peptide-conjugated zinc(II) phthalocyanine contg. the epidermal growth factor receptor-targeted heptapeptide QRHKPRE has been prepd.  The conjugate labeled as ZnPc-QRH* can selectively bind to the cell membrane of HT29 human colorectal adenocarcinoma cells in 10 min followed by internalisation upon prolonged incubation via receptor-mediated endocytosis, leading to localisation in lysosomes eventually.  By manipulating the incubation time, the subcellular localisation of the conjugate can be varied and the cell-death pathways induced upon irradn. can also be altered.  It has been found that photosensitization initiated at the cell membrane and in the lysosomes would trigger cell death mainly through necrosis and apoptosis resp.  I.v. administration of the conjugate into HT29 tumor-bearing nude mice resulted in higher accumulation in the tumor than in most major organs.  The selective binding of this conjugate to tumor has also been demonstrated by comparing the results with those of the analog with a scrambled peptide sequence (EPRQRHK).  The overall results indicate that ZnPc-QRH* is a promising EGFR-targeted photosensitizer for photodynamic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3mVFouidkOLVg90H21EOLACvtfcHk0ljxJ5QmIE9Ieg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1yku7nO&md5=d4c4c1f3fdc76928b6a576d562c93586</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1039%2FC9RA03911B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9RA03911B%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DE.%2BY.%26aulast%3DWong%26aufirst%3DR.%2BC.%2BH.%26aulast%3DWong%26aufirst%3DC.%2BT.%2BT.%26aulast%3DFong%26aufirst%3DW.-P.%26aulast%3DNg%26aufirst%3DD.%2BK.%2BP.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520an%2520epidermal%2520growth%2520factor%2520receptor-targeted%2520peptide-conjugated%2520phthalocyanine-based%2520photosensitiser%26jtitle%3DRSC%2520Adv.%26date%3D2019%26volume%3D9%26spage%3D20652%26epage%3D20662%26doi%3D10.1039%2Fc9ra03911b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, R. C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, D. K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, P.-C.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of phthalocyanine-peptide conjugate for EGFR-targeted photodynamic therapy and bioimaging</span>. <i>Dyes Pigm.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">203</span>, <span class="refDoi"> DOI: 10.1016/j.dyepig.2018.11.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.dyepig.2018.11.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVyhtrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2019&pages=197-203&author=L.+Yuauthor=Q.+Wangauthor=R.+C.-H.+Wongauthor=S.+Zhaoauthor=D.+K.+P.+Ngauthor=P.-C.+Lo&title=Synthesis+and+biological+evaluation+of+phthalocyanine-peptide+conjugate+for+EGFR-targeted+photodynamic+therapy+and+bioimaging&doi=10.1016%2Fj.dyepig.2018.11.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of phthalocyanine-peptide conjugate for EGFR-targeted photodynamic therapy and bioimaging</span></div><div class="casAuthors">Yu, Ligang; Wang, Qiong; Wong, Roy C.-H.; Zhao, Shirui; Ng, Dennis K. P.; Lo, Pui-Chi</div><div class="citationInfo"><span class="NLM_cas:title">Dyes and Pigments</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">197-203</span>CODEN:
                <span class="NLM_cas:coden">DYPIDX</span>;
        ISSN:<span class="NLM_cas:issn">0143-7208</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">To improve the biocompatibility and tumor selectivity, we employed an epidermal growth factor receptor (EGFR) binding peptide (namely GE11, with a sequence of Tyr-His-Trp-Tyr-Gly-Tyr-Thr-Pro-Gln-Asn-Val-Ile) as a tumor directing vector for the delivery of zinc(II) phthalocyanine for targeted photodynamic therapy and bioimaging.  The photophys. properties, cellular uptake, in vitro cytotoxicity, and in vivo biodistribution of this phthalocyanine-peptide conjugate (namely Pc-GE11) have been evaluated.  Pc-GE11 exhibited higher cellular uptake on EGFR-overexpressing epidermoid carcinoma A431 cells when compared with that on human breast adenocarcinoma MCF7 cells (low EGFR expression).  Moreover, pretreatment of A431 cells with GE11 peptide inhibited the cellular uptake of Pc-GE11 significantly and it exhibited exclusive light-activated cytotoxicity toward A431 cells.  Furthermore, Pc-GE11 showed much higher tumor accumulation than the non-targeted control compd. contg. a random peptide sequence (Tyr-Trp-Gly-Pro-Asn-Ile-His-Tyr-Tyr-Thr-Gln-Val) after i.v. administration in A431-tumor bearing mice, indicating the potential application of this GE11 peptide-conjugated photosensitizer for targeted photodynamic therapy and bioimaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2GVl6-CurgLVg90H21EOLACvtfcHk0lhcPTgVLARbnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVyhtrfL&md5=11b2967d14d3a24dccff91dcdb38481f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.dyepig.2018.11.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dyepig.2018.11.055%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWong%26aufirst%3DR.%2BC.-H.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DNg%26aufirst%3DD.%2BK.%2BP.%26aulast%3DLo%26aufirst%3DP.-C.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520phthalocyanine-peptide%2520conjugate%2520for%2520EGFR-targeted%2520photodynamic%2520therapy%2520and%2520bioimaging%26jtitle%3DDyes%2520Pigm.%26date%3D2019%26volume%3D163%26spage%3D197%26epage%3D203%26doi%3D10.1016%2Fj.dyepig.2018.11.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gentilucci, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Marco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerisoli, L.</span></span> <span> </span><span class="NLM_article-title">Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3185</span>– <span class="NLM_lpage">3203</span>, <span class="refDoi"> DOI: 10.2174/138161210793292555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.2174%2F138161210793292555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=20687878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKlurvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=3185-3203&author=L.+Gentilucciauthor=R.+De+Marcoauthor=L.+Cerisoli&title=Chemical+modifications+designed+to+improve+peptide+stability%3A+incorporation+of+non-natural+amino+acids%2C+pseudo-peptide+bonds%2C+and+cyclization&doi=10.2174%2F138161210793292555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization</span></div><div class="casAuthors">Gentilucci, Luca; De Marco, Rossella; Cerisoli, Lucia</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3185-3203</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Functions and properties of native peptides vary from highly specific antibiotics or cytotoxic antitumor drugs, to hormones, neurotransmitters, immunomodulators, etc.  Despite their potential utility as therapeutic agents, there are problems connected with the use of natural peptides, due to the low stability against proteolysis, resulting in a short duration of in vivo activity, and in a low bioavailability.  One way to overcome these disadvantages is the use of modified peptides, the so called peptidomimetics.  Overall, the less peptide character in a drug candidate, the more stable it is towards protease cleavage.  A huge no. of non-peptidic scaffolds have been reported in the literature; nevertheless, several cases have failed to reproduce the activity of the precursor peptide when the scaffold itself contains relevant pharmacophore elements.  Therefore, quasi-peptides still maintain their appeal for applications in medicinal chem.  For the large no. of different unnatural amino acids and peptidomimetics, the overview cannot be all-inclusive.  This review focuses on modified peptides in which the peptide character is still preponderant, with particular emphasis on the chem. methodologies utilized to introduce the modifications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKqrcss8C63rVg90H21EOLACvtfcHk0lhcPTgVLARbnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKlurvN&md5=415952939a1fad8af38d117812205853</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F138161210793292555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210793292555%26sid%3Dliteratum%253Aachs%26aulast%3DGentilucci%26aufirst%3DL.%26aulast%3DDe%2BMarco%26aufirst%3DR.%26aulast%3DCerisoli%26aufirst%3DL.%26atitle%3DChemical%2520modifications%2520designed%2520to%2520improve%2520peptide%2520stability%253A%2520incorporation%2520of%2520non-natural%2520amino%2520acids%252C%2520pseudo-peptide%2520bonds%252C%2520and%2520cyclization%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D3185%26epage%3D3203%26doi%3D10.2174%2F138161210793292555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiwari, R. K.</span></span> <span> </span><span class="NLM_article-title">Cyclic cell-penetrating peptides as efficient intracellular drug delivery tools</span>. <i>Mol. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3727</span>– <span class="NLM_lpage">3743</span>, <span class="refDoi"> DOI: 10.1021/acs.molpharmaceut.9b00633</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.molpharmaceut.9b00633" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVSqtrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=3727-3743&author=S.+E.+Parkauthor=M.+I.+Sajidauthor=K.+Parangauthor=R.+K.+Tiwari&title=Cyclic+cell-penetrating+peptides+as+efficient+intracellular+drug+delivery+tools&doi=10.1021%2Facs.molpharmaceut.9b00633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools</span></div><div class="casAuthors">Park, Shang Eun; Sajid, Muhammad Imran; Parang, Keykavous; Tiwari, Rakesh Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3727-3743</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic cell-penetrating peptides are relatively a newer class of peptides that have a huge potential for the intracellular delivery of therapeutic agents aimed at treating challenging ailments like multidrug resistance bacterial diseases, cancer, and HIV infection.  Although, cell-penetrating peptides (CPPs) have been extensively explored as intracellular delivery vehicles, however, they have some inherent limitations like poor stability, endosomal entrapment, toxicity, and suboptimal cell penetration.  Owing to their favorable properties that avoid these limitations, cyclic CPPs can provide a good alternative to linear CPPs.  Several reviews have been published in the last decade that cover CPPs and cyclic peptides independently.  To the best of our knowledge, this is one of the first reviews that covers cyclic CPPs comprehensively in the light of studies published so far.  In this review, we have detailed examples of cyclic CPPs, their structures, cyclization strategies followed by a detailed account of their advantages over their linear counterparts.  A hot area in cyclic CPPs is the exploration of cell penetration mechanisms; this review highlights this topic in detail.  Finally, we will review the applications of cyclic CPPs, followed by conclusions and future prospects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFdQDLeWoz2LVg90H21EOLACvtfcHk0lhcPTgVLARbnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVSqtrbE&md5=10c81e465de1faf0be041b93a7a73bab</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facs.molpharmaceut.9b00633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.molpharmaceut.9b00633%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BE.%26aulast%3DSajid%26aufirst%3DM.%2BI.%26aulast%3DParang%26aufirst%3DK.%26aulast%3DTiwari%26aufirst%3DR.%2BK.%26atitle%3DCyclic%2520cell-penetrating%2520peptides%2520as%2520efficient%2520intracellular%2520drug%2520delivery%2520tools%26jtitle%3DMol.%2520Pharm.%26date%3D2019%26volume%3D16%26spage%3D3727%26epage%3D3743%26doi%3D10.1021%2Facs.molpharmaceut.9b00633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roxin, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span> <span> </span><span class="NLM_article-title">Flexible or fixed: a comparative review of linear and cyclic cancer-targeting peptides</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1601</span>– <span class="NLM_lpage">1618</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.75</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.4155%2Ffmc.12.75" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=22917248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Gjtb3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=1601-1618&author=%C3%81.+Roxinauthor=G.+Zheng&title=Flexible+or+fixed%3A+a+comparative+review+of+linear+and+cyclic+cancer-targeting+peptides&doi=10.4155%2Ffmc.12.75"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Flexible or fixed: a comparative review of linear and cyclic cancer-targeting peptides</span></div><div class="casAuthors">Roxin, Aron; Zheng, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1601-1618</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Peptides can serve as versatile cancer-targeting ligands and have been used for clin. relevant applications such as cancer imaging and therapy.  A current and long-standing focus within peptide research is the creation of structurally constrained peptides generated through cyclization.  Cyclization is envisioned to enhance the selective binding, uptake, potency and stability of linear precursors.  This review compares closely related linear and cyclic peptides in these respects.  Peptide cyclization generally improves the selective binding and stability of linear precursors; however, not all cyclization strategies and constrained geometries enhance these properties to the same extent.  In some instances, linear analogs actually have better cancer-targeting properties compared with their cyclic counterparts.  Although cyclization does not necessarily improve the cancer-targeting properties of linear analogs, cyclic peptides may obtain properties that allow them to be used for addnl. applications.  This review aims to convey the advantages and limitations of cyclic cancer-targeting peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrViWuXjsVdQbVg90H21EOLACvtfcHk0lhcPTgVLARbnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Gjtb3M&md5=9b5af6d0c7dbbb926cb5a4f4d89dc06f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.75&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.75%26sid%3Dliteratum%253Aachs%26aulast%3DRoxin%26aufirst%3D%25C3%2581.%26aulast%3DZheng%26aufirst%3DG.%26atitle%3DFlexible%2520or%2520fixed%253A%2520a%2520comparative%2520review%2520of%2520linear%2520and%2520cyclic%2520cancer-targeting%2520peptides%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D1601%26epage%3D1618%26doi%3D10.4155%2Ffmc.12.75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zorzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deyle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinis, C.</span></span> <span> </span><span class="NLM_article-title">Cyclic peptide therapeutics: past, present and future</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">29</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2017.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.cbpa.2017.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=28249193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsFGksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=24-29&author=A.+Zorziauthor=K.+Deyleauthor=C.+Heinis&title=Cyclic+peptide+therapeutics%3A+past%2C+present+and+future&doi=10.1016%2Fj.cbpa.2017.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic peptide therapeutics: past, present and future</span></div><div class="casAuthors">Zorzi, Alessandro; Deyle, Kaycie; Heinis, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-29</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cyclic peptides combine several favorable properties such as good binding affinity, target selectivity and low toxicity that make them an attractive modality for the development of therapeutics.  Over 40 cyclic peptide drugs are currently in clin. use and around one new cyclic peptide drug enters the market every year on av.  The vast majority of clin. approved cyclic peptides are derived from natural products, such as antimicrobials or human peptide hormones.  New powerful techniques based on rational design and in vitro evolution have enabled the de novo development of cyclic peptide ligands to targets for which nature does not offer solns.  A look at the cyclic peptides currently under clin. evaluation shows that several have been developed using such techniques.  This new source for cyclic peptide ligands introduces a freshness to the field, and it is likely that de novo developed cyclic peptides will be in clin. use in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwchcMOj1bSbVg90H21EOLACvtfcHk0liCpZVd9V3nZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsFGksLg%253D&md5=4b9581365b92b649dad8c7b22c5bd9c3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2017.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2017.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DZorzi%26aufirst%3DA.%26aulast%3DDeyle%26aufirst%3DK.%26aulast%3DHeinis%26aufirst%3DC.%26atitle%3DCyclic%2520peptide%2520therapeutics%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D38%26spage%3D24%26epage%3D29%26doi%3D10.1016%2Fj.cbpa.2017.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span> <span> </span><span class="NLM_article-title">Radiolabeled multimeric cyclic RGD peptides as integrin α<sub>v</sub>β<sub>3</sub> targeted radiotracers for tumor imaging</span>. <i>Mol. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">472</span>– <span class="NLM_lpage">487</span>, <span class="refDoi"> DOI: 10.1021/mp060049x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp060049x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVKgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=472-487&author=S.+Liu&title=Radiolabeled+multimeric+cyclic+RGD+peptides+as+integrin+%CE%B1v%CE%B23+targeted+radiotracers+for+tumor+imaging&doi=10.1021%2Fmp060049x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabeled Multimeric Cyclic RGD Peptides as Integrin αvβ3 Targeted Radiotracers for Tumor Imaging</span></div><div class="casAuthors">Liu, Shuang</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">472-487</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Integrin αvβ3 plays a significant role in tumor angiogenesis and is a receptor for the extracellular matrix proteins with the exposed arginine-glycine-aspartic (RGD) tripeptide sequence.  These include vitronectin, fibronectin, fibrinogen, lamin, collagen, Von Willibrand's factor, osteoponin, and adenovirus particles.  Integrin αvβ3 is expressed at low levels on epithelial cells and mature endothelial cells, but it is overexpressed on the activated endothelial cells of tumor neovasculature and some tumor cells.  The highly restricted expression of integrin αvβ3 during tumor growth, invasion, and metastasis presents an interesting mol. target for both early detection and treatment of rapidly growing solid tumors.  In the past decade, many radiolabeled linear and cyclic RGD peptide antagonists have been evaluated as the integrin αvβ3 targeted radiotracers.  Significant progress has been made on their use for imaging tumors of different origin by single photon emission computed tomog. (SPECT) or positron emission tomog. (PET) in several tumor-bearing animal models.  [18F]Galacto-RGD is under clin. investigation as the first integrin αvβ3 targeted radiotracer for noninvasive visualization of the activated integrin αvβ3 in cancer patients.  This review will focus on the radiolabeled multimeric cyclic RGD peptides (dimers and tetramers) useful as radiotracers to image the tumor integrin αvβ3 expression by SPECT and PET, and some fundamental aspects for the development of integrin αvβ3 targeted radiotracers.  These include the choice of radionuclide and bifunctional chelators, selection of targeting biomols., and factors influencing the integrin αvβ3 binding affinity and tumor uptake, as well as different approaches for modification of radiotracer pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVh1R-qDKmQ7Vg90H21EOLACvtfcHk0liCpZVd9V3nZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVKgtr8%253D&md5=129f12ebcb72a9210f907715e5964657</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fmp060049x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp060049x%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DS.%26atitle%3DRadiolabeled%2520multimeric%2520cyclic%2520RGD%2520peptides%2520as%2520integrin%2520%25CE%25B1v%25CE%25B23%2520targeted%2520radiotracers%2520for%2520tumor%2520imaging%26jtitle%3DMol.%2520Pharm.%26date%3D2006%26volume%3D3%26spage%3D472%26epage%3D487%26doi%3D10.1021%2Fmp060049x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deyle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinis, C.</span></span> <span> </span><span class="NLM_article-title">Phage selection of cyclic peptides for application in research and drug development</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">1866</span>– <span class="NLM_lpage">1874</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.7b00184</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.7b00184" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFOqt7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2017&pages=1866-1874&author=K.+Deyleauthor=X.-D.+Kongauthor=C.+Heinis&title=Phage+selection+of+cyclic+peptides+for+application+in+research+and+drug+development&doi=10.1021%2Facs.accounts.7b00184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Phage Selection of Cyclic Peptides for Application in Research and Drug Development</span></div><div class="casAuthors">Deyle, Kaycie; Kong, Xu-Dong; Heinis, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1866-1874</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic peptides can bind to protein targets with high affinities and selectivities, which makes them an attractive modality for the development of research reagents and therapeutics.  Addnl. properties, including low inherent toxicity, efficient chem. synthesis, and facile modification with labels or immobilization reagents, increase their attractiveness.  Cyclic peptide ligands against a wide range of protein targets have been isolated from natural sources such as bacteria, fungi, plants, and animals.  Many of them are currently used as research tools, and several have found application as therapeutics, such as the peptide hormones oxytocin and vasopressin and the antibiotics vancomycin and daptomycin, proving the utility of cyclic peptides in research and medicine.With the advent of phage display and other in vitro evolution techniques, it has become possible to generate cyclic peptide binders to diverse protein targets for which no natural peptides have been discovered.  A highly robust and widely applied approach is based on the cyclization of peptides displayed on phage via a disulfide bridge.  Disulfide-cyclized peptide ligands to more than a hundred different proteins have been reported in the literature.  Technol. advances achieved over the last three decades, including methods for generating larger phage display libraries, improved phage panning protocols, new cyclic peptide formats, and high-throughput sequencing, have enabled the generation of cyclic peptides with ever better binding affinities to more challenging targets.A relatively new cyclic peptide format developed using phage display involves bicyclic peptides.  These mols. consist of two macrocyclic peptide rings cyclized through a chem. linker.  Compared to monocyclic peptides of comparable mol. mass, bicyclic peptides are more constrained in their conformation.  As a result, they can bind to their targets with a higher affinity and are more resistant to proteolytic degrdn.  Phage-encoded bicyclic peptides are generated by chem. cyclizing random peptide libraries on phage.  Binders are identified by conventional phage panning and DNA sequencing.  Next-generation sequencing and new sequence alignment tools have enabled the rapid identification of bicyclic peptides.Bicyclic peptide ligands were developed against a range of diverse target classes including enzymes, receptors, and cytokines.  Most ligands bind with nanomolar affinities, with some reaching the picomolar range.  To date, several bicyclic peptides have been pos. evaluated in preclin. studies, and the first clin. tests are in sight.  While bicyclic peptide phage display was developed with therapeutic applications in mind, these peptides are increasingly used as research tools for target evaluation or as basic research probes as well.  Given the efficient development method, the ease of synthesis and handling, and the favorable binding and biophys. properties, bicyclic peptides are being developed against more and more targets, ever increasing their potential applications in research and medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtQln3dL6wo7Vg90H21EOLACvtfcHk0liCpZVd9V3nZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOqt7zP&md5=416350a497d5f8811ac0a52cc441a03e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.7b00184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.7b00184%26sid%3Dliteratum%253Aachs%26aulast%3DDeyle%26aufirst%3DK.%26aulast%3DKong%26aufirst%3DX.-D.%26aulast%3DHeinis%26aufirst%3DC.%26atitle%3DPhage%2520selection%2520of%2520cyclic%2520peptides%2520for%2520application%2520in%2520research%2520and%2520drug%2520development%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2017%26volume%3D50%26spage%3D1866%26epage%3D1874%26doi%3D10.1021%2Facs.accounts.7b00184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span> <span> </span><span class="NLM_article-title">Understanding cell penetration of cyclic peptides</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">10241</span>– <span class="NLM_lpage">10287</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.9b00008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.9b00008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptlCksLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2019&pages=10241-10287&author=P.+G.+Doughertyauthor=A.+Sahniauthor=D.+Pei&title=Understanding+cell+penetration+of+cyclic+peptides&doi=10.1021%2Facs.chemrev.9b00008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding Cell Penetration of Cyclic Peptides</span></div><div class="casAuthors">Dougherty, Patrick G.; Sahni, Ashweta; Pei, Dehua</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">10241-10287</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Approx. 75% of all disease-relevant human proteins, including those involved in intracellular protein-protein interactions (PPIs), are undruggable with the current drug modalities (i.e., small mols. and biologics).  Macrocyclic peptides provide a potential soln. to these undruggable targets because their larger sizes (relative to conventional small mols.) endow them the capability of binding to flat PPI interfaces with antibody-like affinity and specificity.  Powerful combinatorial library technologies have been developed to routinely identify cyclic peptides as potent, specific inhibitors against proteins including PPI targets.  However, with the exception of a very small set of sequences, the vast majority of cyclic peptides are impermeable to the cell membrane, preventing their application against intracellular targets.  This Review examines common structural features that render most cyclic peptides membrane impermeable, as well as the unique features that allow the minority of sequences to enter the cell interior by passive diffusion, endocytosis/endosomal escape, or other mechanisms.  We also present the current state of knowledge about the mol. mechanisms of cell penetration, the various strategies for designing cell-permeable, biol. active cyclic peptides against intracellular targets, and the assay methods available to quantify their cell-permeability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0NDA9U7-1YrVg90H21EOLACvtfcHk0liAGmWWOCUAHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptlCksLs%253D&md5=65f68a9b69f3f7f33641b6a91835b1dd</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.9b00008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.9b00008%26sid%3Dliteratum%253Aachs%26aulast%3DDougherty%26aufirst%3DP.%2BG.%26aulast%3DSahni%26aufirst%3DA.%26aulast%3DPei%26aufirst%3DD.%26atitle%3DUnderstanding%2520cell%2520penetration%2520of%2520cyclic%2520peptides%26jtitle%3DChem.%2520Rev.%26date%3D2019%26volume%3D119%26spage%3D10241%26epage%3D10287%26doi%3D10.1021%2Facs.chemrev.9b00008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, S. J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qvit, N.</span></span> <span> </span><span class="NLM_article-title">Backbone-cyclized peptides: a critical review</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">555</span>, <span class="refDoi"> DOI: 10.2174/1568026618666180518092333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.2174%2F1568026618666180518092333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=29773062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlCqsbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=526-555&author=S.+J.+S.+Rubinauthor=N.+Qvit&title=Backbone-cyclized+peptides%3A+a+critical+review&doi=10.2174%2F1568026618666180518092333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Backbone-Cyclized Peptides: A Critical Review</span></div><div class="casAuthors">Rubin, Samuel J. S.; Qvit, Nir</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">526-555</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Backbone-cyclized peptides and peptidomimetics integrate the biol. activity and pharmacol. features necessary for successful research tools and therapeutics.  In general, these structures demonstrate improved maintenance of bioactive conformation, stability and cell permeability compared to their linear counterparts, while maintaining support for a variety of side chain chemistries.  We explain how backbone cyclization and cycloscan techniques allow scientists to cyclize linear peptides with retained or enhanced biol. activity and improved drug-like features.  We discuss head-to-tail (Cterminus to N-terminus), building unit-to-tail, building unit-to-side chain, building unit-to-building unit, and building unit-to-head backbone cyclization, with examples of building blocks, such as Nα-(ω- thioalkylene), Nα-(ω-aminoalkylene) and Nα-(ω-carboxyalkylene) units.  We also present several methods for recombinant expression of backbone-cyclized peptides, including backbone cyclic peptide synthesis using recombinant elements (bcPURE), phage display and induced peptidyl-tRNA drop-off.  Moreover, natural backbone-cyclized peptides are also produced by cyanobacteria, plants and other organisms; several of these compds. have been developed and commercialized for therapeutic applications, which we .</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppeP4DJ9pFV7Vg90H21EOLACvtfcHk0liAGmWWOCUAHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlCqsbrP&md5=5632ba35249befab43e0998afe51979a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.2174%2F1568026618666180518092333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026618666180518092333%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DS.%2BJ.%2BS.%26aulast%3DQvit%26aufirst%3DN.%26atitle%3DBackbone-cyclized%2520peptides%253A%2520a%2520critical%2520review%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2018%26volume%3D18%26spage%3D526%26epage%3D555%26doi%3D10.2174%2F1568026618666180518092333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tam, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. T. T.</span></span> <span> </span><span class="NLM_article-title">Chemical synthesis of circular proteins</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">27020</span>– <span class="NLM_lpage">27025</span>, <span class="refDoi"> DOI: 10.1074/jbc.r111.323568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1074%2Fjbc.R111.323568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=22700959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFaqtr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=27020-27025&author=J.+P.+Tamauthor=C.+T.+T.+Wong&title=Chemical+synthesis+of+circular+proteins&doi=10.1074%2Fjbc.r111.323568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Synthesis of Circular Proteins</span></div><div class="casAuthors">Tam, James P.; Wong, Clarence T. T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">27020-27025</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Circular proteins, once thought to be rare, are now commonly found in plants.  Their chem. synthesis, once thought to be difficult, is now readily achievable.  The enabling methodol. is largely due to the advances in entropic chem. ligation to overcome the entropy barrier in coupling the N- and C-terminal ends of large peptide segments for either intermol. ligation or intramol. ligation in end-to-end cyclization.  Key elements of an entropic chem. ligation consist of a chemoselective capture step merging the N and C termini as a covalently linked O/S-ester intermediate to permit the subsequent step of an intramol. O/S-N acyl shift to form an amide.  Many ligation methods exploit the supernucleophilicity of a thiol side chain at the N terminus for the capture reaction, which makes cysteine-rich peptides ideal candidates for the entropy-driven macrocyclization.  Advances in desulfurization and modification of the thiol-contg. amino acids at the ligation sites to other amino acids add extra dimensions to the entropy-driven ligation methods.  This minireview describes recent advances of entropy-driven ligation to prep. circular proteins with or without a cysteinyl side chain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF9-dNb_Q-abVg90H21EOLACvtfcHk0liAGmWWOCUAHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFaqtr3F&md5=0f3a72634d8e812369ffcadb12e5342f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R111.323568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R111.323568%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DJ.%2BP.%26aulast%3DWong%26aufirst%3DC.%2BT.%2BT.%26atitle%3DChemical%2520synthesis%2520of%2520circular%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D27020%26epage%3D27025%26doi%3D10.1074%2Fjbc.r111.323568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yudin, A. K.</span></span> <span> </span><span class="NLM_article-title">Contemporary strategies for peptide macrocyclization</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">509</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1038/nchem.1062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1038%2Fnchem.1062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=21697871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFWjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=509-524&author=C.+J.+Whiteauthor=A.+K.+Yudin&title=Contemporary+strategies+for+peptide+macrocyclization&doi=10.1038%2Fnchem.1062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Contemporary strategies for peptide macrocyclization</span></div><div class="casAuthors">White, Christopher J.; Yudin, Andrei K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">509-524</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Peptide macrocycles have found applications that range from drug discovery to nanomaterials.  These ring-shaped mols. have shown remarkable capacity for functional fine-tuning.  Such capacity is enabled by the possibility of adjusting the peptide conformation using the techniques of chem. synthesis.  Cyclic peptides have been difficult, and often impossible, to prep. using traditional synthetic methods.  For macrocyclization to occur, the activated peptide must adopt an entropically disfavored pre-cyclization conformation before forming the desired product.  Here, recent solns. to some of the major challenges in this important area of contemporary synthesis were reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUTda6OkfQprVg90H21EOLACvtfcHk0liAGmWWOCUAHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFWjtrc%253D&md5=32dfd94692ca20901dc8828bcd27ae8c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1062%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DC.%2BJ.%26aulast%3DYudin%26aufirst%3DA.%2BK.%26atitle%3DContemporary%2520strategies%2520for%2520peptide%2520macrocyclization%26jtitle%3DNat.%2520Chem.%26date%3D2011%26volume%3D3%26spage%3D509%26epage%3D524%26doi%3D10.1038%2Fnchem.1062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, G. K. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. T. T.</span></span> <span> </span><span class="NLM_article-title">Making circles: recent advance in chemical and enzymatic approaches in peptide macrocyclization</span>. <i>J. Biochem. Chem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.29199/bccs.101011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.29199%2Fbccs.101011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2017&pages=1-13&author=G.+K.+T.+Nguyenauthor=C.+T.+T.+Wong&title=Making+circles%3A+recent+advance+in+chemical+and+enzymatic+approaches+in+peptide+macrocyclization&doi=10.29199%2Fbccs.101011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.29199%2Fbccs.101011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.29199%252Fbccs.101011%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DG.%2BK.%2BT.%26aulast%3DWong%26aufirst%3DC.%2BT.%2BT.%26atitle%3DMaking%2520circles%253A%2520recent%2520advance%2520in%2520chemical%2520and%2520enzymatic%2520approaches%2520in%2520peptide%2520macrocyclization%26jtitle%3DJ.%2520Biochem.%2520Chem.%2520Sci.%26date%3D2017%26volume%3D1%26spage%3D1%26epage%3D13%26doi%3D10.29199%2Fbccs.101011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chow, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matheson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span> <span> </span><span class="NLM_article-title">Ligation technologies for the synthesis of cyclic peptides</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">9971</span>– <span class="NLM_lpage">10001</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrev.8b00657</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrev.8b00657" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlylsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2019&pages=9971-10001&author=H.+Y.+Chowauthor=Y.+Zhangauthor=E.+Mathesonauthor=X.+Li&title=Ligation+technologies+for+the+synthesis+of+cyclic+peptides&doi=10.1021%2Facs.chemrev.8b00657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Ligation technologies for the synthesis of cyclic peptides</span></div><div class="casAuthors">Chow, Hoi Yee; Zhang, Yue; Matheson, Eilidh; Li, Xuechen</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9971-10001</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Cyclic peptides have been attracting a lot of attention in recent decades, esp. in the area of drug discovery, as more and more naturally occurring cyclic peptides with diverse biol. activities have been discovered.  Chem. synthesis of cyclic peptides is essential when studying their structure-activity relationships.  Conventional peptide cyclization methods via direct coupling have inherent limitations, like the susceptibility to epimerization at the C-terminus, poor soly. of fully protected peptide precursors, and low yield caused by oligomerization.  In this regard, chemoselective ligation-mediated cyclization methods have emerged as effective strategies for cyclic peptide synthesis.  The toolbox for cyclic peptide synthesis has been expanded substantially in the past two decades, allowing more efficient synthesis of cyclic peptides with various scaffolds and modifications.  This review will explore different chemoselective ligation technologies used for cyclic peptide synthesis that generate both native and unnatural peptide linkages.  The practical issues and limitations of different methods will be discussed.  The advance in cyclic peptide synthesis will benefit the biol. and medicinal study of cyclic peptides, an important class of macrocycles with potentials in numerous fields, notably in therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGog_6f0UHYktLVg90H21EOLACvtfcHk0ljao3AwWfyUkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlylsLrE&md5=f7df3ecfe31680fa58f6c58f7cdd7265</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrev.8b00657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrev.8b00657%26sid%3Dliteratum%253Aachs%26aulast%3DChow%26aufirst%3DH.%2BY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMatheson%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DX.%26atitle%3DLigation%2520technologies%2520for%2520the%2520synthesis%2520of%2520cyclic%2520peptides%26jtitle%3DChem.%2520Rev.%26date%3D2019%26volume%3D119%26spage%3D9971%26epage%3D10001%26doi%3D10.1021%2Facs.chemrev.8b00657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kale, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villequey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, X.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deyle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinis, C.</span></span> <span> </span><span class="NLM_article-title">Cyclization of peptides with two chemical bridges affords large scaffold diversities</span>. <i>Nat. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">715</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1038/s41557-018-0042-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1038%2Fs41557-018-0042-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=29713035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVCkurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=715-723&author=S.+S.+Kaleauthor=C.+Villequeyauthor=X.-D.+Kongauthor=A.+Zorziauthor=K.+Deyleauthor=C.+Heinis&title=Cyclization+of+peptides+with+two+chemical+bridges+affords+large+scaffold+diversities&doi=10.1038%2Fs41557-018-0042-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclization of peptides with two chemical bridges affords large scaffold diversities</span></div><div class="casAuthors">Kale, Sangram S.; Villequey, Camille; Kong, Xu-Dong; Zorzi, Alessandro; Deyle, Kaycie; Heinis, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">715-723</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Successful screening campaigns depend on large and structurally diverse collections of compds.  In macrocycle screening, variation of the mol. scaffold is important for structural diversity, but so far it has been challenging to diversify this aspect in large combinatorial libraries.  Here, the authors report the cyclization of peptides with two chem. bridges to provide rapid access to thousands of different macrocyclic scaffolds in libraries that are easy to synthesize, screen and decode.  Application of this strategy to phage-encoded libraries allowed for the screening of an unprecedented structural diversity of macrocycles against plasma kallikrein, which is important in the swelling disorder hereditary angioedema.  These libraries yielded inhibitors with remarkable binding properties (subnanomolar Ki, >1000-fold selectivity) despite the small mol. mass (∼1200 Da).  An interlaced bridge format characteristic of this strategy provided high proteolytic stability (t1/2 in plasma of >3 days), making double-bridged peptides potentially amenable to topical or oral delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmZOAVFLZRH7Vg90H21EOLACvtfcHk0ljao3AwWfyUkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVCkurg%253D&md5=66161a855b4d8317fb456a36765d9766</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fs41557-018-0042-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41557-018-0042-7%26sid%3Dliteratum%253Aachs%26aulast%3DKale%26aufirst%3DS.%2BS.%26aulast%3DVillequey%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DX.-D.%26aulast%3DZorzi%26aufirst%3DA.%26aulast%3DDeyle%26aufirst%3DK.%26aulast%3DHeinis%26aufirst%3DC.%26atitle%3DCyclization%2520of%2520peptides%2520with%2520two%2520chemical%2520bridges%2520affords%2520large%2520scaffold%2520diversities%26jtitle%3DNat.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D715%26epage%3D723%26doi%3D10.1038%2Fs41557-018-0042-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chu, J. C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, P.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, D. K. P.</span></span> <span> </span><span class="NLM_article-title">One-pot synthesis of a cyclic antimicrobial peptide-conjugated phthalocyanine for synergistic chemo-photodynamic killing of multidrug-resistant bacteria</span>. <i>Adv. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">2000204</span>, <span class="refDoi"> DOI: 10.1002/adtp.202000204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1002%2Fadtp.202000204" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2021&pages=2000204&author=J.+C.+H.+Chuauthor=M.+L.+Chinauthor=C.+T.+T.+Wongauthor=M.+Huiauthor=P.-C.+Loauthor=D.+K.+P.+Ng&title=One-pot+synthesis+of+a+cyclic+antimicrobial+peptide-conjugated+phthalocyanine+for+synergistic+chemo-photodynamic+killing+of+multidrug-resistant+bacteria&doi=10.1002%2Fadtp.202000204"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fadtp.202000204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fadtp.202000204%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DJ.%2BC.%2BH.%26aulast%3DChin%26aufirst%3DM.%2BL.%26aulast%3DWong%26aufirst%3DC.%2BT.%2BT.%26aulast%3DHui%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DP.-C.%26aulast%3DNg%26aufirst%3DD.%2BK.%2BP.%26atitle%3DOne-pot%2520synthesis%2520of%2520a%2520cyclic%2520antimicrobial%2520peptide-conjugated%2520phthalocyanine%2520for%2520synergistic%2520chemo-photodynamic%2520killing%2520of%2520multidrug-resistant%2520bacteria%26jtitle%3DAdv.%2520Ther.%26date%3D2021%26volume%3D4%26spage%3D2000204%26doi%3D10.1002%2Fadtp.202000204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics, 2016</span>. <i>CA-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.3322/caac.21332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.3322%2Fcaac.21332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=26742998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A280%3ADC%252BC28rot1Kjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2016&pages=7-30&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2016&doi=10.3322%2Fcaac.21332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer statistics, 2016</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries.  Mortality data were collected by the National Center for Health Statistics.  In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are projected to occur in the United States.  Overall cancer incidence trends (13 oldest SEER registries) are stable in women, but declining by 3.1% per year in men (from 2009-2012), much of which is because of recent rapid declines in prostate cancer diagnoses.  The cancer death rate has dropped by 23% since 1991, translating to more than 1.7 million deaths averted through 2012.  Despite this progress, death rates are increasing for cancers of the liver, pancreas, and uterine corpus, and cancer is now the leading cause of death in 21 states, primarily due to exceptionally large reductions in death from heart disease.  Among children and adolescents (aged birth-19 years), brain cancer has surpassed leukemia as the leading cause of cancer death because of the dramatic therapeutic advances against leukemia.  Accelerating progress against cancer requires both increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKAn5ROFAaRS86Js-BCLiifW6udTcc2ealV70PAIfgZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rot1Kjug%253D%253D&md5=2d4030a531945c5ebaaab181bfd80457</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21332%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202016%26jtitle%3DCA-Cancer%2520J.%2520Clin.%26date%3D2016%26volume%3D66%26spage%3D7%26epage%3D30%26doi%3D10.3322%2Fcaac.21332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. A.</span></span> <span> </span><span class="NLM_article-title">Isolation of a colon tumor specific binding peptide using phage display selection</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">444</span>, <span class="refDoi"> DOI: 10.1016/s1476-5586(03)80046-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2FS1476-5586%2803%2980046-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=14670181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvVehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=437-444&author=K.+A.+Kellyauthor=D.+A.+Jones&title=Isolation+of+a+colon+tumor+specific+binding+peptide+using+phage+display+selection&doi=10.1016%2Fs1476-5586%2803%2980046-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a colon tumor specific binding peptide using phage display selection</span></div><div class="casAuthors">Kelly, Kimberly A.; Jones, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Neoplasia (Wilton, CT, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">437-444</span>CODEN:
                <span class="NLM_cas:coden">NEOPFL</span>;
        ISSN:<span class="NLM_cas:issn">1522-8002</span>.
    
            (<span class="NLM_cas:orgname">Neoplasia Press Inc.</span>)
        </div><div class="casAbstract">Colorectal cancer is the third most common malignancy in the United States.  Improved detection sensitivity of early colorectal neoplasms would have important clin. applications.  Herein, we report on using phage display to generate peptide libraries that detect colon carcinoma tissues.  To accomplish this, we employed pos. selection of a peptide-bearing phage library on poorly differentiated colon carcinoma cells (HT29) and combined this with neg. selection of the phage library on well-differentiated colon carcinoma cells (HCT116).  Anal. of the resulting library identified a nine-amino-acid, disulfide-constrained peptide, CPIEDRPMC (RPMrel), that stained HT29 colon carcinoma cells.  Immunohistochem. staining using FITC-conjugated RPMrel peptide also showed binding of RPMrel to colon tumor tissues from four patients.  We saw no binding of RPMrel to normal colon tissues.  In addn., RPMrel failed to stain a panel of noncolon tissues including the lungs, liver, and stomach.  We further demonstrated that RPMrel coupled to the mitochondrial toxin (KLAKLAK)2 killed HT29 cells.  These studies suggest that RPMrel may be a promising lead candidate in the development of a useful colon tumor diagnostic and targeted drug delivery agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTd-mnPukB17Vg90H21EOLACvtfcHk0li5yFv8krIdXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvVehtg%253D%253D&md5=3d5653fd836a1a254a37efc1d0763d1a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2FS1476-5586%2803%2980046-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1476-5586%252803%252980046-5%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DK.%2BA.%26aulast%3DJones%26aufirst%3DD.%2BA.%26atitle%3DIsolation%2520of%2520a%2520colon%2520tumor%2520specific%2520binding%2520peptide%2520using%2520phage%2520display%2520selection%26jtitle%3DNeoplasia%26date%3D2003%26volume%3D5%26spage%3D437%26epage%3D444%26doi%3D10.1016%2Fs1476-5586%2803%2980046-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W. K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, S. S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, C. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, C. H.</span></span> <span> </span><span class="NLM_article-title">A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">292</span>– <span class="NLM_lpage">302</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2010.09.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.jconrel.2010.09.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=20854857" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFSqtb7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2010&pages=292-302&author=Z.+J.+Liauthor=W.+K.+K.+Wuauthor=S.+S.+M.+Ngauthor=L.+Yuauthor=H.+T.+Liauthor=C.+C.+M.+Wongauthor=Y.+C.+Wuauthor=L.+Zhangauthor=S.+X.+Renauthor=X.+G.+Sunauthor=K.+M.+Chanauthor=C.+H.+Cho&title=A+novel+peptide+specifically+targeting+the+vasculature+of+orthotopic+colorectal+cancer+for+imaging+detection+and+drug+delivery&doi=10.1016%2Fj.jconrel.2010.09.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery</span></div><div class="casAuthors">Li, Zhi Jie; Wu, William Ka Kei; Ng, Simon Siu Man; Yu, Le; Li, Hai Tao; Wong, Clover Ching Man; Wu, Ya Chun; Zhang, Lin; Ren, Shun Xiang; Sun, Xue Gang; Chan, Kam Ming; Cho, Chi Hin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">292-302</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Colorectal cancer (CRC) is the third most common malignancy and the fourth most frequent cause of cancer deaths worldwide.  Ligand-mediated diagnosis and targeted therapy would have vital clin. applications in cancer treatment.  In this study, an orthotopic model of colorectal cancer was established in mice.  In vivo phage library selection was then utilized to isolate peptides specifically recognizing the vasculature of colorectal cancer tissues.  A phage (termed TCP-1 phage) was isolated by this manner and it homed to the colorectal cancer tissues by 11- to 94-fold more than other organs.  Chem. synthetic peptide (CTPSPFSHC, termed TCP-1) displayed by TCP-1 phage inhibited the homing ability of the phage to the tumor mass when co-injected i.v. with the TCP-1 phage into mice with colon cancer.  Meanwhile, immunostaining anal. indicated that TCP-1 phage and peptide localized in the vasculature of the colorectal cancer tissue, but not of normal tissues.  Moreover, TCP-1 peptide bound to blood vessels of surgical tissue samples of human colorectal cancer.  After i.v. injection of FITC-labeled TCP-1 into the tumor-bearing mice for 20 h, there was a strong fluorescent signal in the tumors but not other tissues when obsd. under blue light.  In addn., TCP-1 conjugated with a pro-apoptotic peptide specifically induced apoptosis of tumor-assocd. blood vessels in vivo.  The data define a novel peptide TCP-1 as an effective agent for imaging detection and drug delivery for colorectal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_WXoajF6pC7Vg90H21EOLACvtfcHk0lh_1UdLA8QfuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFSqtb7L&md5=650c2f678aaadb98fd098dd296ce58a8</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2010.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2010.09.015%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%2BJ.%26aulast%3DWu%26aufirst%3DW.%2BK.%2BK.%26aulast%3DNg%26aufirst%3DS.%2BS.%2BM.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DH.%2BT.%26aulast%3DWong%26aufirst%3DC.%2BC.%2BM.%26aulast%3DWu%26aufirst%3DY.%2BC.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DRen%26aufirst%3DS.%2BX.%26aulast%3DSun%26aufirst%3DX.%2BG.%26aulast%3DChan%26aufirst%3DK.%2BM.%26aulast%3DCho%26aufirst%3DC.%2BH.%26atitle%3DA%2520novel%2520peptide%2520specifically%2520targeting%2520the%2520vasculature%2520of%2520orthotopic%2520colorectal%2520cancer%2520for%2520imaging%2520detection%2520and%2520drug%2520delivery%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2010%26volume%3D148%26spage%3D292%26epage%3D302%26doi%3D10.1016%2Fj.jconrel.2010.09.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span> <span> </span><span class="NLM_article-title">Biological evaluation of a novel doxorubicin-peptide conjugate for targeted delivery to EGF receptor-overexpressing tumor cells</span>. <i>Mol. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1021/mp100243j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp100243j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=375-386&author=S.+Aiauthor=J.+Duanauthor=X.+Liuauthor=S.+Bockauthor=Y.+Tianauthor=Z.+Huang&title=Biological+evaluation+of+a+novel+doxorubicin-peptide+conjugate+for+targeted+delivery+to+EGF+receptor-overexpressing+tumor+cells&doi=10.1021%2Fmp100243j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Biological Evaluation of a Novel Doxorubicin-Peptide Conjugate for Targeted Delivery to EGF Receptor-Overexpressing Tumor Cells</span></div><div class="casAuthors">Ai, Shibin; Duan, Jianli; Liu, Xin; Bock, Stephanie; Tian, Yuan; Huang, Zebo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">375-386</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) is overexpressed in a variety of epithelial malignancies and thus can be used for EGFR-targeted therapy to improve antitumor efficacy.  Therefore we synthesized a novel conjugate of doxorubicin (DOX) with an EGFR-binding peptide (NH2-CMYIEALDKYAC-COOH; EBP) via an ester bond at position 14 of DOX through a glutarate spacer.  To confirm that the DOX-EBP conjugate is capable of targeting tumor cells overexpressing EGFR, we compared the cellular accumulation, intracellular distribution and in vitro cytotoxicity of DOX-EBP and free DOX.  After treating with equimolar concn. of DOX-EBP or free DOX, the conjugate accumulated at significantly higher levels in EGFR-overexpressing cells than in non-EGFR-overexpressing cells, while the intracellular accumulation of free DOX was almost the same in all the cells.  However, the intracellular accumulation of DOX-EBP was significantly reduced in EGFR-overexpressing cells preincubated with inhibitory anti-EGFR monoclonal antibody, demonstrating the involvement of EGFR pathway in the transport of the conjugate.  Confocal fluorescence microscopy reveals that the conjugate was distributed in cytoplasmic and perinuclear areas during the first 30 min, whereas the free DOX was accumulated in both cytoplasm and nuclei.  After 24 h, however, the DOX signal in the cells treated with DOX-EBP was also distributed in the nuclei, suggesting the release of DOX from the conjugate and entry into the nuclei.  Biodistribution and in vivo antitumor expts., together with in vitro cytotoxicity, indicate that the therapeutic competence of DOX-EBP was due to its increased accumulation in EGFR-expressing tumor cells.  Furthermore, the survival of tumor-bearing mice treated with DOX-EBP was significantly higher than that with free DOX.  These data demonstrate the enhanced anticancer efficacy and reduced systemic toxicity of DOX-EBP conjugate with targeting ability to EGFR-overexpressing tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVSrJQxo4pvbVg90H21EOLACvtfcHk0lh_1UdLA8QfuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSitLw%253D&md5=dced6f94494c99afd91e8e3e7481b21f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fmp100243j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp100243j%26sid%3Dliteratum%253Aachs%26aulast%3DAi%26aufirst%3DS.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBock%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DBiological%2520evaluation%2520of%2520a%2520novel%2520doxorubicin-peptide%2520conjugate%2520for%2520targeted%2520delivery%2520to%2520EGF%2520receptor-overexpressing%2520tumor%2520cells%26jtitle%3DMol.%2520Pharm.%26date%3D2011%26volume%3D8%26spage%3D375%26epage%3D386%26doi%3D10.1021%2Fmp100243j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">St.
Amant, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Florinas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fazenbaker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Alaniz, J. R.</span></span> <span> </span><span class="NLM_article-title">Tuning the Diels-Alder reaction for bioconjugation to maleimide drug-linkers</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2406</span>– <span class="NLM_lpage">2414</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.8b00320</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.8b00320" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFOqsr7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2018&pages=2406-2414&author=A.+H.+St.%0AAmantauthor=D.+Lemenauthor=S.+Florinasauthor=S.+Maoauthor=C.+Fazenbakerauthor=H.+Zhongauthor=H.+Wuauthor=C.+Gaoauthor=R.+J.+Christieauthor=J.+R.+de+Alaniz&title=Tuning+the+Diels-Alder+reaction+for+bioconjugation+to+maleimide+drug-linkers&doi=10.1021%2Facs.bioconjchem.8b00320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tuning the Diels-Alder Reaction for Bioconjugation to Maleimide Drug-Linkers</span></div><div class="casAuthors">St. Amant, Andre H.; Lemen, Daniel; Florinas, Stelios; Mao, Shenlan; Fazenbaker, Christine; Zhong, Haihong; Wu, Herren; Gao, Changshou; Christie, R. James; Read de Alaniz, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2406-2414</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The thiol-maleimide linkage is widely used for antibody-drug conjugate (ADC) prodn.; however, conjugation of maleimide-drugs could be improved by simplified procedures and reliable conjugate stability.  Here, we report the evaluation of electron-rich and cyclic dienes that can be appended to antibodies and reacted with maleimide-contg. drugs through the Diels-Alder (DA) reaction.  Drug conjugation is fast and quant. due to reaction acceleration in water, and the linkage is more stable in serum than in the corresponding thiol-maleimide adduct with the same drug.  ADCs produced using the DA reaction (DAADCs) are effective in vitro and in vivo, demonstrating the utility of this reaction in producing effective biotherapeutics.  Given the large no. of com. available maleimide compds., this conjugation approach could be readily applied to the prodn. of a wide range of antibody (or protein) conjugates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNcpT6Rr87XrVg90H21EOLACvtfcHk0lh_1UdLA8QfuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFOqsr7O&md5=6dcd7ac21f0c021215a18ea8429fe36b</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.8b00320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.8b00320%26sid%3Dliteratum%253Aachs%26aulast%3DSt.%2BAmant%26aufirst%3DA.%2BH.%26aulast%3DLemen%26aufirst%3DD.%26aulast%3DFlorinas%26aufirst%3DS.%26aulast%3DMao%26aufirst%3DS.%26aulast%3DFazenbaker%26aufirst%3DC.%26aulast%3DZhong%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DC.%26aulast%3DChristie%26aufirst%3DR.%2BJ.%26aulast%3Dde%2BAlaniz%26aufirst%3DJ.%2BR.%26atitle%3DTuning%2520the%2520Diels-Alder%2520reaction%2520for%2520bioconjugation%2520to%2520maleimide%2520drug-linkers%26jtitle%3DBioconjugate%2520Chem.%26date%3D2018%26volume%3D29%26spage%3D2406%26epage%3D2414%26doi%3D10.1021%2Facs.bioconjchem.8b00320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sauer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mielert, A.</span></span> <span> </span><span class="NLM_article-title">The order of reactivity of dienes towards maleic anhydride in the Diels-Alder reaction</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">1962</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.1002/anie.196202683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1002%2Fanie.196202683" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1962&pages=268-269&author=J.+Sauerauthor=D.+Langauthor=A.+Mielert&title=The+order+of+reactivity+of+dienes+towards+maleic+anhydride+in+the+Diels-Alder+reaction&doi=10.1002%2Fanie.196202683"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fanie.196202683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.196202683%26sid%3Dliteratum%253Aachs%26aulast%3DSauer%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DD.%26aulast%3DMielert%26aufirst%3DA.%26atitle%3DThe%2520order%2520of%2520reactivity%2520of%2520dienes%2520towards%2520maleic%2520anhydride%2520in%2520the%2520Diels-Alder%2520reaction%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1962%26volume%3D1%26spage%3D268%26epage%3D269%26doi%3D10.1002%2Fanie.196202683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, B.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raab, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhakta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenrick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons-Reponte, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tien, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tibbitts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baudys, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saad, O. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scales, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hass, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solis, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuji, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flagella, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spencer, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khawli, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebens, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandlen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sliwkowski, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheller, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polakis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junutula, J. R.</span></span> <span> </span><span class="NLM_article-title">Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1038/nbt.2108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1038%2Fnbt.2108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=22267010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2012&pages=184-189&author=B.-Q.+Shenauthor=K.+Xuauthor=L.+Liuauthor=H.+Raabauthor=S.+Bhaktaauthor=M.+Kenrickauthor=K.+L.+Parsons-Reponteauthor=J.+Tienauthor=S.-F.+Yuauthor=E.+Maiauthor=D.+Liauthor=J.+Tibbittsauthor=J.+Baudysauthor=O.+M.+Saadauthor=S.+J.+Scalesauthor=P.+J.+McDonaldauthor=P.+E.+Hassauthor=C.+Eigenbrotauthor=T.+Nguyenauthor=W.+A.+Solisauthor=R.+N.+Fujiauthor=K.+M.+Flagellaauthor=D.+Patelauthor=S.+D.+Spencerauthor=L.+A.+Khawliauthor=A.+Ebensauthor=W.+L.+Wongauthor=R.+Vandlenauthor=S.+Kaurauthor=M.+X.+Sliwkowskiauthor=R.+H.+Schellerauthor=P.+Polakisauthor=J.+R.+Junutula&title=Conjugation+site+modulates+the+in+vivo+stability+and+therapeutic+activity+of+antibody-drug+conjugates&doi=10.1038%2Fnbt.2108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates</span></div><div class="casAuthors">Shen, Ben-Quan; Xu, Keyang; Liu, Luna; Raab, Helga; Bhakta, Sunil; Kenrick, Margaret; Parsons-Reponte, Kathryn L.; Tien, Janet; Yu, Shang-Fan; Mai, Elaine; Li, Dongwei; Tibbitts, Jay; Baudys, Jakub; Saad, Ola M.; Scales, Suzie J.; McDonald, Paul J.; Hass, Philip E.; Eigenbrot, Charles; Nguyen, Trung; Solis, Willy A.; Fuji, Reina N.; Flagella, Kelly M.; Patel, Darshana; Spencer, Susan D.; Khawli, Leslie A.; Ebens, Allen; Wong, Wai Lee; Vandlen, Richard; Kaur, Surinder; Sliwkowski, Mark X.; Scheller, Richard H.; Polakis, Paul; Junutula, Jagath R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">184-189</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The reactive thiol in cysteine is used for coupling maleimide linkers in the generation of antibody conjugates.  To assess the impact of the conjugation site, we engineered cysteines into a therapeutic HER2/neu antibody at three sites differing in solvent accessibility and local charge.  The highly solvent-accessible site rapidly lost conjugated thiol-reactive linkers in plasma owing to maleimide exchange with reactive thiols in albumin, free cysteine or glutathione.  In contrast, a partially accessible site with a pos. charged environment promoted hydrolysis of the succinimide ring in the linker, thereby preventing this exchange reaction.  The site with partial solvent-accessibility and neutral charge displayed both properties.  In a mouse mammary tumor model, the stability and therapeutic activity of the antibody conjugate were affected pos. by succinimide ring hydrolysis and neg. by maleimide exchange with thiol-reactive constituents in plasma.  Thus, the chem. and structural dynamics of the conjugation site can influence antibody conjugate performance by modulating the stability of the antibody-linker interface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkINkMwQTMFrVg90H21EOLACvtfcHk0liOHZeWVXPRzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGqtLg%253D&md5=c647fc5bdfe93dfdabb15ca40934837f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fnbt.2108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.2108%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DB.-Q.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DRaab%26aufirst%3DH.%26aulast%3DBhakta%26aufirst%3DS.%26aulast%3DKenrick%26aufirst%3DM.%26aulast%3DParsons-Reponte%26aufirst%3DK.%2BL.%26aulast%3DTien%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DS.-F.%26aulast%3DMai%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DTibbitts%26aufirst%3DJ.%26aulast%3DBaudys%26aufirst%3DJ.%26aulast%3DSaad%26aufirst%3DO.%2BM.%26aulast%3DScales%26aufirst%3DS.%2BJ.%26aulast%3DMcDonald%26aufirst%3DP.%2BJ.%26aulast%3DHass%26aufirst%3DP.%2BE.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DSolis%26aufirst%3DW.%2BA.%26aulast%3DFuji%26aufirst%3DR.%2BN.%26aulast%3DFlagella%26aufirst%3DK.%2BM.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DSpencer%26aufirst%3DS.%2BD.%26aulast%3DKhawli%26aufirst%3DL.%2BA.%26aulast%3DEbens%26aufirst%3DA.%26aulast%3DWong%26aufirst%3DW.%2BL.%26aulast%3DVandlen%26aufirst%3DR.%26aulast%3DKaur%26aufirst%3DS.%26aulast%3DSliwkowski%26aufirst%3DM.%2BX.%26aulast%3DScheller%26aufirst%3DR.%2BH.%26aulast%3DPolakis%26aufirst%3DP.%26aulast%3DJunutula%26aufirst%3DJ.%2BR.%26atitle%3DConjugation%2520site%2520modulates%2520the%2520in%2520vivo%2520stability%2520and%2520therapeutic%2520activity%2520of%2520antibody-drug%2520conjugates%26jtitle%3DNat.%2520Biotechnol.%26date%3D2012%26volume%3D30%26spage%3D184%26epage%3D189%26doi%3D10.1038%2Fnbt.2108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Entradas, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldron, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volk, M.</span></span> <span> </span><span class="NLM_article-title">The detection sensitivity of commonly used singlet oxygen probes in aqueous environments</span>. <i>J. Photochem. Photobiol., B</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>204</i></span>,  <span class="NLM_fpage">111787</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2020.111787</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2Fj.jphotobiol.2020.111787" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=31958676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsFOjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2020&pages=111787&author=T.+Entradasauthor=S.+Waldronauthor=M.+Volk&title=The+detection+sensitivity+of+commonly+used+singlet+oxygen+probes+in+aqueous+environments&doi=10.1016%2Fj.jphotobiol.2020.111787"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The detection sensitivity of commonly used singlet oxygen probes in aqueous environments</span></div><div class="casAuthors">Entradas, Tiago; Waldron, Sarah; Volk, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111787</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The sensitivity for singlet oxygen (1O2) of two convenient 1O2 probes, 1,3-diphenylisobenzofuran (DPBF) and 9,10-Anthracenediyl-bis(methylene)dimalonic acid (ABDA), has been investigated in different aq. environments.  Both probes are com. available at reasonable cost and can be used with std. UV-vis spectrometers.  Although DPBF is not sol. in neat water and is not specific to the detection of 1O2, it has very high, essentially diffusion-limited, reactivity towards 1O2; it can trap up to 50% of all 1O2 created in alc./water or micellar soln., and even more when replacing H2O by D2O, which makes it highly useful when the process under investigation does not yield much 1O2.  On the other hand, ABDA has a much lower reactivity, reacting with only 2% of the singlet oxygen generated in H2O, as well as a smaller extinction coeff., resulting in a much smaller spectroscopic response, but is sol. in neat water and is specific for 1O2, allowing for discrimination from other reactive oxygen species.  The results presented here not only allow a comparative assessment of the usefulness of the two 1O2 probes, but also provide a ref. for an accurate abs. quantification of the amt. of 1O2 generated in an expt. from the obsd. absorbance bleach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrIjDnr9MT9BrVg90H21EOLACvtfcHk0liOHZeWVXPRzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsFOjt7Y%253D&md5=0a5e1df32543ac54e2af2287206f7bab</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2020.111787&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2020.111787%26sid%3Dliteratum%253Aachs%26aulast%3DEntradas%26aufirst%3DT.%26aulast%3DWaldron%26aufirst%3DS.%26aulast%3DVolk%26aufirst%3DM.%26atitle%3DThe%2520detection%2520sensitivity%2520of%2520commonly%2520used%2520singlet%2520oxygen%2520probes%2520in%2520aqueous%2520environments%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%252C%2520B%26date%3D2020%26volume%3D204%26spage%3D111787%26doi%3D10.1016%2Fj.jphotobiol.2020.111787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, W.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, D. K. P.</span></span> <span> </span><span class="NLM_article-title">Highly photocytotoxic 1,4-dipegylated zinc(II) phthalocyanines. Effects of the chain length on the in vitro photodynamic activities</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">4560</span>– <span class="NLM_lpage">4566</span>, <span class="refDoi"> DOI: 10.1039/b814627f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1039%2Fb814627f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=19039364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVChtb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=4560-4566&author=J.-Y.+Liuauthor=X.-J.+Jiangauthor=W.-P.+Fongauthor=D.+K.+P.+Ng&title=Highly+photocytotoxic+1%2C4-dipegylated+zinc%28II%29+phthalocyanines.+Effects+of+the+chain+length+on+the+in+vitro+photodynamic+activities&doi=10.1039%2Fb814627f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Highly photocytotoxic 1,4-dipegylated zinc(ii) phthalocyanines. Effects of the chain length on the in vitro photodynamic activities</span></div><div class="casAuthors">Liu, Jian-Yong; Jiang, Xiong-Jie; Fong, Wing-Ping; Ng, Dennis K. P.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4560-4566</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A new series of 1,4-dipegylated zinc(ii) phthalocyanines have been synthesized and spectroscopically characterised.  The derivs. ZnPc[O(CH2CH2O)nMe]2 (n = 2, 4, ca. 12) have been prepd. by mixed cyclisation of the corresponding disubstituted phthalonitriles with an excess of unsubstituted phthalonitrile in the presence of Zn(OAc)2·2H2O and 1,8-diazabicyclo[5.4.0]undec-7-ene.  The other two analogs ZnPc[O(CH2CH2O)nMe]2 (n = 6, 8) have been prepd. by chain elongation reaction of ZnPc[O(CH2CH2O)4H]2.  These macrocycles are highly sol. and remain non-aggregated in DMF as shown by the sharp Q-band absorption.  Compared with the unsubstituted zinc(ii) phthalocyanine, these di-α-substituted analogs have a red-shifted Q band (at 689 vs. 670 nm) and exhibit a relatively weaker fluorescence emission and a higher efficiency at generating singlet oxygen.  Upon illumination, these compds. are highly cytotoxic toward HT29 human colorectal carcinoma and HepG2 human hepatocarcinoma cells.  The compds. with medium-length substituents are particularly potent, having IC50 values as low as 0.02 μM.  The high photodynamic activity of these compds. can be attributed to their high cellular uptake and low aggregation tendency in the biol. media, which promote the generation of reactive oxygen species inside the cells.  The effects of the chain length on the aggregation behavior, photophys. properties, cellular uptake and in vitro photodynamic activities of this series of compds. have also been examd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1prlVcKgYRrVg90H21EOLACvtfcHk0liOHZeWVXPRzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVChtb%252FE&md5=013f54d31c4495f606a1d1379f0439cc</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1039%2Fb814627f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb814627f%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.-Y.%26aulast%3DJiang%26aufirst%3DX.-J.%26aulast%3DFong%26aufirst%3DW.-P.%26aulast%3DNg%26aufirst%3DD.%2BK.%2BP.%26atitle%3DHighly%2520photocytotoxic%25201%252C4-dipegylated%2520zinc%2528II%2529%2520phthalocyanines.%2520Effects%2520of%2520the%2520chain%2520length%2520on%2520the%2520in%2520vitro%2520photodynamic%2520activities%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2008%26volume%3D6%26spage%3D4560%26epage%3D4566%26doi%3D10.1039%2Fb814627f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsuo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishizuka, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, G.</span></span> <span> </span><span class="NLM_article-title">Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models</span>. <i>BMC Res. Notes</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">140</span>, <span class="refDoi"> DOI: 10.1186/1756-0500-4-140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1186%2F1756-0500-4-140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=21554739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsV2gs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=140&author=T.+Matsuoauthor=S.+S.+Nishizukaauthor=K.+Ishidaauthor=T.+Iwayaauthor=M.+Ikedaauthor=G.+Wakabayashi&title=Analysis+of+the+anti-tumor+effect+of+cetuximab+using+protein+kinetics+and+mouse+xenograft+models&doi=10.1186%2F1756-0500-4-140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of the anti-tumor effect of cetuximab using protein kinetics and mouse xenograft models</span></div><div class="casAuthors">Matsuo, Teppei; Nishizuka, Satoshi S.; Ishida, Kazushige; Iwaya, Takeshi; Ikeda, Miyuki; Wakabayashi, Go</div><div class="citationInfo"><span class="NLM_cas:title">BMC Research Notes</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">140</span>CODEN:
                <span class="NLM_cas:coden">BRNMAT</span>;
        ISSN:<span class="NLM_cas:issn">1756-0500</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The binding of EGFR and its ligands leads to autophosphorylation of receptor tyrosine kinase as well as subsequent activation of signal transduction pathways that are involved in regulating cellular proliferation, differentiation, and survival.  An EGFR inhibitor, cetuximab, binds to EGFR and consequently blocks a variety of cellular processes.  KRAS/BRAF mutations are known to be assocd. with a low response rate to cetuximab.  In the present study, to clarify the anti-tumor mechanisms of cetuximab, we evaluated the KRAS/BRAF status, phosphorylation level of the EGFR pathway, and the tumor suppression effect in vivo, using a human colon cancer cell line HT29, which exhibited the highest EGFR expression in response to the cetuximab therapy among the 6 colorectal cancer cell lines tested.  Findings: The conventional growth suppression assay did not work efficiently with cetuximab EGF, TGF-α, and IGF activated the EGFR/MAPK cell signaling pathway by initiating the phosphorylation of EGFR.  Cetuximab partially inhibited the EGFR/MAPK pathway induced by EGF, TGF-α, and IGF.  However, cetuximab exposure induced the EGFR, MEK, and ERK1/2 phosphorylation by itself.  Mouse xenograft tumor growth was significantly inhibited by cetuximab and both cetuximab-treated and -untreated xenograft specimens exhibited phosphorylations of the EGFR pathway proteins.  Conclusions: We have confirmed that cetuximab inhibited the EGFR/MAPK pathway and reduced tumor growth in the xenografts while the remaining tumor showed EGFR pathway activation.  These results suggest that: (i) The effect of cetuximab in growth signaling is not sufficient to induce complete growth suppression in vitro; (ii) time-course monitoring may be necessary to evaluate the effect of cetuximab because EGFR signaling is transmitted in a minute order; and (iii) cetuximab treatment may have cells acquired resistant selectively survived in the heterogeneous cancer population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo16h67f82FkLVg90H21EOLACvtfcHk0lhHkJYJH1peFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsV2gs7c%253D&md5=83957fe9f4e1e9d7a7ee222b6938043e</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1186%2F1756-0500-4-140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-0500-4-140%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuo%26aufirst%3DT.%26aulast%3DNishizuka%26aufirst%3DS.%2BS.%26aulast%3DIshida%26aufirst%3DK.%26aulast%3DIwaya%26aufirst%3DT.%26aulast%3DIkeda%26aufirst%3DM.%26aulast%3DWakabayashi%26aufirst%3DG.%26atitle%3DAnalysis%2520of%2520the%2520anti-tumor%2520effect%2520of%2520cetuximab%2520using%2520protein%2520kinetics%2520and%2520mouse%2520xenograft%2520models%26jtitle%3DBMC%2520Res.%2520Notes%26date%3D2011%26volume%3D4%26spage%3D140%26doi%3D10.1186%2F1756-0500-4-140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.-M.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation of PCNA by EGFR inhibits mismatch repair and promotes misincorporation during DNA synthesis</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">5667</span>– <span class="NLM_lpage">5672</span>, <span class="refDoi"> DOI: 10.1073/pnas.1417711112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1073%2Fpnas.1417711112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=25825764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVOnsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2015&pages=5667-5672&author=J.+Ortegaauthor=J.+Y.+Liauthor=S.+Leeauthor=D.+Tongauthor=L.+Guauthor=G.-M.+Li&title=Phosphorylation+of+PCNA+by+EGFR+inhibits+mismatch+repair+and+promotes+misincorporation+during+DNA+synthesis&doi=10.1073%2Fpnas.1417711112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of PCNA by EGFR inhibits mismatch repair and promotes misincorporation during DNA synthesis</span></div><div class="casAuthors">Ortega, Janice; Li, Jessie Y.; Lee, Sanghee; Tong, Dan; Gu, Liya; Li, Guo-Min</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5667-5672</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Proliferating cell nuclear antigen (PCNA) plays essential roles in eukaryotic cells during DNA replication, DNA mismatch repair (MMR), and other events at the replication fork.  Earlier studies show that PCNA is regulated by post-translational modifications, including phosphorylation of Tyr-211 (Y211) by epidermal growth factor receptor (EGFR) kinase (EGFRK).  However, the functional significance of Y211-phosphorylated PCNA remains unknown.  Here, the authors show that PCNA phosphorylation by EGFRK alters its interaction with mismatch-recognition proteins MutSα and MutSβ and interferes with PCNA-dependent activation of MutLα endonuclease, thereby inhibiting MMR at the initiation step.  Evidence is also provided that Y211-phosphorylated PCNA induces nucleotide misincorporation during DNA synthesis.  Thus, these findings reveal a novel mechanism by which Y211-phosphorylated PCNA promotes cancer development and progression via facilitating error-prone DNA replication and suppressing the MMR function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_i7H-3LEUm7Vg90H21EOLACvtfcHk0lhHkJYJH1peFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVOnsL4%253D&md5=d2c8d751e3603118a46eddfbfef177f5</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1417711112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1417711112%26sid%3Dliteratum%253Aachs%26aulast%3DOrtega%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%2BY.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DTong%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DG.-M.%26atitle%3DPhosphorylation%2520of%2520PCNA%2520by%2520EGFR%2520inhibits%2520mismatch%2520repair%2520and%2520promotes%2520misincorporation%2520during%2520DNA%2520synthesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2015%26volume%3D112%26spage%3D5667%26epage%3D5672%26doi%3D10.1073%2Fpnas.1417711112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, T.</span></span> <span> </span><span class="NLM_article-title">The functions and applications of RGD in tumor therapy and tissue engineering</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">13447</span>– <span class="NLM_lpage">13462</span>, <span class="refDoi"> DOI: 10.3390/ijms140713447</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.3390%2Fijms140713447" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=23807504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1GlurvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=13447-13462&author=F.+Wangauthor=Y.+Liauthor=Y.+Shenauthor=A.+Wangauthor=S.+Wangauthor=T.+Xie&title=The+functions+and+applications+of+RGD+in+tumor+therapy+and+tissue+engineering&doi=10.3390%2Fijms140713447"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The functions and applications of RGD in tumor therapy and tissue engineering</span></div><div class="casAuthors">Wang, Fen; Li, Yuanyuan; Shen, Yingqiang; Wang, Anming; Wang, Shuling; Xie, Tian</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">13447-13462, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Arginine-Glycine-Aspartic (RGD), is the specific recognition site of integrins with theirs ligands and regulates cell-cell and cell-extracellular matrix interactions.  The RGD motif can be combined with integrins overexpressed on the tumor neovasculature and tumor cells with a certain affinity, becoming the new target for imaging agents and drugs and gene delivery for tumor treatment.  Further, RGD as a biomimetic peptide can also promote cell adherence to the matrix, prevent cell apoptosis and accelerate new tissue regeneration.  Functionalizing material surfaces with RGD can improve cell/biomaterial interactions, which facilitates the generation of tissue-engineered constructs.  This paper reviews the main functions and advantages of RGD, describes the applications of RGD in imaging agents, drugs, gene delivery for tumor therapy and highlights the role of RGD in promoting the development of tissue engineering (bone regeneration, cornea repair, artificial neovascularization) in recent years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp_ftvayY6XLVg90H21EOLACvtfcHk0lhHkJYJH1peFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1GlurvL&md5=fc7f335ac589ff88e25e21f5ae4e4458</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3390%2Fijms140713447&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms140713447%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DT.%26atitle%3DThe%2520functions%2520and%2520applications%2520of%2520RGD%2520in%2520tumor%2520therapy%2520and%2520tissue%2520engineering%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26spage%3D13447%26epage%3D13462%26doi%3D10.3390%2Fijms140713447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, D. F.</span></span> <span> </span><span class="NLM_article-title">Reference materials for fluorescence measurement</span>. <i>Pure Appl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1107</span>– <span class="NLM_lpage">1114</span>, <span class="refDoi"> DOI: 10.1351/pac198860071107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1351%2Fpac198860071107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADyaL1cXlsFyrtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1988&pages=1107-1114&author=D.+F.+Eaton&title=Reference+materials+for+fluorescence+measurement&doi=10.1351%2Fpac198860071107"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Reference materials for fluorescence measurement</span></div><div class="casAuthors">Eaton, David F.</div><div class="citationInfo"><span class="NLM_cas:title">Pure and Applied Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1107-14</span>CODEN:
                <span class="NLM_cas:coden">PACHAS</span>;
        ISSN:<span class="NLM_cas:issn">0033-4545</span>.
    </div><div class="casAbstract">A review with 19 refs. is given on std. practices and materials for fluorescence measurements and the avoidance of exptl. inadequacies attendant on their application in practical use.  Appropriate methods are discussed which strike a balance between ease of application, generality of use, and reliability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDXpSTvcElrLVg90H21EOLACvtfcHk0ljcSr9cti0Fdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXlsFyrtL0%253D&md5=51ba5738e8da49584e6393251022a47f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1351%2Fpac198860071107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252Fpac198860071107%26sid%3Dliteratum%253Aachs%26aulast%3DEaton%26aufirst%3DD.%2BF.%26atitle%3DReference%2520materials%2520for%2520fluorescence%2520measurement%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D1988%26volume%3D60%26spage%3D1107%26epage%3D1114%26doi%3D10.1351%2Fpac198860071107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maree, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nyokong, T.</span></span> <span> </span><span class="NLM_article-title">Syntheses and photochemical properties of octasubstituted phthalocyaninato zinc complexes</span>. <i>J. Porphyrins Phthalocyanines</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">782</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1002/jpp.388</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1002%2Fjpp.388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotVSlsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2001&pages=782-792&author=S.+E.+Mareeauthor=T.+Nyokong&title=Syntheses+and+photochemical+properties+of+octasubstituted+phthalocyaninato+zinc+complexes&doi=10.1002%2Fjpp.388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses and photochemical properties of octasubstituted phthalocyaninato zinc complexes</span></div><div class="casAuthors">Maree, Suzanne E.; Nyokong, Tebello</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Porphyrins and Phthalocyanines</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">782-792</span>CODEN:
                <span class="NLM_cas:coden">JPPHFZ</span>;
        ISSN:<span class="NLM_cas:issn">1088-4246</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A selection of octasubstituted phthalocyaninato Zn complexes were synthesized and their photochem. studied.  The substituents included cholesterol, estrone, naphthol and phenoxy groups substituted with CH3, di-CMe3, CMe3, NO2, NH2, CHO, COOH and H.  In general, complexes contg. electron-donating groups (di-CMe3 and CMe3) attached to the phenoxy ring are photochem. unstable with photobleaching quantum yields of the order of 10-3.  In the presence of electron-withdrawing groups (NO2, CHO, and CO2H) the photobleaching quantum yields were of the order of 10-6 to 10-5.  Singlet O quantum yields (ΦΔ) ranged from 0.01 to 0.73.  The lowest ΦΔ was obsd. for the highly aggregated complex with naphthol.  All the complexes showed aggregation at high concns.  Electrochem. redn. using a thin-layer spectroelectrochem. cell showed that the complexes become more monomeric following redn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO-LcmDUP2xbVg90H21EOLACvtfcHk0ljcSr9cti0Fdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotVSlsL0%253D&md5=c4e9ed5d01b0e94e6a5e169a8e81a703</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fjpp.388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjpp.388%26sid%3Dliteratum%253Aachs%26aulast%3DMaree%26aufirst%3DS.%2BE.%26aulast%3DNyokong%26aufirst%3DT.%26atitle%3DSyntheses%2520and%2520photochemical%2520properties%2520of%2520octasubstituted%2520phthalocyaninato%2520zinc%2520complexes%26jtitle%3DJ.%2520Porphyrins%2520Phthalocyanines%26date%3D2001%26volume%3D5%26spage%3D782%26epage%3D792%26doi%3D10.1002%2Fjpp.388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiho, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroshima, K.-i.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, K.</span></span> <span> </span><span class="NLM_article-title">An improved colorimetric assay for interleukin 2</span>. <i>J. Immunol. Methods</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1016/0022-1759(86)90183-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=10.1016%2F0022-1759%2886%2990183-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=3490518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;key=1%3ACAS%3A528%3ADyaL2sXjtFSjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1986&pages=157-165&author=H.+Tadaauthor=O.+Shihoauthor=K.-i.+Kuroshimaauthor=M.+Koyamaauthor=K.+Tsukamoto&title=An+improved+colorimetric+assay+for+interleukin+2&doi=10.1016%2F0022-1759%2886%2990183-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">An improved colorimetric assay for interleukin 2</span></div><div class="casAuthors">Tada, Hiroko; Shiho, Osamu; Kuroshima, Kenichi; Koyama, Masaru; Tsukamoto, Kyozo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-65</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">Mosmann's method for measuring the no. of viable cells with a tetrazolium salt, 3-(4,5-dimethyl-thiazol-2-yl)-2,5-di-phenyltetrazolium bromide (MTT), was modified to make it possible to measure a large no. of interleukin 2 (IL-2) samples at one time with less labor and more accuracy.  Each step of the method was examd. in detail and modified (the modified MTT method).  An IL-2-dependent mouse natural killer cell line, NKC3, was used as an indicator cell line.  The incubation period before adding MTT was reduced to 24 h.  A soln. of 10% SDS-0.01 N HCl was used to dissolve the MTT formazan produced.  The authors compared the value obtained by the modified MTT method and the conventional [3H]thymidine method, and confirmed that the ests. of IL-2 content were almost equal.  The variation of IL-2 content measured by both methods was within 5% in terms of the std. error.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz6JaDrAXBbrVg90H21EOLACvtfcHk0ljcSr9cti0Fdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXjtFSjtw%253D%253D&md5=0208ea4486aca20fcc30ed18d065dd2d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2886%2990183-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252886%252990183-3%26sid%3Dliteratum%253Aachs%26aulast%3DTada%26aufirst%3DH.%26aulast%3DShiho%26aufirst%3DO.%26aulast%3DKuroshima%26aufirst%3DK.-i.%26aulast%3DKoyama%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DK.%26atitle%3DAn%2520improved%2520colorimetric%2520assay%2520for%2520interleukin%25202%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1986%26volume%3D93%26spage%3D157%26epage%3D165%26doi%3D10.1016%2F0022-1759%2886%2990183-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i35"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01677">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_17654"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01677?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01677</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">HPLC chromatograms, MALDI-TOF mass spectra, additional spectra, and in vitro results (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_001.pdf">jm0c01677_si_001.pdf (1.42 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01677/suppl_file/jm0c01677_si_002.csv">jm0c01677_si_002.csv (1.96 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01677&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-4%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01677" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01677" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a56c3fcd03d66","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
